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Abstract

This study explored and described the experience of people with a diagnosis of
cancer, as they transitioned from life as a chemotherapy patient to life after treatment as
a cancer survivor. The purpose of this study was to ultimately improve the care of
people as they transitioned into life after completion of chemotherapy treatment. There
is minimal information related to this phase of the cancer trajectory, therefore this study
was intentionally exploratory and descriptive.
To achieve the proposed outcome a two-phased approach was undertaken. In
Phase One a qualitative approach was followed using Grounded Theory to the
descriptive level of data analysis. The study was undertaken in a large tertiary hospital
in Western Australia. The sample comprised of 14 cancer survivors who had completed
chemotherapy treatment in the previous four to twelve weeks. Data was collected via
semi structured telephone interviews. Descriptors of issues and experiences that arose in
the first six months following completion of chemotherapy were elicited. Data was
subsequently transcribed, coded and organised into themes of congruent relevance.
Cancer survivors were found to transition through two stages in the early weeks
following completion of chemotherapy. When physical symptoms and emotional losses
were all encompassing, the survivors displayed vulnerability due to the loss of the
treatment environment and a range of challenging emotions. As the weeks passed and
physical symptoms began to abate, the survivors began to display characteristics of
resilience, self empowerment and information seeking strategies which both informed
and protected the survivor. The domains that challenged the survivor throughout this
transition period encompassed physical, social, psychological and spiritual issues.
In Phase Two of the study, key findings from Phase One were utilised to inform
the adaptation of an existing quality of life tool, Quality of life – Cancer Survivor,
which was identified following an extensive literature review. The adapted tool, Quality
of Life – Chemotherapy Cancer Survivor, was assessed for clarity, content validity and
apparent internal consistency by an expert panel of six oncology nurses who were
employed within the same tertiary hospital setting. Feedback from this process was used
to further amend the original tool. The researcher intends to pilot test the revised tool
with cancer survivors in preparation for a larger scale population based study following
this Masters study.
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This study has provided an insight into the survivorship issues as people
transition to life after chemotherapy and findings begin to fill a gap in understanding
which has not previously be addressed in the available literature. Implications for future
research and clinical practice including, gaps in survivor’s knowledge and transition
process issues, are provided.
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Chapter One
Introduction

Cancer and survivorship were once considered contradictory terms. Advances in
screening, diagnosing and treating cancers over the past 20 years have resulted in
improved cancer survival rates. It has been estimated that more than 60% of all people
diagnosed with cancer are alive five years after their initial diagnosis (Jefford et al.,
2008). With a rising incidence in cancer diagnosis due to an ageing population and a
rising survival rate from the initial cancer diagnosis, there is increasing cancer
prevalence within the Australian community. Australian survival rates for cancer are
high by world standards, in 2004 survivors of cancer represented 3.2% of the population
(Australian Institute of Health and Welfare [AIHW], 2008).
The incidence of cancer continues to increase globally, and the prevalence of
cancer in developed countries is increasing dramatically. Prevalence of cancer refers to
the number of people who have previously received a cancer diagnosis and who are still
alive at a given point in time, whereas incidence is the number of new cancers
diagnosed in a specified period of time. Prevalence figures are therefore affected by
both the incidence and survival. In Australia in 2010, cancer accounted for 19% of the
total burden of disease (AIHW, 2010). Survival rates following a cancer diagnosis have
improved to such an extent that cancer is now considered one of the top six chronic
conditions in Australia (Australian Bureau of Statistics, 2011). Chronic diseases are
illnesses that are prolonged in duration, do not often resolve spontaneously and are
rarely cured completely (AIHW, 2002). This is a dramatic turn around for a condition
that was once considered rapidly fatal; cancer remains one of the most feared illnesses
within the general population despite increasingly successful outcomes, this fear sets it
apart from other chronic conditions (Rassmussen & Elverdam, 2007; Tritter & Calnan,
2002).
The significant change in the cancer care trajectory has led to a new phase in the
cancer care continuum widely known as “cancer survivorship”. The most commonly
accepted definition is the one advocated by the National Coalition of Cancer
Survivorship which is “the experience of living with, through and beyond a diagnosis of
cancer” (Hewitt, Greenfield, & Stovall, 2006, p. 27). The continuum of cancer was once
mostly linear beginning with diagnosis, moving on to treatment and then a limited
remission, followed by recurrence and death within a short time frame or for the few
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fortunate individuals the pathway became follow up monitoring and a confirmation of
cure at the five year post diagnosis mark.
The current continuum of cancer is much more cyclical once the primary
treatment is complete, for those who are considered cured there is now a long pathway
of monitoring and managing long term side effects of treatment. There are now several
episodes of recurrence of cancer for the individual which is managed by subsequent
treatment and ongoing monitoring before eventual death. The timeline in this cycle may
amount to many years.

Background
A diagnosis of cancer is one of the most feared health conditions within Western
societies; the diagnosis brings with it stress, physical and psychological consequences,
the stigma of cancer and segregation from significant others and the general population
(Skillbeck & Payne, 2003; Stringer, 2008; Towers, 2007). Whilst coming to terms with
the diagnosis, the person diagnosed with cancer also faces a multitude of decisions and
challenges across a spectrum of physical, psychological and social domains. The
challenges whilst undergoing acute cancer treatment are well researched and
documented with the focus of effort concentrating on completing treatment and aiming
for cure.
Despite ongoing fear and misunderstanding of cancer as a disease with a fatal
outcome, substantial investments in cancer research have resulted in better outcomes for
individuals diagnosed with cancer, with significant success in terms of improved
survival rates (Hewitt, et al., 2006). There are a number of factors attributed to the trend
of increased relative survival from cancer across the continuum of care. First the
increased education of the population as a whole about the signs and symptoms of
cancer; second the benefits of screening; and finally the importance of self examination
have increased the awareness of prompt action in seeking advice. Primary care has
made considerable improvements in the diagnosis of cancer and the follow up methods
related to suspicious signs and symptoms of cancer. Further, service redesign has
improved referral pathways and a led to more widespread availability of treatment.
Advances in scientific knowledge and technology have led to more effective
investigations and staging of disease and the addition of subspecialisation in cancer
treatments have further increased the effectiveness of treatments (AIHW, 2008).
Surviving cancer has consequences that can change an individual’s way of life
considerably. The impact of cancer does not end after treatment; the 2008 “Health and
2

Wellbeing Survey” in the United Kingdom found that cancer survivors reported poorer
health and well being than the general population (Department of Health, Macmillan
Cancer Support, & NHS Improvement, 2010). As this is a relatively new phenomenon
to health, research in this area continues to identify new issues which need addressing.
Survivors of cancer have been strong advocates for the development of survivorship
care, led largely by the National Coalition of Cancer Survivorship in the United States
of America (USA).
There is now a growing body of published research addressing long-term
survivorship issues. “Living beyond Cancer” (2004) reported there were 10 million
cancer survivors in the USA, many of who were at the end of treatment and found
themselves “in a world that is intimately familiar, yet forever changed” (Reuben, 2004,
p. 5). There are as many research domains in cancer survivorship as there are in cancer
treatments and symptom management. However, there is a great imbalance in the
amount of research undertaken in these domains as shown in Figure 1. PubMed
citations between 1992-2004 have almost doubled for adult cancer treatment research
from 11,928 to 23,736, whilst citations for adult cancer survivorship research has almost
trebled they are still relatively small numbers 132 to 374 during the same period (Aziz
& Rowland, 2003). Since 2005 there has been an exponential rise in the research
approaches to the domain of cancer survivorship with 57,041 citations available on the
PubMed database in 2011.

Figure 1. Illustration of the imbalance between adult cancer treatment and adult cancer
survivorship PubMEd citations available on an annual basis between 1992 and 2011.
3

Of significance, times of transition during the cancer trajectory have been
identified as being particularly stressful. It has been stated that many newly diagnosed
cancer sufferers who have completed treatment, found the period of time to the first
follow up visit to be an anxious period (Hewitt, et al., 2006; Morgan, 2009; O'Neill,
1975). During this time the individual and their family are confronted with a fear of
recurrence and the prospect of having to deal with the physical and emotional pain
(O'Neill, 1975). Mullen (1985), a clinician and a cancer survivor himself, postulated
that:
Survival, in fact, begins at the point of diagnosis, because that is the time when
patients are forced to confront their own mortality and begin to make
adjustments that will be part of their immediate, and to some extent, long term
future (p. 270).

Mullen (1985) also described the survivorship journey according to three seasons:
acute survival (beginning at diagnosis, dominated by interventions, fear and anxiety are
constant elements); extended survival (begins when the patient goes into remission and
undergoes periodic follow-up, psychologically dominated by fear of recurrence and a
period of treatment-related physical limitations); permanent survival (commonly known
as the time when a person is deemed to be “cured”, although person is indelibly affected
by longer-term effects on mental and physical health from the secondary effects of
cancer treatment). This study focused on the under researched early extended survival
season, specifically, the time from when a patient completes primary treatment.

Research Problem
The time following the completion of treatment has been acknowledged to be as
challenging as the time spent undergoing treatment (Hewitt, et al., 2006; Leigh, 1992).
Very little is known about the issues and challenges that individuals face as they
transition from acute cancer treatment into the post treatment extended survival phase
particularly in relation to chemotherapy. As more people survive cancer there is an
identified need to increase evidence-based knowledge about the survivors’ lived
experiences (Carter, 1993; Ganz, Schag, Lee, Polinsky, & Tran, 1992). Specialist
oncology nurses contribute significantly to information and education during treatment
based on evidence, however preparing the individual for post treatment life is
predominantly based on anecdotal evidence and previous patient feedback. There is a
4

lack of evidence based studies in this area and very little is known about the actual
patient experiences as they transition into life after chemotherapy.
On completion of chemotherapy, patients are discharged home and experience a
gap of four to eight weeks before their next hospital visit to begin the follow up or the
surveillance part of their cancer journey. This time in particular has been identified as a
time when cancer survivors may be left feeling abandoned and uncertain about their
future care. Several authors consider the transition time from active treatment to post
treatment care as a critical time for the survivors’ long-term health (Cardy, 2006;
Taylor, 2008).

Study Purpose
The purpose of this two-phase study was to further understand the specific needs
of cancer survivors as they transition from chemotherapy into life after cancer, and, to
develop a method by which these needs could be measured. This study was undertaken
in two sequential phases.

Phase One: Qualitative.
The aim of this phase was to identify the key experiences of cancer patients on
completion of chemotherapy as they transition to life after cancer treatment.

Objectives.
1. To explore and describe from the patient’s perspective, the experience following
the completion of chemotherapy.
2. To identify factors which improved or exacerbated this experience.
3. To identify the main themes relating to patient experiences of this transition
from chemotherapy.

Phase Two: Quantitative.
The aim of this phase was to either develop a new research instrument or to modify
an existing instrument which could be used to explore the needs of a large population of
cancer survivors. Rather than develop a new instrument, the researcher modified an
existing instrument for the Australian context: Quality of Life – Cancer Survivors(QOLCS). This instrument was originally developed and validated by (Ferrell, Hassey Dow,
& Grant, 1995). This tool was primarily chosen because the items were consistent with
the majority of key themes identified in Phase One. The revised instrument Quality of
5

Life – Chemotherapy Cancer Survivors (QOL-CCS) was then reviewed by an expert
panel to assess clarity, apparent internal consistent and content validity.

Questions.
1. To what extent are the items in the QOL-CCS clear?
2. To what extent do the domains in the QOL-CCS confirm internal consistency?
3. To what extent do the domains in the QOL-CCS confirm content validity?

Significance of the Study
In order to meet the needs of this growing population it is important to first
recognise and understand those needs. This study provides an understanding of the
needs of the 5000 cancer survivors who transition from chemotherapy to life after
cancer in Western Australia each year. The number of survivors within this cohort is set
to rise exponentially in the next 20 years as the successes of current treatment
improvements and earlier diagnosis continue to be delivered in cancer care to a rising
number of cancer patients. The increased number of cancer patients projected in
Western Australia is connected to both an increasingly aging population and a rising
population due to migration projections. The results of this study will contribute to
improving the quality of education and information that is provided to patients as they
complete chemotherapy. This study will highlight the physical, emotional, social and
spiritual experiences that patient encounter during the immediate post treatment time
period. No Australian studies were identified that focussed specifically on this transition
of care in cancer patients following the completion of chemotherapy.

Definition of Terms
There is a great deal of international debate about when survivorship begins.
This will be discussed in greater depth in the literature review chapter. The following
terms surrounding survivorship are used throughout this thesis.

Cancer Survivor: An individual is considered a cancer survivor from the time of
diagnosis through the balance of his or her life (Hewitt, et al., 2006; Morgan, 2009)

Cancer Survivorship: The experience of living with, through and beyond a diagnosis of
cancer (Clark et al., 1996)
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Oncology Nurses: Nurses who have undertaken specialist training to work specifically
with cancer patients throughout their patient journey.

Prevalence: Prevalence of cancer refers to the number of people who have previously
received a cancer diagnosis and who are still alive at a given point in time.

Quality of Life: “an individual’s perception of their position in life in the context of
culture and the value system in which they live and in relation to their goals, standards
and concerns” (World Health Organisation, 2007).

Summary of the Chapter and Organisation of the Thesis
This initial chapter has provided the introduction, purpose, objectives,
questions, background significance and definition of terms for the study. The relevant
literature is discussed in Chapter Two, where the context of survivorship and current
levels of knowledge are discussed. Chapter Three describes Phase One of this study,
which was the qualitative methodology approach, alongside the ethical considerations
associated with this research. Chapter Four presents the findings from Phase One. For
clarity, the method and findings for Phase Two, a quantitative approach, is found in
Chapter Five. In Chapter Six the findings are discussed in relation to current knowledge.
The conclusion and recommendations are also found in this chapter.
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Chapter Two: Literature Review
Introduction
This chapter presents an overview of the literature currently available, in relation
to the survivorship experience for people with a diagnosis of cancer, as they transition
from completion of active chemotherapy treatment to life after cancer. The topics
addressed during this review are: development of a survivorship concept; current level
of knowledge regarding survivorship experiences and research; context of survivorship
following chemotherapy treatment for cancer; differences in survivorship experience
related to tumour type; differences in individual experiences at different timelines;
quality of life issues relating to survivorship and survivorship knowledge in the
Australian context. Themes relating to the family experience have not been included in
this literature review, except from the viewpoint of the person diagnosed with cancer.
Further, given the differences in survivorship issues for children and adolescents, this
literature review focused solely on adults diagnosed with cancer, as they comprised the
target population for this study.
The literature review commenced with a search of the following databases:
CINHAL, MEDLINE, ProQuest Nursing & Allied Health Source and PsycINFO. All
years were included as this research domain is in its infancy and it was considered
important to understand the context within which this research was grounded. The
search terms used were:
•

survivorship;

•

cancer survivor;

•

transitional survivorship;

•

treatment end;

•

end of chemotherapy treatment;

•

research;

•

quality of life.

The last search term “quality of life” was added following the realisation that quality of
life in cancer survivors was a recurring theme when searching with the other search
terms. The words cancer and oncology were used interchangeably with all search terms
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to ensure all relevant information was captured. All additional appropriate references
cited in relevant studies were also reviewed.

Development of Survivorship Concept
The concept of survivorship as a new and distinct phase of the cancer care
continuum has been increasingly developed over the past two decades. Advances in
technology and treatment have changed the trajectory of the illness to a chronic disease
in many instances, and it is now estimated that 61% of those diagnosed with cancer will
be alive in five years (Ferlay et al. 2010).
Macmillan Cancer Support in the United Kingdom (UK) have represented this
new cancer continuum in the diagram below, representing both the stages and the
directions which are now evident in the cancer journey.

Remains well
Remission
Long term
effects
Diagnosis

Primary
Treatment

Recurrence

Active &
Advanced
Disease

2nd and
Subsequent
Treatments

End of
Life

Survivorship Assessment and Care Plan

Figure 2. Survivorship Care Pathway -Illustration of the different phases of health or
illness that a person with cancer may experience from diagnosis onwards. Reproduced
from Vision and five key shifts by Department of Health, Macmillan Cancer Support, &
NHS Improvement, 2010. The National Cancer Survivorship Initiative Vision, p. 23.
Copyright 2010 by Crown. Reprinted with permission.
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As the number of cancer survivors increased throughout the 1970s and 1980s, a
cancer survivorship advocacy community emerged. As a result numerous physical,
medical, psychosocial, economic and legal issues were identified as a legacy of having
had a cancer diagnosis and treatment. In the USA in 1986, representatives of 20
organisations amalgamated to form the National Coalition of Cancer Survivorship
(NCCS). This organisation evolved from a peer-support organization to what is now in
2012 a formidable advocacy group, which sets public policy priorities on behalf of
people with cancer. The first goal of the NCCS was to change the perception and use of
the term “cancer victims” to that of “cancer survivors” (Morgan, 2009). In 1996 the
National Cancer Institute (NCI) created the Office of Cancer Survivorship (OCS) in
recognition of the increasingly large number of individuals surviving cancer and their
unique and understudied needs (Hewitt, et al., 2006).
The combined efforts of the NCCS have forged many new approaches to
survivorship care and research. One of their leading policy documents “Lost in
Transition” (2006) is used by health professionals internationally. The first
recommendation of this policy is particularly pertinent to this study: “Health care
providers, patient advocates and other stakeholders should work to raise awareness of
the needs of cancer survivors, establish cancer survivorship as a distinct phase of cancer
care, and act to ensure the delivery of appropriate survivorship care” (Hewitt, et al.,
2006 p. 3). Historically, the concept of survivorship generally held by society was often
associated with living through extraordinary life situations such as earthquakes,
volcanic eruptions, floods, or evil wrong doings such as victims of violence or war
(Breaden, 1997; Dow, 1990). Being associated with cancer holds a heavy social stigma
as does being a holocaust survivor; many people may not want to be labelled as a
survivor or thought of as different to anyone else (Markus, 2004). Whilst the true
meaning of the words is simple, the connotations associated can be complex. The word
Survivor is derived from the middle French word survivre to outlive, and from the Latin
word supervivere to live more (Merriam-Webster, 2012).
Sontag (1978) articulated societal perceptions that cancer = death and people
with cancer were victims. Other preferred terms for survivors include fighters, thrivers,
champions, patients or simply individuals who have had a life threatening disease
(Hewitt, et al., 2006; Reuben, 2004). It appears that society still holds Sontag’s (1978)
view. Previous studies identified that public attitudes towards cancer appear to be
pessimistic and that cancer is perceived as contagious, a death sentence, threatening, a
10

dreaded condition and painful (Rendle, 1997). Corner (1988) summarised several
studies regarding health care professionals and attitudes to cancer and concluded that
most attitudes were negative. Whilst researchers continued confirming negative
attitudes to cancer the improvements in treatments were gradually increasing the
numbers of people surviving cancer.
A source of debate and consideration in this area of research has been the
definitions that have been attached to the survivorship journey. This was particularly
evident in earlier years when the starting point of survivorship was contentious. The
range of views included: survivorship starting at the point of diagnosis; survivorship
starting on completion of initial treatment; or survivorship starting when the person had
lived five years beyond their diagnosis (Breaden, 1997; Reuben, 2004). In one of the
seminal cancer survivorship papers Mullen (1985) suggested that “survivorship begins
at the point of diagnosis, because this is the time when patients are forced to confront
their own mortality and begin to make adjustments that will be a part of their immediate
and long- term future” (p. 270).
The NCCS defined cancer survivorship as “the experience of living with,
through and beyond a diagnosis of cancer” (Hewitt, et al., 2006) and further stated that
“an individual is considered a cancer survivor from the time of diagnosis, through the
balance of his or her life” (p. 27). These latter definitions are by far the most accepted at
present and are used throughout this thesis (Morgan, 2009; National Cancer
Survivorship Initiative, 2010).
The NCCS purposefully chose the term survivorship at its inception in 1986,
believing that it promoted empowerment in those with a diagnosis of cancer (Twombly,
2004). Since then it has been used extensively to promote the new stage in the cancer
continuum, however, very little research has been undertaken to elicit the acceptability
of the term survivor to those cancer patients to whom it refers. Hewitt et al. (2006)
inferred the term survivorship was less palatable to the European community because of
the holocaust associations; however in recent years the majority of publications from
Europe widely use the survivorship terminology. Park, Zlateva and Blank (2009)
undertook an interesting study in which they explored whether survivors in the first one
to three years identified themselves as: a “survivor”, a “victim”, a “patient” or a “person
with cancer”. The most popular self-identity in this study was “survivor” for 83% of the
cohort, and “person who has had cancer” for 81% of the cohort. Of note, the
researchers concluded that each individual identity carried meaning for the individual
that affected not only health behaviours, but also interactions with others. The
11

researchers postulated that survivors who self-identified with the “patient” label may
have experienced reduced feelings of control and hope. These patients may continue to
relinquish responsibility for their health to their health care team, thus maintaining the
passive role. There was an association between self-identifying as survivors and having
a better psychological well being. The findings from this study were congruent with
other studies of long-term cancer survivors (Deimling, Bowman, & Wagner, 2007;
Deimling, Kahana, & Schumacher, 1997; Park, et al., 2009).
Many researchers have identified the multi-dimensional nature of survivorship.
It encompasses physical, psychosocial and economic sequelae of cancer diagnosis and
its treatment, as well as issues related to health care delivery, access and follow up care
among both paediatric and adult survivors of cancer ( Ferrell, Dow, Leigh, Ly, &
Gulasekaram, 1995; National Cancer Survivorship Initiative, 2010). The complex
nature of survivorship issues and needs impact upon many aspects of care ranging from
prevention, screening and rehabilitation through to end of life care (Morgan, 2009).
Survivorship as a health care concept is still a relatively new phenomenon, despite or
perhaps due to this, there remains a struggle to deliver one accepted definition of who is
a survivor and when survivorship begins. What is accepted, however, is that survivors
have many unique needs, which are at present not well understood.

Current Level of Knowledge Regarding Survivorship Experiences and Research
The goal of survivorship research is to understand and thereby reduce the
adverse effects of a cancer diagnosis and treatment in order to optimize outcomes for
cancer survivors and their families (Aziz & Rowland, 2003; Ganz, 2003). The focus of
cancer care has traditionally been confined to diagnosis and treatment. Consequently,
there has been a plethora of research in these two areas compared with survivorship. For
example, by 2004 the imbalance in research cited in PubMed related to active cancer
treatment (n=23,736) was enormous compared with the research relating to cancer
survivorship (n=374) (Aziz & Rowland, 2003). Since 2005 there has been an
exponential rise in research related to cancer survivorship with 57,041 citations
available on the PubMed database in 2011. The inequity in research contributes to the
survivorship conundrum. Whilst the concerted research effort into cancer treatments has
resulted in great strides forward producing more cancer survivors, the lack of
survivorship research has resulted in a widespread failure to recognise and address the
psychosocial needs of cancer survivors because of a variety of barriers (Kaplan, 2008).
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The approach to survivorship research has been fragmented as the isolated
approaches of survivorship research have made oversight of the process difficult
(Breaden, 1997). It is now increasingly understood that there are as many research
domains in cancer survivorship as there are in cancer treatments. While the physical and
emotional impact of cancer treatment in the acute period are well known, there is less
understanding about the fact these effects can continue well beyond treatment (Hewitt,
et al., 2006). Survivorship research has demonstrated there are significant longer term
implications for the survivor as a result of the cancer diagnosis and its subsequent
treatments; this has been referred to in several texts as the “price of survival” (Davies,
2009; Ganz,2002; Gotay & Muraoka, 1998; Hewitt, et al., 2006; Hewitt, Rowland, &
Yancik, 2003).
Recently there has been a considerable increase in the amount of research
undertaken to develop and test interventions to improve the survivorship experience.
This work has included studies on the use and delivery of follow up care plans (Ganz &
Hahn, 2008; Morgan, 2009) and screening tools (Holland & Reznik, 2005; Pigott,
Pollard, Thomson, & Aranda, 2008). However, what appears to be lacking in this
approach is a determination of the individual’s unique lived experience of cancer
treatment, that is, the follow up care needs as determined by patients’ own perceptions
(Adewuyi-Dalton, Zieland, Grunfeld, & Hall, 1998; Mullen, 1985; Schlairet, Heddon, &
Griffis, 2010). A handful of researchers have explored the individual’s experience of
survivorship according to specific timeframes (Carter, 1993; Gotay & Muraoka, 1998),
or following specific interventions (Emery et al., 2008; Galvao & Newton, 2005), or by
tumour group (Baravelli et al., 2009; Brennan, Butow, & Spillane, 2008; Dizon, 2009).
There is now growing evidence of unmet needs in the first year after treatment, with a
2009 study showing that one in four cancer survivors had at least five unmet physical or
psychological needs (Hindle, 2010, Lobb, 2009).
The NCCS has clearly set the agenda for cancer survivorship research by
directing that it should address the physical, psychosocial and economic domains of a
cancer diagnosis and its treatments, whilst retaining the focus on the health and the life
of the person with the cancer history. Intervention studies are needed that develop or
test strategies to promote optimal health status in survivors of cancer, information on
survivors of cancer who have previously been understudied, and research on the impact
of cancer on the family (Hewitt, et al., 2006; Rowland, Aziz, Tesauro, & Feuer, 2001).
The importance of survivorship was demonstrated by the development of a
committee by the Institute of Medicine of the National Academies in the USA. The role
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of this committee was to investigate medical and psychosocial issues faced by cancer
survivors and to make recommendations to improve their health care and quality of life.
As previously discussed, the expert committee produced a pivotal report focusing on
survivors of adult cancer during the phase of care that follows primary treatment, this
report was entitled: “From Cancer Patient to Cancer Survivor: Lost in Transition”
(Hewitt, et al., 2006). Findings were based on evidence from the research literature
rather than indirectly from survivors. The report provides an excellent summation of
what was known and understood in relation to survivorship in the USA until 2005 and
concludes with ten recommendations, the first aiming to raise awareness of the needs of
cancer survivors and establishing cancer survivorship as a distinct phase of cancer care.
Understanding what cancer patients need to know and from whom they receive
information during the course of their care is essential to ensuring quality care (Finney
Rutten, Arora, Bakos, Aziz, & Rowland, 2005). The current study sought to contribute
to this important body of knowledge by providing evidence to further raise the
awareness of the unique needs of cancer survivors as they transition from completion of
chemotherapy treatment into follow up care.

Context of Survivorship Following Chemotherapy Treatment for Cancer
The period following primary cancer treatment is recognised as under researched
and therefore lacking in evidence based guidance for health care providers (Breaden,
1997; Hewitt, et al., 2006; Little & Sayers, 2004; Rassmussen & Elverdam, 2007).
Cytotoxic chemotherapy is one of the main treatment modalities used to manage cancer;
in Australia if optimal treatment rates are achieved 51% of those treated for cancer will
receive chemotherapy (Blinman et al., 2012). Despite the significant number of people
who receive chemotherapy there is a considerable lack of chemotherapy survivorship
related research available, although there is a plethora of research related to
chemotherapy delivery and treatment of side effects.
Several researchers have identified the mixed emotions of completing treatment.
Elation on completing treatment is often coupled with anxiety of losing contact with the
treatment team and fellow patients. Conversely, a desire never to see the treatment team
again may exist. This suggests an association between somatic anxiety and substantial
psychological distress (Allen, Savadatti, & Levy, 2009; Doyle, 2008). Survivors
frequently and with intense language described feeling abandoned, pushed out or cast
adrift by the health care system at the time of treatment completion (Allen, et al., 2009;
Jefford, et al., 2008; Rancour, 2008).
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Qualitative and quantitative studies have attempted to establish the issues faced
by patients completing treatment for cancer; the following themes have emerged from
the literature:
•

Thoughts and fears about cancer including: fear of recurrence; anxiety about the
future; isolation, fear of death and intrusive or avoidance thoughts about cancer.

•

Physical and psychological consequences of treatment including: the possibility
of early menopause; late or longer term effects such as fatigue.

•

Returning to normal including: dealing with changes to identity; body image;
returning to work; and uncertainty about health and effects of treatment.

•

Sexuality and fertility including: decreased libido; erection and ejaculatory
difficulties; reduced frequency of sexual intercourse; anxiety about future
infertility; and decreased interest in having a child.

•

Follow up including: ambivalence about discontinuing treatment; fear of future;
follow up appointments; and longer term effects of treatment.

•

Impact of cancer on family and friends.

•

Financial implications including: a loss of income and assets during treatment
and ongoing challenges obtaining insurances and mortgages.

(Department of Health, 2010; Hewitt, et al., 2006; Jefford, et al., 2008; Karahalios et
al., 2007).
The physical impact of chemotherapy in the short term has been acknowledged
in several papers that discuss the longevity of some side effects such as fatigue (Jefford
et al., 2011; Speigel & Kato, 1996; Spiegel, Kraemer, & Bloom, 1989). It has also been
identified the likelihood of post cancer disabilities were more than three times as likely
if chemotherapy was a part of the treatment (Taylor et al., 2004). Available papers
suggest there is a new balance to be found as a return to good health may not
necessarily be a return to the normality of life before cancer (Dow, 1990). It would
appear that survivorship has at least two stages: surviving the initial diagnosis and
subsequently the aftermath of treatment (Leigh, 1992). The NCCS identified that many
patients completed their primary treatment unaware of their heightened health risks, and
lack of preparation to manage their future health care needs (Hewitt, et al., 2006).

Differences in Survivorship Experience Related to Tumour Type
The cancer sites with the highest frequency of survivors were recently described
as: breast (22%), prostate (19%) colorectal (10%) and gynaecologic (9%) (Kaplan,
2008; Ries et al., 2004; Rowland, 2008). When contemplating the survivorship
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experience in relation to the actual cancer diagnosis each tumour group will be unique
in terms of needs, even those with the same cancer type and treatment regime will
identify very different needs (Hewitt, et al., 2006; Hodgkinson, Butow, & Hunt, 2007;
Jefford, Karahalios, Angle, Baravelli, & Akkerman, 2007; Jefford, et al., 2011). For
example, Fox and Lyon (2006) argued that lung cancer patients may have a unique view
of transition from completion of chemotherapy, as treatment related symptoms may
exacerbate disease related symptoms and further contribute to poorer quality of life
outcomes, as well as survivorship. For this reason the authors believe that specialized
care must extend beyond the treatment phase. Hewitt et al. (2006) discussed long-term
needs unique to specific tumours, showing there are wide ranges of physical and
psychological side effects which are evident in the long term profile of cancer survivors.
There is however no evidence to indicate when these side effects become evident or if
they are burdensome during the immediate post treatment episodes.
Fox and Lyon (2006) found that survivors of lung cancer experienced distressing
symptoms; specifically depression and fatigue, well into cancer survivorship and these
clustered symptoms significantly influence quality of life. There are some distinctions
to be found in the survivorship experience according to the initial cancer diagnosis.
Taylor & Odey (2011) reported that colorectal cancer patients identified fewer physical
symptoms or concerns than other cancer survivors. Jefford et al. (2011) however,
identified a range of distressing, embarrassing and potentially life threatening
complications to which colorectal cancer patients are susceptible. Breast cancer patients
often experience physical side effects unique to their cancer treatment, which cause an
early menopause. The post treatment effects of menopause can affect fatigue, quality of
life and sleep. Success in treatment for ovarian cancer, once an almost fatal form of
cancer, has now caused a psychological shift from preparing for death at diagnosis to
preparing for life after cancer. Cochrane (2003) compared this to the phrase “health
within illness” a concept commonly used in HIV/AIDS literature. Rassmussen &
Elverdam (2007) claimed that regardless of the type or location of the cancer and the
treatment received, cancer survivors have similar experiences in the process of
surviving cancer. Jefford et al., (2008) identified common themes in their research with
survivors across a range of tumour types, which appears to support Rassmussen &
Elverdam’s (2007) claims. It would seem that survivors encounter a range of common
experiences such as fatigue and a range of disease / treatment-specific experiences such
as early menopause.
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Differences in Individual’s Experiences at Different Timelines.
For many of the 114,000 people diagnosed with cancer each year in Australia
(AIHW, 2010), resuming the routines of work and family life after completing active
treatment may be especially difficult. Anxiety over cancer recurrence may dominate at
this time, and questions also arise about the next steps in the care continuum (Alfano &
Rowland, 2006; Breaden, 1997; Jefford, et al., 2008). The transition from diagnosis and
active treatment to survivorship is an understudied phase in the cancer trajectory
(Hewitt, et al., 2006; Stanton et al., 2005). Research to date has shown the longer term
picture of the journey many experience, the needs at time of transition onto this journey
remain as yet only marginally explored.
The period prior to the first follow up visit is likely to be an anxious time when
the individual and their family are confronted with the fear of recurrence and having to
deal again with the physical and emotional pain (O’Neill, 1975). This highlights the
importance of understanding patients’ issues and concerns on completion of
chemotherapy, to ensure that health care practitioners are aware of potential information
needs. Personal accounts of having cancer by Armstrong (2001) and Carr (2004), have
added to the literature by expressing their feelings of being powerless after completion
of treatment and being unsure about what they were supposed to do to help themselves.
Earlier studies have also identified these feelings (Breaden, 1997; Pelusi, 1997).
Transition at the end of treatment can be a traumatic time for patients; whilst
they are finally leaving treatment behind they are also leaving what has become a safety
net of health professional connection, no longer being required to attend clinic visits,
hospital stays and even emergency attendances. Patients who look forward to the day
they would complete the arduous demands of treatment are often surprised by the void
(Hewitt, Barmundo, Day, & Harvey, 2007; Rancour, 2008). Well planned and
coordinated care to facilitate transition from acute cancer treatment to life after cancer
has been identified as critical; a deficit in this knowledge will increase risks for the
survivor (Hewitt, et al., 2006).
Mullen (1985) developed a framework for the survivorship process, which
entailed distinct phases that an individual moves through; he described this as the three
“seasons” of survival in the survivorship journey:
•

Acute Survival – beginning at diagnosis and dominated by diagnostics and
therapeutic interventions – fear and anxiety are constant and important elements
of this stage.
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•

Extended survival – this period is entered as the patient goes into watchful
waiting with periodic examination. Psychologically this period is dominated
with fear of recurrence and contains a period of physical limitations following
the therapeutic interventions.

•

Permanent survival – “cure”, although the person that has got to this stage of the
cancer experience is indelibly affected by it. Longer-term effects on health from
secondary effects of cancer treatment may represent another area of risk
(Mullen, 1985).

No specific timeframes exist for the stages described by Mullen and it has been
suggested that not all patients experience all stages (Decker, Haase, & Bell, 2007;
Morgan, 2009; Mullen, 1985).
A transition implies moving from one relatively stable state, with an experience
of disorganization and upheaval during the process, toward another stable state (Boyle,
2006; Clarke-Steffen, 1993). Any transition implies the letting go of old relationships,
forms, methods and roles, even if the nature of the transition is perceived as positive one
(e.g. promotion, marriage or completing treatment for cancer); all transitions imply
leaving the familiar and suggest a sense of loss or grief. Survivors can feel lost and
confused by the sudden cessation of treatment. They may be pronounced “cancer free”
or have “no evidence of disease” but rarely are they told they are cured (Rancour,
2008). Studies have revealed that periods of highest distress for women with breast
cancer are associated with transition points in treatment (Kaplan, 2008). Comprehensive
reviews of available literature report the period after completion of treatment brings its
own unique, and in some cases, still poorly understood challenges. Whilst survivors are
relieved to be ending treatment, many survivors report being unprepared to manage the
long-term effects of cancer and its treatment. Survivors are articulating that being
labelled disease free does not mean being free from disease (Alfano & Rowland, 2006;
Hewitt, et al., 2006; Reuben, 2004).
As they transition to recovery survivors want to know: who will follow them;
which symptoms to monitor; when to be alert to changes in health; what their “new
normal” will be and how they can reduce their risk of recurrence and remain healthy
(Alfano & Rowland, 2006; Hewitt, et al., 2007). Similarly, it has been demonstrated that
survivors also want to know and understand their follow up plan; who will monitor their
health and risks; and what they can do for themselves to adapt and prevent further
recurrences (Rancour, 2008). Getting the balance of information correct is important;
many survivors claimed to have been overwhelmed at the end of active treatment and
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were given so much information about follow up care verbally they couldn’t take it all
in (Hewitt, et al., 2007).
It is evident the cancer experience changes the psyche of individuals as they
move between roles of patient and survivor. When a person is diagnosed with cancer
they become a patient, they also become a part of the community of practice that
consists of specialist doctors, nurses and technicians who are mobilized to have an
impact on the patient. As the person completes treatment they must change roles yet
again, from being a patient to being a survivor, adjusting to limited contact with the
health professional team and a requirement to assume the responsibility of self
monitoring and to find a new equilibrium (Allen, 2009).

Quality of Life Issues Relating to Survivorship
The World Health Organisation (2007) defined quality of life as “an individual’s
perception of their position in life in the context of culture and the value system in
which they live and in relation to their goals, standards and concerns” (p.1). Ferrans
(2005) explains that quality of life has been conceptualized as normal functioning,
social usefulness, general well being, ability to fulfil life’s goals, and happiness and life
satisfaction, this description is supported by several authors (Albaugh & Hacker, 2008;
Wochna Loerzel, McNees, Powel, Su, & Meneses, 2008). The meaning of health and
life itself can be altered following a diagnosis of cancer (Vachon, 2001). Cancer
survivors report struggling to achieve a balance in their life’s and a sense of wholeness
and life purpose after a life altering experience (Ferrell, 2004). It is therefore evident
that one’s own perception of quality of life is determined in accordance with one’s own
values of normal, being culturally acceptable and usefulness. It includes the ability to
set goals and have a purpose in life. Quality of life measures are now commonly found
in many research papers and are widely used to determine how individuals assess their
own general well being. However, there is a lack of consensus on a health related
quality of life definition. Ganz (2000) labels the health effects of cancer and its
treatments on perceived quality of life as “the price of survival” (p. 324).
Fatigue is a commonly described symptom considered to greatly impact on
quality of life. Broeckel, Jacobsen, Balducci, Horton, & Lyman (2000) found that
breast cancer survivors 3-36 months following adjuvant chemotherapy reported more
fatigue than a comparison group with no history of cancer. Adjuvant chemotherapy
indicates that the survivors have had chemotherapy in addition to another treatment to
assist in amelioration or cure of the breast cancer. This USA quantitative study
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compared results to two surveys between cancer survivors post chemotherapy and
women who had never been diagnosed with cancer. Overall the cancer cohort scored
lower in both surveys, and physical aspects were much more poorly scored than
psychological aspects. Women who were older and married scored higher in
psychological well being than the remainder of the group (Broeckel, Jacobsen,
Balducci, Horton, & Lyman, 2000).
A third of breast cancer survivors have reported severe fatigue associated with
higher levels of depression, pain and sleep disturbances (Bower et al., 2000). Bennett,
Winter-Stone & Nail (2006) undertook a review of available literature relating to
exercise intervention in cancer survivors and concluded that many cancer survivors
reported a decline in their physical functioning, including basic body mobility and
engagement in work and leisure activities, during cancer treatment and immediately
afterwards related to fatigue. Their paper presented a conceptual model, which provides
opportunities for further studies to increase an understanding of how exercise
interventions may work for survivors.
A comprehensive conceptual model of quality of life in cancer survivors was
developed by Ferrell, Hassey Dow, et al. (1995). This team recognised that whilst on
active treatment the main focus of care had been physical and psychological well-being.
Several months later the focus shifted to social and spiritual well-being, often with a
change in direction around managing physical and psychological well-being, for
example the late effects of fatigue or cognitive impairment whilst not life threatening
are certainly life altering. There is a lack of agreement about what constitutes the
dimensions of quality of life, however the domains in this model are consistent with the
predominant view ( Ferrell, Hassey Dow, et al., 1995; Spiker, 1990)
Based on this quality of life model, Ferrell, Dow et al., (1995) also developed
and tested a quality of life instrument for longer term cancer survivors; the aim of this
instrument was to measure the specific concerns of this group of survivors. The Quality
of Life – Cancer Survivors tool (QOL-CS) is based upon a previous quality of life
instrument developed by researchers at the City of Hope National Medical Centre
(Ferrell, Dow, et al., 1995). The instrument has been widely used in cancer care and has
been adapted for several different cancer populations across a range of ages, tumour
types and languages, for example: Hispanic patients with cancer, (Juraz, Ferrell, &
Borneman, 1998); breast cancer survivors (Ferrell et al., 1996) and ovarian cancer
survivors (Ferrell, Smith, Juarez, & Melancon, 2003).
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Short, Vasey, Joseph & Tunceli (2005) showed that 20% of cancer survivors have
cancer related disabilities one to five years after diagnosis. Re-establishing oneself back
into pre-cancer lifestyle norms may occur gradually during the course of active cancer
therapy or abruptly following completion of treatment depending upon individual’s
requirements of hospitalization and recovery (Boyle, 2006). The positive aspects of
cancer survivors’ quality of life perception include a greater appreciation of life (Bush,
Haberman, Donaldson, & Sullivan, 1995; Mellon, 2002), and a healthier lifestyle
(Alfano & Rowland, 2006; Allen, et al., 2009; Mellon, 2002). Hoffman & Stoval
(2006) showed that survivors who were informed about their options believe they have
some personal control over decision-making generally have higher quality of life.
Reported negative aspects of quality of life perception have included longer term side
effects of cancer (Dow, Ferrell, Leigh, Ly, & Gulasekaram, 1996), altered sexuality and
self-image (Ganz et al., 1996) and economic problems (Ferrans, 2005). Control, aches
and pains, uncertainty, satisfaction, future appearance and fatigue were the most
consistent domains shown to affect perception of quality of life. Quality of life was also
reported to be higher in those who had survived for longer than five years past diagnosis
(Morgan, 2009).
Spirituality has been described as an important aspect of quality of life for
patients with cancer; it encompasses not only religiosity but also other dimensions such
as hopefulness, transcendence and purpose. Spirituality is linked to life meaning;
previous literature has described the importance of spirituality as a component of
deriving meaning from cancer (Ferrell et al., 2003). Roos & Powell (2005), both cancer
survivors from Australia, eloquently discussed the journey from a person confronted
with cancer to a patient and then back to an individual but changed. These changes
occur along a continuum of meaning based on negotiation with information the person
receives along the journey. In negotiating this process the person is dealing with issues
of self, issues of meaning and issues of identity all of which link to the original quality
of life definition from the World Health Organisation at the beginning of this section. It
would appear that maintaining or restoring quality of life is vital to all cancer survivors.

Survivorship Knowledge in the Australian Context.
One of the few Australian studies in this domain and timeline is a qualitative
study undertaken by Jefford et al. (2008), which looked at survivorship issues following
treatment completion from the viewpoint of 22 survivors and 20 health care
professionals. Through a process of focus groups, this study found that dealing with
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fatigue, anxiety about cancer recurrence, others expecting you to be back to normal,
having to create new expectations about physical ability, and anxiety about leaving the
hospital system, were the most commonly reported. The participants ranged in length of
survivorship from less than 12 months to over 10 years with over 75% of participants
being over a year post treatment. The strength of the current study is that it focused
solely on patients who had completed chemotherapy within three months.
There is a great deal of congruence between Jefford et al.’s (2008) findings and
the quality of life research discussed previously in this section. This work has been
instrumental in highlighting the issues of survivorship in the Australian context and has
led to the development of the Australian Survivorship Centre based at Peter MacCallum
Cancer Institute in Melbourne, Victoria. Jefford et al.’s (2008) findings have provided a
broad platform on which more specific research can now add to the understanding of
survivorship challenges in Australia. Jefford and his team continue to build upon this
research with a series of interventions designed to address the unmet needs identified in
the 2008 study. For example, developing and testing written information booklets
(Jefford et al., 2007) and more recently, piloting nurse-led follow up support for patients
with bowel cancer (Jefford et al., 2011).
Lobb et al. (2009) recently added to the Australian context with findings from a
study undertaken in Western Australia with 66 survivors of haematological
malignancies. Participants were surveyed using a structured quantitative instrument in
order to establish their unmet needs on the completion of treatment. Findings were
consistent with those identified earlier in this chapter as well as the work of the Jefford
team (2008) as discussed above. Lobb et al.’s (2009) research began to explore the
perception of strategies which may help to meet the unmet needs, for example, use of
case managers. It was also reported that 59% (n=39) patients perceived it would have
been helpful to speak to a professional at treatment completion about the experience of
diagnosis and treatment, and making the transition from active treatment.
The current study builds upon the work by Jefford et al. (2008) and Lobb et al.’s
(2009) work by specifically targeting individual survivors within the early transition
phase, who had completed chemotherapy and providing them with the opportunity to
openly discuss their needs through a semi structured interview process. An
understanding of the concerns from the survivors’ perspective allowed the researcher to
develop items for an instrument that could be used clinically to determine specific needs
at completion of chemotherapy treatment. It is anticipated that development of such an
instrument would assist health professionals to provide care that is: tailored to an
22

individual’s care needs; facilitates the delivery of appropriate information in a timely
manner; and supports a smoother transition for patients as they leave the acute care
setting.

Summary of Chapter Two
The increasing prevalence of cancer survivors in developed countries is a clear
challenge to both clinicians and researchers alike. Whilst it is important to continue
looking for cures and improvements in treatment experiences, it is now evident that
research and care of cancer survivors is equally important. The literature review
confirmed that cancer is an extreme experience that disrupts people’s lives and sense of
identity. For the previous months whilst undergoing treatment patients are forced to
relinquish normal life, social roles and often work, in order to cope with the complex
treatment requirements and physical side effects that cancer treatments are known to
cause. Once treatment is completed, this is often the first time the individual has an
opportunity to reflect on the impact of being diagnosed with a cancer and what that
means to them as an individual, as a family member, and as a member of the wider
community. At this stage survivors often begin to articulate their search for the
understanding of their new ”normal” and acceptance of their new self after the treatment
journey. Health care professionals can provide timely and appropriate support into the
transition period once the key issues and concerns of survivors at this time are
understood.
The findings from this literature review were used to shape the development of
the interview guide for this study in order to clarify the key issues and concerns of
survivors. It is known that improved and timely education facilitates better
psychological health in cancer patients and survivors, however this needs to be based on
actual requirements; currently we do not understand the full range of gaps in knowledge
relating to this cohort of survivors. The number of cancer survivors continues to rise,
the increasing number of cancer survivors is occurring alongside an increasing
incidence in cancer diagnosis due in part to an ageing population. Health services will
not be able to continue managing the increasing demand of new patients and survivors
in the current model of care delivery, unless new models of care are developed to more
efficiently meet individual patient needs. Research is vital to identify the issues for
survivors in the transition period and to test new methods of survivorship care delivery
across a continuum of care ranging from self management strategies due to nurse-led
clinics and shared care models.
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This study will contribute and build upon the current knowledge available in the
survivorship continuum, by concentrating on an area of need that has not been wholly
addressed in the research to date. That being, the specific timeline immediately after the
completion of chemotherapy treatment, given than over half of all cancer patients will
receive chemotherapy this study presents an opportunity to understand the needs of a
sizable proportion of the survivorship community.
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Chapter Three: Methodology

Introduction to the Chapter
This chapter describes the qualitative approach used for Phase One and the
ethical considerations for this study. It illustrates the processes employed to collect and
analyse the data and also discusses ethical considerations that occurred before and
during the study. The purpose of this study was to ultimately improve the care of people
as they transitioned into life after completion of chemotherapy treatment. There is
minimal information related to this phase of the cancer trajectory, therefore this study
was intentionally exploratory and descriptive.
In order to achieve the proposed outcome a two-phase approach was
undertaken. In Phase One a Grounded Theory qualitative approach was followed to the
descriptive level of data analysis. Data was collected via semi structured telephone
interviews which elicited the descriptors of issues and experiences that arose for patients
in the first six months following completion of chemotherapy. In Phase Two, findings
from Phase One were used to embark on a quantitative approach in which an existing
cancer survivorship instrument was amended with the intention of using the revised tool
to explore survivorship issues that occur during the first three months following the
completion of chemotherapy. The revised questionnaire was then tested for clarity,
content validity and apparent internal consistency with an expert panel of senior
chemotherapy nurses from a large tertiary cancer service in Western Australia.
To assist with clarity in reading this thesis, the methodology for Phase Two is
presented in Chapter Five where it is described in conjunction with the results for Phase
Two.
Phase One: Qualitative
The intention of this study was to contribute to a very limited body of
knowledge regarding the early survivorship period of persons diagnosed with cancer. A
qualitative research approach was chosen to facilitate the exploration of the
phenomenon and to gain a richer understanding of the experiences of individuals.
Qualitative research provides systematic processes to enable the researcher to explore
behaviour, feelings and experiences of individuals and how they make sense of these
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perceptions. This approach is particularly useful in areas where little is known or
understood (Burns & Grove, 2009; Holloway & Wheeler, 2010; Liamputtong, 2009).

Grounded Theory
As previously described, this phase of the study was exploratory and employed
the Grounded Theory approach to the descriptive level of analysis. Grounded Theory is
an approach whereby theory is generated based on the data, which has been collected
and analysed. The constant comparative method is utilised to analyse the data, and this
necessitates comparing and contrasting the concepts identified in the data. Grounded
Theory enables a problem to be studied from the perspective of the individuals affected.
It captures social process within the social context and is a particularly useful approach
when little is known about a particular area. Grounded Theory of health-related
phenomena has implications for nursing practice; it identifies how individuals make
sense of their experiences (Birks, Chapman, & Francis, 2006; Burns & Grove, 2009;
Holloway & Tordes, 2010; Portney & Watkins, 2000; Walker & Myrick, 2006; Wuest,
1995). For people with a cancer diagnosis completing chemotherapy treatment, the use
of Grounded Theory facilitated a greater understanding of their physical and
psychological experiences. This perspective can lead to improvements in nursing care
provision.
Grounded Theory was first described by Glaser & Strauss (1967) in their
seminal work “The Discovery of Grounded Theory”. Since this time the method has
been both adopted and adapted by many other researchers in the social sciences and
health care fields, especially in nursing (Carpenter, 1995; Charmaz, 2007; Corbin, 1986;
Corbin & Strauss, 2008; Morse, 2001). Notably, Strauss & Corbin (1990) in their book
“Basics of Qualitative Research: Techniques & Procedures for Developing Grounded
Theory” detailed a significant refinement to the 1967 procedures. Grounded Theory is
still a relatively new approach compared with other methods and therefore continues to
be developed, transformed and critiqued. It is interesting to note that in later years
Glaser and Strauss disagreed about the fundamental procedural issues of the
methodology. These approaches subsequently became known as the Glaserian &
Straussian approaches; the main differences surrounded data analysis and how theory
was induced from the data (Birks, et al., 2006; Heath & Cowley, 2004; Walker &
Myrick, 2006; Woods, 2003).
According to the literature, Grounded Theory originates from sociology,
although Glaser (2005) has refuted this claim. The sociological roots are specifically
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connected with symbolic interactionism, which theorises that meaning is negotiated and
understood through interactions with others in social process (Blummer, 1986; Dey,
1999; Jeon, 2004; Polit & Beck, 2006; Starks & Brown, 2007). The epistemological
basis of Grounded Theory in symbolic interactionism provides a great deal of
congruence for the field of nursing and the strong links between Grounded Theory,
symbolic interactionism and nursing are evident in the nursing literature (Milliken &
Schreiber, 2001; Morse, 1994; Stern, 1994). Symbolic Interactionism was first noted in
1937 by Herbert Blummer and was constructed from the basis of many intellectuals.
This perspective in partnership with Grounded Theory provides patterns of human
behaviour, experiences, common perceptions, and how people make sense of their
world in common circumstances.
As discussed, the purpose of this study to qualitatively identify, explore and
describe the experience of cancer survivorship transition from chemotherapy to life a
cancer survivor. Hence, Grounded Theory was used to the level of data analysis to
identify the meaning described by cancer survivors and provide an insight into their
own reality and perception of the interactions they had experienced during this period.

Research Setting
This study took place in one of three public tertiary hospitals in Western
Australia, within the medical oncology and haematology departments. The departments
provide care to over 2000 public and private patients per year from both metropolitan
and rural Western Australia. All types of solid cancer tumours and haematological
malignancies with the exception of allogeneic transplants are treated at this centre; there
is also a strong culture of clinical trials. Care is provided using a multidisciplinary
approach lead by haematologists, medical oncologists, a nurse practitioner and other
senior cancer nurses. Patients cared for in this setting have complex treatment
requirements and visit the hospital on multiple occasions during the course of their
chemotherapy treatment. Oncology care is now primarily an out patient managed
system of care delivery with inpatient episodes reserved for the exceptionally unwell
person. As a state wide treatment centre the research setting provided the opportunity to
draw from a wide range of candidates.

Sample Selection
The accessible population for this study were those patients treated at the cancer
centre described in the research setting above. Participants were recruited from the
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medical oncology and haematology departments and had a cancer diagnosis. As the
hospital is a state-wide treatment centre for cancer it provided the opportunity to draw
from a wide range of potential participants. The research sample for this study was
drawn from a target population of all individuals who received chemotherapy in
Western Australia.
A purposive sampling method was used. This approach enabled the researcher to
select certain participants to ensure that a wide range of patient characteristics were
represented in the data. In adopting this approach it was important to clearly indicate the
characteristics and rationale for inclusion or exclusion when participants were selected
(Burns & Grove, 2009; Gerrish & Lacey, 2010; Holloway & Wheeler, 2010). In
keeping with the purposive sampling approach, a set of pre determined criteria were
used to select chemotherapy patients for interview. Participants were selected to reflect
varying experiences of the transition period between four and 24 weeks following
completion of chemotherapy. This period of time was considered long enough for
individuals to have recovered from the immediate physical effects of the final
chemotherapy treatment, but not too long for participants to have forgotten the details of
the experience. Participants had a minimum of four to six months of chemotherapy
treatments; this was considered a long enough time period to have settled into a pattern
of care and also reflected the average timeline for the most commonly delivered
chemotherapy regimens. No exceptions to cancer type were made as the area of research
interest related to the treatment rather than the disease. For this reason there were no
specific requirements set for gender, geographical location, or family setting.
Participants under the age of 25 years have been identified as a unique population with
unique needs, which are being addressed at the national arena and were therefore
excluded. Likewise, those participants already recruited into a clinical trial were
intentionally excluded as they were already subject to intense data collection which
usually includes mandated follow up visits within the trial period during which patients
receive additional support. This was considered to potentially conflict with the current
study. Further, participation would have placed these patients at risk of research
burden..
Participants were recruited using the approaches of self-selection or active
invitation. Posters and leaflets were posted in both departments with contact details
made available; patients who were interested often spoke with the chemotherapy nurses
requesting more information and then either phoned the researcher directly or asked the
nurses to express interest on their behalf. This approach yielded only a small number of
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participants (n=4). The second approach was to write to all eligible individual
participants who were identified as meeting the inclusion sampling criteria by the
chemotherapy nurses. Those who were invited were provided with a letter of
introduction, a study information sheet, a tick box form to opt out, and an addressed
reply paid envelope (Appendix A). This method was more successful. Of the 20
patients who were invited, 10 patients agreed to participate in the study and 10 patients
chose to opt out by returning the opt out letter. Nine patients did not specify a reason for
their decision to opt out and one patient chose not to participate as he felt too unwell..
The researcher made frequent visits to both departments providing education about the
research and opportunities for discussion with the nursing team, in order to maintain the
profile of the research and also the individual nurses understanding of the process to
support discussion with potential participants. If an opt-out letter was not received by
the date indicated in the letter then the potential participant was telephoned to ascertain
their willingness to be a part of the process, if they agreed then the date and time for the
interview was confirmed during this call. On the day of the interview a text message
was sent confirming the interview time, telephone number and the contact details of the
researcher if they wished to change the arrangement. At the agreed time the researcher
telephoned the participant, confirmed the convenience for the individual, ascertained
permission to record the interview once again and repeated the explanation about the
study before the interview commenced.
Recruitment continued until theoretical saturation became evident. Theoretical
saturation occurs when no new relevant codes or concepts are identified in comparison
with the data already collected, only redundancy of previously collected data (Burns &
Grove, 2009; Gerrish & Lacey, 2010; Munhall, 2007). A total of 14 participants were
interviewed; ten were female and four were male. Ages ranged from 35 years to 78
years with a mean of 58 years. The length of time since completion of chemotherapy
ranged from four weeks to 14 weeks, with an average time since completion of
chemotherapy being ten weeks. The diagnosis of cancer included, gynaecological,
colorectal, breast and haematological with six having a haematological malignancy and
therefore being treated in the haematology department. The participants lived
throughout Western Australia, with eight based in Perth and four living in the far north
and south west regions of Western Australia (see Table 1).
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Table 1
Demographic characteristics of cancer survivors who participated in the interviews
Demographic domains

Variables

n

Gender

Male

4

Female

10

30-60

8

>60

6

Time since completing

4 weeks

1

treatment

6 weeks

1

8 weeks

2

9 weeks

1

10 weeks

4

11 weeks

3

12 weeks

2

Breast

1

Colon

1

Lymphoma

3

Multiple Myeloma

5

Ovary

4

Perth Metropolitan

10

South West Region

3

Pilbara Region

1

Age

Cancer Types

Place of residence

Theoretical Sensitivity
Theoretical sensitivity has been described as a key characteristic of Grounded
Theory. Glaser (1967) highlighted the importance of a researcher’s awareness of the
subtleties of the data. Theoretical sensitivity provides the researcher with the ability to
have insight, thus providing understanding and meaning to the data. This sensitivity
may be gained from literature or from professional experience. The researcher of this
study was a cancer nurse with over 25 years of cancer nursing experience; many of
these years having been spent delivering chemotherapy and leading teams of nurses who
care for these patients. Hence theoretical sensitivity was demonstrated as a key
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component of this research process. As a new researcher, this was managed by honest
reflection, memos and regular clarifying discussions with research supervisors.
Interviews
Interviews were chosen as the approach for data collection in this study.
Interviews were semi-structured and undertaken by telephone at a time and in a place
convenient to the participants. The flexibility of interviews enabled the researcher to
explore the subject matter in greater detail than other available approaches such as the
written survey. The support for interviews is robust in the qualitative academic
environment as a means of data collection. Interviews are considered to provide a prime
opportunity to capture an individual’s feelings, experiences, perceptions, thoughts and
social context; knowledge is produced as a result of interaction between the interviewer
and the interviewee (Kvale, 1996; Liamputtong, 2009; Marshall & Rossman, 2006). An
in-depth interview is considered the best approach for accessing the lived experience of
health and illness from individuals who are disempowered by their illness, not only is
this approach flexible but it allows statements to be followed up with additional
prompting and questions to clarify meanings immediately ( Holloway & Wheeler, 2010;
Low, 2007). An exploratory approach was used with a semi-structured interview
technique and the use of probes were used when opportunities arose to obtain further
information in a specific area. The questions were intentionally broad e.g. “ how long is
it since you completed chemotherapy and how have you felt since then?”. This enabled
the interview to be directed by the participant rather than the researcher. The questions
were contained within an interview guide (Appendix B). This was used to focus the
interview on the main domains being explored. The sequencing of questions varied
between individual participants. The guide ensured that the researcher had collected
similar types of data from all the informants (Holloway & Wheeler, 2010).
Traditionally interviews take place in a face-to-face situation, however due to
the tyranny of distance for many participants who lived rurally or in outer metropolitan
regions, interviews in this study were conducted by telephone. Holloway & Wheeler
(2010) supported the use of telephone interviews particularly relating to the benefits of
convenience, cost savings, immediacy of responses and spontaneity between the
researcher and the participant. A stated disadvantage of telephone interviews has been
identified as a lack of deep interaction as the interviewer and participant know each
other from a distance. The telephone interview approach required the researcher to rely
on well-developed communication skills as non-verbal cues were not available to
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establish how comfortable the participant was with the process. Equally the participant
can be unclear how much they were being listened to. Therefore, in order to facilitate
this discussion the researcher gave very clear instructions at the beginning of the
interview so that the participant could decline answering any questions they were not
comfortable to answer. The ability to use silence as a strategy to give the participant an
opportunity to reflect is very limited in a telephone interview. The researcher frequently
made small noises such as “um” or “yes” to indicate she was listening and encouraged
the participant to continue talking. She also clarified participants’ understanding of what
had been said by reflecting the key statements back to the participant for confirmation.
Occasionally participants checked the researcher was being attentive by asking
questions such as “Do you know what I mean?” or “Does that make sense?”
As an approach, telephone interviews versus face to face interviews have been
tested with no difference found between the number and quality of responses (Garbett &
McCormack, 2001; Gerrish & Lacey, 2010; Midanik & Greenfield, 2003). The
telephone interview requires a similar sequenced approach as in face-to-face interviews;
greeting the person on the telephone, confirming the purpose of the call and clarifying
that the time was convenient. Asking if the participant was comfortable and did they
have a drink was also deemed important. The introduction offered the chance to build a
rapport, explain what the study was aiming to address and clarifying any questions
about the process, including confidentiality. At this stage, permission to digitally record
the interview was obtained and consent to partake in the study was captured on the
verbal recording. The interview then commenced with an open general question which
set the scene by asking how long it had been since the participant had completed
chemotherapy and how they had been in general since then.
The duration of the interviews was determined by the participant and ranged
from 18-42 minutes. Interviews were recorded onto compact discs that were labelled
with the date and a pseudonym. Pseudonyms were also used in the transcription process
to ensure confidentiality. Demographic information was collected at the beginning of
the interview including the participant’s gender, age, treatment length, diagnosis (see
Table 1). The interviews were transcribed verbatim by an experienced individual to
ensure the participants’ words were preserved as accurately as possible. The researcher
who listened to the recordings many times in order to become immersed in the data
checked the accuracy of the transcripts. The transcriber signed a confidentiality
agreement (Appendix C) prior to commencement of this process.
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Data Analysis
The analysis of data followed the Grounded Theory approach of the constant
comparative method of data analysis first described by Glaser and Strauss (1967). The
Grounded Theory approach was followed to the descriptive level only; this included the
identification of codes, and the grouping of codes into themes. This method of analysis
on the data provided during interviews by the survivors and provided a descriptive
framework of their experiences at this time. The analysis did not follow Grounded
Theory to the theoretical level which would have analysed and processed the data with
the intent of generating theory and concepts which would have explained the survivors’
actions. In the descriptive method of analysis the researcher moves through the analysis
comparing each incident in the data with other incidents for similarities and differences;
those found to be similar are grouped together with a higher level descriptor. In this
process the researcher is able to differentiate one theme from another and identify
specific issues related to each theme (Corbin & Strauss, 2008; Holloway & Wheeler,
2010).
Once transcription of each interview was complete, the document was formatted
with page numbers and line numbers, as well as half sheet columns to leave space for
theme identification. Open coding was used first where transcripts were read line by line
and descriptive coding was applied identifying information, which was considered
important; the codes labelled common themes or categories. Holloway & Wheeler
(2010) suggested this type of coding prevents researchers from imposing their own
framework and ideas on the data. Initially 82 codes were identified (Appendix D). The
codes were then grouped together with codes of similar meaning that were linked to the
same phenomenon. This phase is identified as axial coding and is the step which allows
the researcher to connect different codes, identified in the initial coding. This
organisation of the data enabled connections to be made between a major category and
sub categories (Minicheiello, Aroni, & Hays, 2008). This new group of codes was then
further condensed to a smaller number of common themes. To reduce the risk of
inferential leaps by a novice researcher, constant discussion and exploration occurred
with research supervisors. External research supervisors assessed the credibility and
consistency of the thematic developments performing independent coding and analysis.
Appendix E provides an overview of the development from initial codes to a major
theme; this information may be used to establish the existence of an audit trail for this
research study.
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Trustworthiness and Rigour
There remains both confusion and disagreement within the qualitative research
field of nursing in relation to ensuring and validating the quality of a research approach.
There are numerous attempts to define what constitutes a good, trustworthy qualitative
study (Rolfe, 2006; Sandelowski, 1986; Sandelowski & Barroso, 2002). However
despite over 25 years of debate the one thing for which there does appear to be
agreement is that reaching a consensus on quality criteria is unlikely in the immediate
future (Morse, Barrett, Mayan, Olson, & Spiers, 2002). A solution to providing
trustworthiness (rigour) of a study may be possible if the reader is able to appraise the
events, influences and actions of the researcher (Koch, 2006)
Several approaches to demonstrate rigour have been demonstrated in the
literature. Guba & Lincoln (1989) framed the domains which need to be addressed as
credibility, transferability and dependability. Sandelowski (1986) and Beck (1993) both
determine dependability to be auditability, meaning that another researcher can follow
the decision trail employed by the investigator in the study. For the purpose of this piece
of research the Beck (1993) criteria to demonstrate trustworthiness in order to facilitate
the critique of qualitative research was applied to highlight the steps taken by the
researcher to illustrate credibility, auditability and fittingness as detailed below.
Credibility
Demonstrating credibility requires the researcher to describe the phenomenon
they are exploring in accurate detail. This description needs to be instantly recognisable
to people who have had that experience, or have professional expertise in that area
(Beck, 1993; Cooney, 2011; Glaser & Strauss, 1967; Guba & Lincoln, 1989). This
study utilised the Grounded Theory approach to the descriptive level of data analysis
which should enable the findings to accurately reflect the participant’s experience. In
order to demonstrate the credibility of the study the researcher opted to engage experts
in the field. This approach is supported by Cooney (2011) and Cutcliffe (2005) who
claimed that there is more resonance in the findings if credibility is agreed upon by an
expert panel rather than those who provided the raw data in the first instance.
Auditibility
By developing a comprehensive record of all methodological decisions, the
researcher creates an audit trail which provides sufficient detail to enable other
researchers to repeat the study in the same setting (Beck, 1993; Guba & Lincoln, 1989;
Jenks, 1995). In keeping with the Grounded Theory approach the researcher used
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memos in sufficient detail to provide detail of the approach taken, whilst recognising
that an audit trail is not a concept commonly described in Grounded Theory. The
memos provided enough detail to demonstrate how the initial 82 codes developed into
the themes (Appendix F) discussed in the findings chapter and supported by quotes
from the participants.
Researcher reflexivity is considered an important component of the Grounded
Theory approach (Cooney, 2011; Strauss & Corbin, 1998). An awareness and a
demonstration of the researcher’s personal assumptions, values and biases is an
important part of the discussion process. As the researcher has considerable experience
and expertise it was important to hold regular and frank discussions with the research
supervisors particularly during the thematic development stage of the study, to ensure
that bias was not determining the direction of the findings.
Fittingness
Otherwise described as transferability, fittingness determines that the findings
should be meaningful to others in similar situations (Beck, 1993; Koch, 1994;
Sandelowski, 1986). In order to demonstrate this criterion, the researcher has detailed in
this methodology chapter, the study context, survivor participant demographic profile
and characteristics of the study setting to enable future researchers to determine the
transferability of the study.
In conclusion Beck’s (1993) criteria of credibility, auditability and fittingness
have been utilised to demonstrate the rigour of this study undertaking the Grounded
Theory approach to the descriptive level of data analysis.

Ethical Considerations
Ethical approval to conduct this study was obtained from the Committees for
Conduct of Ethical Research at Sir Charles Gairdner Hospital (HREC 2008-070) and
Edith Cowan University (HREC 3706).
For Phase One, each patient participant received a letter of introduction and
study information sheet describing the study (Appendix A) and inviting his/her
involvement. The letter of invitation provided details regarding the purpose of the study,
use of information and an assurance of anonymity. Verbal consent to take part in the
study and have the interviews recorded was recorded at the beginning of each interview.
The letter of introduction clarified that individuals were under no obligation to be
involved in the study.
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For Phase Two, potential participants were sent a letter of introduction to the
study that provided details about the study and the requirements for participating in this
phase. A copy of the QOL-CCS and survey tools used for the testing of clarity, content
and apparent internal consistency was also included. Return of the completed survey
tools was accepted as implied consent.
Sources of raw data, questionnaires and computer diskettes were secured in a
locked filing cabinet in the office of the researcher at the Department of Health Western
Australia. Shredding of written data and deletion of electronic files will occur five years
following publication of findings in accordance with item 2.1 in the Australian Code for
the Responsible Conduct of Research (2007). No name related information will be used
in written reports or presentations, as only group data will be presented. Any data
collected has been used exclusively for this study and will be destroyed at the
individual’s request at any stage. It was also made clear to participants they could
withdraw from the study at any stage without repercussions to their treatment (patient
participants) or employment (chemotherapy nurses). As previously stated the transcriber
was required to sign a confidentiality contract and all recordings. Pseudonyms replaced
the participants’ names on the transcripts. A second researcher analysed the data to
provide an unbiased view and ensure a validity check.

Conclusion
In summary, this chapter has described the qualitative methodology used for
Phase One of the study as well as the ethical considerations for both phases. It has
illustrated the processes employed to collect and analyse the data and finally discussed
the ethical considerations that occurred before and during the study. The findings of this
study are outlined in Chapter Four. Direct quotes from the interview transcripts have
been used to highlight emerging themes. The participants are coded Survivor 1 (S01)
onwards for identification and attribution throughout the chapter A discussion of the
Phase Two quantitative methodological approach and findings for the study will be
presented in Chapter Five.
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Chapter Four
Phase One Findings
Introduction
This chapter presents the qualitative findings from Phase One of the study. Code
numbers rather than names of the cancer survivors who were interviewed have been
used. Analysis of the interview transcripts exposed cancer survivors’ perceptions of
completing chemotherapy treatment and the period immediately following this time.
Findings have been configured into two major categories according to a timeline on the
treatment journey. The first being experiences as chemotherapy completes, and the
second being experiences as the cancer survivor transitions onto the next stage of the
journey.

Figure 3. Illustration of findings displaying the relationships between timelines,
categories and subcategories of cancer survivors’ experiences.

Experiences on Completion of Chemotherapy
In this phase of the survivors’ journey, experiences related to the loss of the
treatment experience, emotional changes, and dealing with the physical effects of
chemotherapy (NB Chemotherapy was usually referred to as “Chemo” by the
participants in this study). Due to the complexity and interlinks between these
categories further sub categories were generated for clarity. Loss of the treatment
experience contains the following domains: loss of identity, loss of the treatment
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community and loss of perceived planned future. The emotional changes category has
been divided into the domains of: feelings of isolation, feelings of low mood and
unexpected emotional changes.

Loss of the Treatment Experience.
Survivors who were interviewed described going through a time of change.
Chemotherapy units, health care professionals, appointments for chemotherapy and
blood tests had been their reality for at least six months previously. This experience
occurred alongside other patients, family and friends and a community who supported
and shared the treatment experience. As this episode of the treatment journey drew to a
close, many adjustments were said to be required. This category was further divided to
include the domains of: loss of identity, loss of the treatment community and loss of
planned future; although they remain inextricably interlinked from the perspective of
cancer survivors.

Loss of identity.
Loss of identity related to patients no longer understanding or feeling like they
belonged and was a concept they struggled to express clearly, “It was a little bit, oh how
would you explain, like it was, like it was all over and sort of a little bit lost.” (S05);
and “In general [I am] feeling a bit lost in terms of where to go from here” (S04). The
readjustment appeared to be in making sense of their new situation and feeling as
though they no longer belonged, “I think I felt like I had landed back on Earth but in a
foreign country” (S04). There was an awareness that changes had occurred either within
themselves or their perceived place within society, “Just that sense of I can’t just re-join
the flock again and carry on as before” (S04). The fundamental question at this time
appeared to relate to finding their new place of belonging, “I am not who I was and I’m
not receiving treatment, so who am I?” (S04).
These feelings appeared to be heightened by the lack of preparation at the end of
treatment:
Because when you’re sick you just deal with the sickness and you’ve got a task at
hand but when all that’s over it’s just a different experience to that which I didn’t
expect … I was cut completely free and that was it. (S07)
The end of treatment was perceived as a sudden event, despite most patients knowing
their proposed treatment plan for months prior to completion:
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Suddenly you’re an outpatient, ready or not the systems finished with you …
You need an initiation back out from being a patient. It’s almost like being
homeless really. You’re not in the cycle any more. You are not really being
cared for in that sense (S04);
Suddenly it was right you no longer need us any more so that’s the end of that
…because I was going through it for so long that when it came to an abrupt halt
…you were a little bit lost (S11).
Loss of the treatment community.
Analysis of the interviews demonstrated that it wasn’t solely the loss of structure
and the task of being a patient that was being experienced, patients were also aware that
they lost connections with the treatment community in the form of health care
professionals and other patients: “There are a lot of nurses around that you can talk to
and people who are feeling sick as well” (S07):

There is such a sense of community I think when you are having chemo, the
support you get from the staff, from other patients and from other patient’s family
and friends I found really quite inspiring. After the treatment, it’s quite isolated.
(S04)
When treatment ended, there was an awareness among participants that they didn’t
belong to this community any longer and a sense that they didn’t know where to go
next, “You can’t really ring up the nurses because they are busy dealing with all the
new people … the support stops and you are not sure where to go” (S03); “It’s almost
like being homeless really” (S04).
Another participant said:
Well I know the girls there are really busy and they are really great and it was like
"oh! Excuse me, remember me, remember you were treating me, now I'm here
you don't need me anymore, I was special last week! How come I'm not special
this week?" and I was probably being a bit silly but I think they just haven't got
the time to fuss over, I mean I was being fussed over obviously I was having the
needles and I was having the chemo and I was having all this and people were
being sweet and kind and it was just lovely in that sense but suddenly it was right
you are no longer need us any more so that’s the end of it. (S11)
In summary, survivors valued the sense of community they experienced from
fellow patients and health care professionals, they experienced an acute sense of loss in
relation to the easy access to support that they received during their treatment episode.
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Loss of perceived planned future.
At the end of treatment whilst all of the above mentioned losses were creating
the turmoil as described, the opportunity to plan for the future appeared to be stifled by
the fear of what the future might hold, “That feeling of ambivalence I think, about what
I want to do in the future. What’s the point if it is going to come back?” (S04).
The challenge for the survivor to deal with the depth of these feelings was indicated to
be enormous:
It [having cancer] knocks around your sense of stress and security and the
confidence in the future and you just start feeling really vulnerable. And that was
probably the biggest thing for me, the biggest hurdle for me to get over. (S07)
Another survivor explained:
I really wasn’t that happy for a long time afterwards to be honest – it sets you
back and you sit around and you think you’re going to live forever and then you
realise you’re going to kick the bucket and then you haven’t got a chance anyway.
(S08)
Some of the survivors realised this episode of chemotherapy was not automatically the
end of their treatment journey, therefore the original plan they had focused on during
treatment was lost and readjustment to a new plan was needed already, “It would be
quite devastating to have done what I have done and then have a scan say that you
didn’t get a remission” (S07).Survivors also had an understanding that for them
chemotherapy may not necessarily be the end of their treatment journey, this was
especially problematic if the final chemotherapy date was in a state of flux:
I think not having an end date and being up in the air deciding that I had radiation
and also I had a mastectomy. So for me, chemo was sort of the end of treatment. I
still had decisions to make. So there were still emotional personal things going on.
So I guess what I’m saying is, I can’t just say “I’ve finished chemo and there’s no
other stuff happening”. Like still things in life to look at, and deal with. (S01)
The vulnerability experienced appeared to be strongly linked to the uncertainty of their
prognosis, “I suppose afterwards I found that was the time I needed emotional support
because that is the time I felt the most vulnerable” (S04); “ I’d get quite weepy … So
that I suppose knocks around your sense of stress and security and the confidence in the
future and you just start feeling really vulnerable” (S07); “I think it is still in the back of
my mind all the time, just worried that it is going to reappear” (S03).
One survivor recognised the fear caused her to have ‘bad days’:
There are days when you wake up and think you’ve got through all this treatment
and especially after I thought it was over and you didn’t feel well on a particular
day and you were thinking, God I’ve gone through all these months of this to no
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avail and I’m still feeling like this and you feel sorry for yourself … and you
know that you have gone through all of this and are all the tests going to come
back and say we’re not much further ahead. (S10)
Survivors whilst not overtly discussing this fear on a regular and open basis were aware
that it was an underpinning feature of their current emotional state. One survivor
discussed how she prepared for the worst whilst going through treatment:
When you are going for treatment you have a lot of time sitting in those waiting
rooms and there are a lot of people who get to know each other and they talk
across each other and you can’t help but listen to what they have to say and your
taking it all on board, I suppose how there treatments are going and all the time I
was listening to things that they are doing and how much time they have off
before being back again and I was actually preparing myself for all of that I was
thinking oh well this is not curable or this is something that you are going to have
to get on with. (S11)
In conclusion, the loss of the treatment episode of care in the survivors’ journey
encompassed experiences of loss of belonging and disconnect, loss of the patient role
and its accompanying tasks, loss of the treatment community including ready access to
support and finally a fear for their future knowing that treatment offered no guarantees.

Emotional Changes.
This category, whilst still concentrating on the end of treatment timeline, has
been further divided into the sub-categories: feelings of isolation, fear for the future,
feeling low in mood, and unexpected emotional changes. For all the survivors end of
treatment was expressed as a time of great emotional turmoil. Survivors expressed the
shock, vulnerability, isolation and fear that they experienced at this time. With a few
powerful words they were able to express their complete disarray at this time, “It’s
really frightening. Like it’s really frightening” (S01); “I’m a bit numb still” (S05).
The sudden loss appeared to be such a shock to individuals, “I was cut free and that was
it” (S07); “I think I found the first time I had chemo because you were used to going
(for chemotherapy) when it was cut off, it was a major shock” (S03).

Feelings of isolation.
Even when expecting the feeling of isolation, the emotional turmoil was evident.
This emotional turmoil encompassed a sense of isolation which strongly linked to the
emotions felt to the losses or disconnects that survivors perceive experiencing, “I feel
quite isolated that at the end you go ‘Oh my God!’ I’ve now got to navigate my own
ship” (S04).
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A survivor who had been through the journey before was prepared for this stage:
The second time I was more prepared for it … I mean the second time my
husband stopped work so I had someone here but I still felt, I don’t know how to
explain it because you are used to having that support and when it stops it is a lot
different. (S03)
Another survivor explained how this isolation affected her, “Some days I would have a
little bit of a cry to myself and feel a bit down … I would be home all alone … it was
tedious sometimes” (S13).
These feelings were not solely limited to the treatment community, but also to
the wider social circle of the survivor, “When you are sick and going through the
treatment you’ve got people ringing and enquiring about you and that sort of thing and
now that doesn’t sort of happen.” (S05). Conversely, another survivor described how
her cancer diagnosis caused friends to avoid her:
Some friends don’t know how to react, so there are some friends who I haven’t
seen in ages … it’s almost like they wait for you to be well again so they can cope
and so you just have to understand that it where people are at. (S10)
Survivors felt that others did not understand what they were going through which
enhanced their feelings of isolation and vulnerability, “Sometimes I’d feel as though
nobody cared what I was going through” (S09); the lack of understanding is further
compounded by the feeling of isolation:
I would have thought that someone popping in to see how you were going
probably would have unleashed an avalanche of tears if they had known what I
had been through … I was too sick to be out and about. And you get a bit house
bound as well so that didn’t help. (S07)
In summary, survivors were experiencing an array of emotions whilst feeling generally
isolated, this was compounded by a perceived lack of acknowledgment from others
about their tumultuous experience.

Feelings of low mood.
Survivors expressed a range of negative emotions to demonstrate the low mood
they experienced at the end of treatment, some felt too ill to feel any emotion at all,
“You don’t feel anything …You are just too sick to complain, you just want it to end.
Just get through the next thing you had to get through, the next day or the next hour”
(S07).
One survivor expressed feeling extremely low and suicidal on occasions
towards the end of chemotherapy (S01), others expressed not only the depth of feeling
42

but also the duration of this emotional state, feeling frightened (S01); “On the inside I
didn’t feel particularly great at all. I felt quite deflated” (S04). Another said, “It was
what made me depressed or I would bounce around … generally sort of get down and
sort of like a lot of people get depressed … it certainly affected all that year … I really
wasn’t that happy for a long time afterwards to be honest” (S08).
One survivor described the unpredictable nature of recovery after treatment as
particularly detrimental to her emotional health:

I think it was the unpredictability of it that made it difficult, you know it’s not like
anything you had before, when you have the flu and you start to get better and
you think ok I’m on a roll, but with this you felt like it was one step forward and
one step back. (S10)
Even when survivors were excited and positive about the prospect of finishing
chemotherapy, emotional swings occurred:
Initially I was quite excited to finish chemo and really sort of looking forward to
that wishful thinking, you know all the things that you are going to do … And I
was actually really surprised at how depressed I got and how emotional I became,
probably about a month after treatment. (S04)
Survivors had clearly encountered many emotional changes along the journey to this
point; they often appeared to have unanticipated emotions.

Unexpected emotional changes.
Survivors described events or people who upset them which appeared to take
them by surprise:
Psychologically, some unforeseen difficult and upsetting moments, which I didn’t
anticipate. You know, emotionally fragile sometimes. A bit like post-traumatic
stress, you know … I would start talking about my experience to somebody or I
would see something on T.V which was about cancer or needles or something and
I would get a bit upset and then I would need to have a real bawl and that took me
by surprise … I was quick to get upset a few times with things and just beautiful
things as well you know, gifts and people doing nice things for you. I’d cry a lot.
Kindness made me cry a lot. (S07)
Survivors own expectations also contributed to the emotional turmoil experienced:
I sort of expected myself to feel full of life and feel absolutely fabulous. But I
didn’t … And the pressure to be, something new or, yeah there is a bit of pressure.
Just got to be really happy. And every day is fabulous. (S04)
The desire to protect loved ones placed an additional burden on survivors:
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My sisters would ring each day but there’s a need to protect the people that you
love as well you know, but I didn’t want to discuss what I was going through with
them because they had gone through the journey with me already. So the more
together you are the more they can relax and let go, I just wanted them to relax a
bit. So I felt like I wore the emotional thing pretty deep. (S07)
External pressures such as financial responsibilities also contributed to the emotional
burden:
Well, I couldn’t get sick leave … Because I don’t own a house or anything like
that but I’ve been saving pretty hard to try to get something like that. So because I
had liquid assets they didn’t find me eligible … So that, that’s really stressful
when you’re a single woman who has been diagnosed, yeah, it’s really stressful.
(S01)
In conclusion, the completion of chemotherapy treatment is an emotionally
tumultuous time; survivors expressed a myriad of mostly negative emotions including
fears, isolation, low moods and unpredictable emotional behaviour. Coupled with the
feeling of being disconnected and loss of structure from the treatment experience, this
was clearly a very difficult all encompassing experience to navigate through.

Physical Changes.
On completion of chemotherapy physical changes are common, some transient,
and some permanent. This section explores the physical effects experienced at the end
of treatment. All of the survivors were dealing with physical changes, which were
impacting on their day to day lives and emotions at the end of treatment. The range
included unique complaints such as:
The muscle wasting, fatigue, my stomach was sensitive to certain foods so I had
aversions to certain foods, so I under ate for a while because I did have a
perforated duodenum so I’m not sure if it was because of that or the drugs or both.
I felt a slight passing nausea which made me not want to eat certain things. (S07)
Another survivor said:
Okay except I’m having a lot of trouble when my body gets warm. I get these
terrible itching all over me like ants crawling all over me . . . From the top of my
head … its not like an ordinary itch, its like something crawling all over your
body, you know, like ants. (S09)
Some physical changes were described by several survivors and included: constipation, nausea, weight loss, swollen legs, hallucinations caused by drugs, joint
stiffness, sore mouth, taste changes and memory impairment.
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Hair loss was another common physical change experienced by several of the survivors.
In addition, when hair had regrown the change in body image had a significant impact
on one survivor:
I have had a little cry, I look so different … I used to have long hair right the way
down my back and it got all knotted with the chemotherapy and I had to shave it
all off, I have white hair now … I look so different, it’s a different ball game…I
was a pretty little girl before now I look like a business tycoon. (S13)
The overwhelming physical change discussed was fatigue which was expressed
as physical weakness and lack of energy, “Fatigue was the big one … physically I felt
quite tired” (S04); “I think I just had a physical depression. I don’t think I was mentally
depressed, I think my body was depressed” (S07); “Tiredness, definitely … when I
finished I was tired for quite a while” (S09). The awareness of fatigue was related to
how much they were able to do:
I’ve still been tired. It’s better now though that the chemo has stopped. When I
was going through the chemo, I was extremely tired but it is getting better, slowly
… I was in bed at 7:30 or 8 o’clock every night. So that’s not normal no. (S03)
Mentally, I want to do things but physically I can do some small things but it gets
very tiring because I have lost so much muscle and condition and God knows
what else. (S14)
No energy, not being able to get out of bed and each day was the same as the last,
that’s the awful thing, you think tomorrow you’ll feel a bit better… I thought I
was getting better and then I would have a day where I was completely without
energy and completely exhausted. (S10)
The fatigue prevented survivors from working, “I was just obliterated so I
stopped and I haven’t done any work since then” (S01). Or the fatigue caused them to
modify their work hours in a staged way, “I was working full time and then I went part
time because I had to have a hysterectomy. So I had the six weeks off, I went back part
time and then when my chemo changed I was too tired” (S04); “I can’t work, I’m not
physically strong enough to work yet, but luckily I have income protection” (S11).
Survivors identified that doing simple things, such as walking short distances was
challenging, “Well I started off just trying to walk to the corner because I had lost all
my muscle strength. I was all floppy. Then I started walking around the block slowly,
holding on to somebody” (S07).

Especially in comparison to pre treatment energy levels:
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I just have to pace myself, so it’s like being old, you know, when you are
continually pacing yourself and thinking no I can’t do too much … I was working
10 hour days going out at night and I was pretty much doing what I wanted. (S10)
“I’m simply not as strong as I would like to be … I still have to work on doing a bit of
exercise and more walking”. (S12)

The frustration of having time to do things but not the energy was another challenge to
survivors at the end of treatment:
What I’ve noticed is that when people are getting treatment often they don’t have
the energy or time or resources to participate in anything else but after treatment
you suddenly have all this time and you are not well enough to go back into your
old life or your new life. (S04)
Fatigue was identified as a significant contributing factor to the challenge of
remembering:
I had a notebook and I would take that with me. ‘Cause it’s really hard when
you’re emotionally in there and you’re so tired, to remember it all, so I didn’t
need to get myself to remember it off the top of my head. I always and I still do it,
still mentally list stuff. (S01)
Survivors were aware that they weren’t remembering important information that they
wanted to retain: “I often felt like I knew that I couldn’t get my brain to the places
where it needed to go. It was just like my head was murky” (S10)

Because you can’t remember. If you are sick, then your memory is shot to pieces
and if you are tired you are not absorbing information. So you know you have got
to go see a doctor in four weeks but you can get easily confused … It hasn’t been
that great and I haven’t really recovered that well and since the chemo has stopped
there. (S07)
Fatigue had a strong negative effect on emotions and feelings:
You are really weak and you want to look like you’ve got things together but I
just drifted around and cried a bit because I just got so fed up trying to haul my
body out of bed and you feel so weak. You feel weak like a kitten … when you
get up you collapse … And that makes you feel so pathetic but then you feel
pathetic emotionally….I was so low on energy that I just didn’t feel anything to
intensely it was just like a depression so I didn’t feel anything that intensely but
once I started to get better and my energy went up my emotions were more
intense so it upsets you more. (S07)
However a positive effect was noted as fatigue improved, survivors were aware of even
slight improvements in fatigue levels, “Physically, you know where you are physically
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weak in the first few weeks. And then you get your energy back which is such a boost
to your mood to get some energy back” (S07). Another said, “I have a reasonable level
of energy, I can walk a little bit faster. Like last week I was aware I went to the garbage
bin, and I did it without feeling like I needed to collapse was great” (S01).
The relationship between fatigue and level of mood is so intertwined it was said
to be impossible to consider one without the other, a change in one has a corresponding
effect on the other, “There’s no way to disconnect the impact that physical exhaustion
has on your spirit and emotion” (S01). Only one survivor (S11) did not have any issues
with fatigue and described herself as having “absolutely bounds of energy” since
completing treatment in comparison to feeling continually tired whilst having
chemotherapy. Interestingly this survivor displayed positive self talk from diagnosis
onwards:
My conclusion was at the very beginning that my life would not be worth living if
I let this get to me, that’s how it would be, if I couldn't live my life as best I could
and let this get to me then life would just be unbearable as far as I'm concerned.
So I just incorporated it. (S11)
Survivors recognised that some changes were going to be long term; one survivor
whose cancer had affected his back discussed the emotional toll of the physical change:
I would like to have been how I was before …well that may happen but not to the
same extent, I find it pretty boring just sitting at home, because I’m limited in the
fact that I can’t do a lot of exercise, I can’t do any gardening or tinkering in the
shed … I know myself that certain things won’t happen that way again, you know
the body’s damaged it’s never going to repair itself to the full extent … I may or
may not have to wear a back brace for the rest of my life. (S14)
Over half the survivors experienced an unplanned/unexpected hospital
admission, because they were so physically unwell at the end of chemotherapy
generally due to infections. Survivors described being extremely unwell due to
infections, adverse treatment events and allergic reactions, which for the individual
were all encompassing and for some resulted in several weeks in hospital after the
completion of treatment. Whilst the survivors were still connected with the treatment
community they were not well enough to begin their transition onwards, physically they
remained dependant on their hospital teams and psychologically they had not begun to
experience the losses related to treatment end.
In summary, the time immediately after completion of chemotherapy was filled
with experiences of loss in social, spiritual, psychological and physical domains. Social
domains include the loss of relationships with the treating teams and fellow patients,
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spiritually, self perception has often altered with a loss of self identity and an increased
awareness that they have changed as a result of their journey; with a resulting need to
revaluate their future. Psychologically survivors displayed a range of altered emotions
including shock, vulnerability, isolation and fear. Physical changes were evident and
common across all survivors, although there was variation across the range of physical
changes; fatigue was common and compounding.

Experiences in Transition
For the purpose of this study, transition is defined as the process or period in
which a person with a cancer diagnosis undergoes a change and passes from one stage
or state to another. Cancer survivors often refer to their coping skills or ability to cope.
In this study to cope is considered to represent the ability to deal successfully with a
difficult problem or situation.
From the evidence provided thus far, it was clear that at the end of treatment
survivors faced a series of personal challenges they felt physically unwell, emotionally
in turmoil, socially disconnected with a lack of recognition of their suffering from
others, and were questioning their future. Analysis of the interviews demonstrated that
as survivors began to improve physically particularly from symptoms of fatigue, they
also began the process of transition towards their new future. The process of transition
involved dealing with the highlighted personal challenges whilst finding new balance,
working towards their future goals and achieving a normal life.
As the all-encompassing effects of physical fatigue begin to recede, the intrinsic
characteristics of human nature took over. This section has been divided into two
categories resilience and empowerment; in the interests of clarity the empowerment
section has been further sub categorised into self-awareness, self-protecting, self
informing and self-management.

Resilience
As physical strength of the survivors began to return, their personal resolve also
began to return. During the interviews survivors articulated a range of personal values
and beliefs which helped them to cope with the process of transition, “I just live life as
normal” (S02); “I mean my attitude is that I not going lie down and die” (S08).
Another survivor explained:
I’m quite a positive person I suppose and that seems to make a difference …Yeah,
I suppose I am quite blessed as a person my observation is that everyone in life
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gets an opportunity to go through a crisis and that it is how you handle things
rather than what is happening to you. Attitude is everything. (S04)
Another said, “I think . . . I know, I promised myself that no matter what happens . . . if
I’m to die from this or if it came back or anything like that I would be okay if I make
sure I’m true to myself” (S01). This survivor describes what the impact would be for
her if she was not positive:

I can’t let this affect me … I can’t let this get to me … I didn’t even voice it, I just
thought I’m going to do this and get through this as a part of my day or week and
incorporate it into that … I can’t imagine not being positive, that’s me, it would
be just awful to live negatively, I couldn’t love that way, it’s not how I live, life
would not be worth living, If I had to live that way , it would be too miserable, far
too miserable. (S11)
Survivors appeared to accept that this was their personal challenge:

I think just accept what’s what. You can’t choose what is sent to you, can you? …
You can choose the way you accept it. And I think most people can with a bit of a
push, looking at it in the right light rather than the ‘woe is me’ attitude which I
know a lot do have. There is nothing you can do about it. (S06)
Another survivor highlighted her personal balance:
Where I am emotionally and mentally, that has been the biggest thing that I’ve
protected. That doesn’t mean that I haven’t physically tried to take care of myself
… a couple of months ago I pushed a little bit more than the average person
would. I wasn’t meaning to. I’ve always been like that as a person though, so
there’s some things you just can’t straight away turn an off switch on … I’m not
going to blame myself around that. I do things; I’m a do things person. (S01)
One survivor described how she was surprised to find the inner strength she had, “I
don’t know where that strength came from, it must have been the Lord, I don’t know
where I got the strength, I was really strong … it changed my whole life … I think I feel
more confident now than when I started (S13).

Survivors displayed acceptance as they worked through the transition phase, that this is
a long term journey from which they may not fully recover:
Be prepared for the long haul, be prepared to be inconvenienced, it’s your life, if
you want it you’ve got to put up with it and follow what is told to you and don’t
expect miracles overnight … it’s about five years before you know how things
are going but at the moment you are in for the long haul … it’s a long road to go
before I get back to somewhere that I was before, if not totally back to where I
was. (S14)
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However being accepting did not mean giving in, “Well I’m not about to sit at home
and think ‘I wish I had done this because a week down the track and my feet aren’t any
better’” (S06). Survivors drew on their own personal resolve and coping skills during
this period, “Something, just within myself has come up at a time when I needed it”
(S01); “I just dealt with it by myself” (S03); “I’ll get through it like I normally do and
that’s it” (S04); “I worked my way through it … I was down in the doldrums for a
while so I worked my way through it” (S08).
Survivors displayed differing views on emotional resilience from firm views about
anxiety and depression:
No I don’t believe in that [Depression] sorry … Well the whole thing is if you let
things get you down, and they do at times, like when your husband passes away.
You don’t spend 42 years with someone and it doesn’t get to you and that took
quite a few years to get over, I’ll admit. But when I think health is concerned, how
can I put it? We were brought up to always look after our health so we were a
healthy family … we are all of a similar outlook on life. Get on with it. (S06)
To actively managing potential emotional issues:

I’ve been pretty proud of myself mentally; I wasn’t pushing myself to be positive,
feeling what I was feeling. Ever since I was diagnosed I’ve been going to see a
breast cancer counsellor and getting help regularly, it just helps me to process and
get through it … I don’t want to be pushing down anything, stuff that I haven’t
resolved. (S01)
There was also an awareness of the need to be kind to themselves:

Be kind to yourself and take it slowly, don’t expect too much, you know it is
going to go up and down and you are going to have bad days and sad days …you
just have to pace yourself and the people around you have to understand that and
be good to you too. (S10)
From the analysis it was clear that resilience is a complex web of personal
values, attitudes and attributes that each person brings to their personal cancer journey.
The importance of acceptance, understanding this is their challenge and maintaining a
positive attitude appeared highly important to survivors. The resilient streak displayed
here was not evident at the end of treatment when physical fatigue dominated the
person’s outlook. It could therefore be concluded that human resilience changed a
person’s focus as the process towards transition began.
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Empowerment
Once survivors began to articulate and display their resilient spirit, the next step
in the transition process was becoming self-empowered. This was displayed in a series
of complex strategies which contributed to their self-empowerment and ability to take
control of their destiny towards achieving their personal goal. The action of
empowerment was further divided into four categories of actions: self-awareness,
seeking support, self-protection, self informing and self-management were all found to
be important aspects related to empowerment of the survivor.

Self-awareness.
Survivors were aware they had maintained a mostly passive role during
treatment and that transition required a different behaviour from them:
You kind of sit around and take what you need to take during the treatment but
when you get better you don’t want to do that anymore. You want to be a bit more
pro-active and less passive. When you are sick you are happy just to lie there and
let anyone jab anything in you, you know? But that is not suitable for when you
are well. You need to be a bit more self-determining about your life. I could have
gone six months without any follow up treatment if I hadn’t followed it up. (S07)
Whilst survivors were able to take control of limited aspects of their treatment plan, the
following survivor’s emphasis has shifted from her need for treatment to her need for
rest, … “and then I said, actually I’m due to start radiation in a couple of weeks … look,
no, I need to go and have this holiday rather than change the dates again” (S01). This
same survivor identified that she had personally changed and learnt the skill of assertion
in order to meet her own needs:
I did get through this, and I’ve learnt so much about myself, and I’ve learnt so
much about, my ability to be assertive, my ability to sit in a doctor’s office for
once and know what I want and actually say to him “no, look what you’ve just
said to me has made me feel incredibly anxious. (S01)
Survivors’ ability to self manage their future included testing this control by rebelling
against normal expected care, “Ironically, I started smoking, heavier than I have done
for years and years and years in January. There was that bit of me that wanted to be
really rebellious and you know I can and will and who is going stop me? … Almost a
bit defiant” (S04).

However this individual soon reverted back to self-management processes that would
support her goal of good physical health:
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I’ve just given up this week so I am feeling very virtuous and it is kind of that
sense of I suppose that smoking for me is a coping mechanism. It’s one of those
things that I go to. Not healthily, I know that but old behaviour that dictates how I
do feel about myself. I’m making some choices out of caring for myself rather
than being rebellious. And I am sure it is part of this coming back out, actually
being able to function for more than an hour at a time. (S04)
The ability to foster their personal resilience and take control of their destiny was not
developed in isolation, for some recognition and support from others was an important
enabler:
I’m a bit angry now and I’ve identified that I have become a bit crabby and angry
and my boss has said that ‘I think you have spent so long being passive and
accepting of everything that has been happening to you that now you’ve got your
strength back you have become intolerant of things you don’t want to put up with’
making me a bit crabby. And I’ve got a lot of complaints about life at the moment!
I don’t like being like that so I have some issues … I’m always having to
apologise to people for being so grumpy. (S07)
Another survivor identified:
And also, he said to me “Ask lots of questions, ask lots of questions. You don’t
have to be a bitch about it, ask lots of questions. Because as soon as you start
asking lots of questions they’re going to give you more information, and they’ve
realised you’re interested.”… he gave me this great pep talk, and it was really
great. And he also gave me someone who is not your traditional Western
medicine…. I think, it’s not that I don’t trust Western medicine but I just didn’t
want to hand myself over and go “what did you think?” (S01)
Seeking support.
Survivors were adept at finding emotional support that suited their needs, they
displayed self awareness of whom they chose to reveal their inner emotions too, often
rationally protecting their family and therefore indirectly themselves:

I could talk to them [breast care nurses] in a way about stuff that maybe my
family couldn’t quite hear, because they might freak out a little bit. But I could
just say life’s really crap, I’m feeling a bit suicidal, or whatever was going on, you
know? (S01)
Survivors protected themselves from the consequences of sharing their emotions, they
were acutely aware of the impact of others and their need to create distance in order to
reduce their own anxieties and emotional needs, one survivor chose to stay in the WA
for treatment even though her family was on the east coast:
But they’re very stressful, emotionally (my family). So it was kind of good to have
the distance, even though physically it was something your family could do,
emotionally it was easier … I didn’t need to protect them, this has been a big
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exercise for me learning to put myself first, emotionally and part of my family
issue is that emotionally it would have been all about other people first … So
when I’m saying protect I’m really meaning that I disclosed or didn’t disclose
things to protect myself, my emotions. (S01)
Survivors often sought professional emotional support to enable self control of their
emotional health, their relationships and their personal goals:
Ever since I got diagnosed I’ve been going to the breast cancer counsellor, and
getting help quite regularly, it just helps me process and get through it …I don’t
want to be pushing down anything, stuff that I haven’t resolved (S01);
“I went to see a psychologist at the same time to kind of pre-empt that transition
back into non-treatment” (S04); “I think it really helps to have someone else to
listen to what you say and weigh it up a little bit and have some ideas to help”
(S13).
Self-protecting.
Self-protecting proved to be another important empowerment strategy, once
survivors had started to gather their resilience and take control of their destiny, there
was a need to maintain a focus on a positive future even if there was a continual
background fear for their future. Survivors were particularly focused on maintaining a
positive outlook and approach in order to do this they avoided negative environments,
situations and people as much as possible:
Because I joined the cancer support group and that was good but it was also
with people that were sort of the cancer has recurred the second, third and fourth
time and I feel like I am in a really different place from them (S04).
Survivors were aware of the impact of others emotions on themselves and could focus
clearly on self protecting distancing strategies:
There is a lady who is from down this way as well and she is a few months behind
me and she was a little bit negative and she was struggling mentally coping with
the diagnosis and that type of thing and talking about death and that sort of stuff
and I found that a bit hard to handle. It brought me down talking to her. But I’d
always try to be positive about it. (S05)
Survivors were able to set boundaries around their information needs whilst managing
their self-protection tactics:

It really rattled my cage that flyer because I had been so motivated and I had been
so positive about getting back and getting on top of things and feeling so great and
I just felt that was a real crushing blow and I couldn’t let that go without saying
something … So if I could continue to receive information that wasn’t anything to
do with death and funerals I’d be happy to receive it. (S07)
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Survivors used humour to hide their true feelings, either to protect family and friends:
I’d get quite weepy but then I just laughed and told them not to take any notice, I
do this a lot … there’s a need to protect the people that you love as well … the
more together you are the more they can relax and let go and I just wanted them to
relax a bit. (S07)
Survivors also felt the need to appear in control, “you want to look like you’ve got
things together” (S07); “I would crack jokes about it but I wasn’t that happy about
things” (S08). Survivors were aware of their self image to others and engaged close
acquaintances to help manage these connections:
Protect yourself from well wishers because you’ll have to say your story over and
over again and you are tired and exhausted so you don’t want to have to repeat the
same thing over and over again and upset them more because you sound so tired
and weak they can hear it in your voice … Have someone to protect you. My mum
stood between me and phone calls a bit, which was good. (S07)
In order to maintain her positive energy one survivor described her avoidance of
dwelling on the past:
… I try not to look back on it either, why don't I look back? I don't look back
because that’s past and I very rarely look back in the past anyway you know so I
again it is a part of me and a part of the way I think so I guess it is forward always
with me. (S11)
Another participant avoided the present issues in both her actions and how she thought
about herself:

I haven’t even marked it on the calendar, I suppose a bit of an avoidance thing, I
don’t dwell on it, I hedge around it all the time, I don’t let it get me down, I don’t
think I’m a cancer patient, I never think that … but I suppose I am though. (S13)
Distraction was also found to be a useful self-protection strategy; by keeping busy so
there wasn’t time to think about the particular areas of concern, “My thing would be to
keep busy and you know I guess, don’t let it get you down and find something to do that
you can do without thinking about it” (S08).

Self-management strategies.
Survivors’ personal beliefs were indicated as having a strong impact on how
they developed strategies to manage the physical and psychological impacts of cancer
and the chemotherapy treatment during this transition period. Physically survivors were
able to monitor and modify their activity to support their recovery from fatigue and
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their gradual physical improvement, by setting goals and targets and testing their
abilities, their choices included who they wished to get support from and what help they
wanted to aid recovery:
Obviously not one hundred per cent, but relative to chemo I’m …waking up
feeling reasonably awesome, and everything …I have a reasonable level of
energy, I can walk a little bit faster. Like last week I was aware I went to the
garbage bin, and I did it without feeling like I needed to collapse was great. So
it’s just really simple things, like, I’ve got more energy, I wouldn’t say I’ve even
maybe seventy per cent. But relative to how crap I was in chemo it feels like a
hundred and fifty per cent. (S01)
Survivors were aware of different interactions in public, alongside the smallest
physical improvements, “I really noticed that physically I was getting stronger. I started
Pilates and making a commitment and now my hair has come back people don’t
automatically look at you and assume”(S04); “if its physical I get quite stiff, but I’m
getting stronger and stronger in terms of fitness” (S08).

Survivors were adept at managing their lifestyle to their slowly improving fatigue
levels; this appeared to be an intuitive approach rather than a strategically planned
action, “You can’t force anything, if your body doesn’t want to do it, there is not much
you can do” (S12).

Survivors discussed how they slowly adapted but constantly reassessed their ability and
progress:
I used to potter a little bit … Then I’d sit down and have a rest and then get up and
do something else and sit down and have a rest …When I go food shopping, my
husband always used to, we always used to go together . . . But I am starting to go
a little bit on my own now. (S05)
Well I started … just trying to walk to the corner because I had lost all my muscle
strength. I was all floppy. Then I started walking around the block slowly, holding
on to somebody and then I got a treadmill and so when I started back at work I
started getting on the treadmill and then I started to do 30 minutes on 6 kilometres
per hour … I was full time and exercising 5 mornings as week, on the bike once a
week. Now I do it on the weekends as well. I just found the contrast between bad
and good and did it when I felt good. (S07)

For other physical side effects of chemotherapy, some of which started during
treatment and continued into the transition phase, survivors used a range of approaches,
often dependent upon previous coping skills and strategies. Self-management of side
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effects was demonstrated for many physical symptoms such as dealing with the problem
of constipation, this survivor had a goal which they monitored, if they didn’t achieve
this, then they used prior knowledge to rectify the situation:
If I don’t go to the toilet one day then I’ll take some prunes or have some oats
or something the next day and if that doesn’t work then I’ll take the pill. I’ve
never had to in my life before but when they say this can happen well I look
after it so it doesn’t happen. (S06)
Another survivor talked about how he self-managed insomnia, again he had a goal,
monitoring and a solution in process to deal with this based on his own knowledge:

I found the solution to my lack of sleep, the easiest way was listening to tapes if
you watch TV or read a book you fall asleep then I’d wake up and I was worse.
This way I fall asleep with the ear phones, they drop out and I don’t hear
anything anymore. (S08)

All of the above actions are based on previous knowledge and expectations,
individuals have their own acceptable goals which they monitor and take action to
rectify as needed. Survivors throughout the interviews described a range of areas where
knowledge deficit hindered their ability to self-manage and cope with their physical and
emotional recovery from chemotherapy and their transition onwards. This tended to be
in domains that were previously unchartered by the patient, in other words they had no
prior experience and knowledge on which to draw to rectify the situation. For example
at the end of treatment one survivor said:

I just felt like a malingerer, laying around, not doing anything and if someone had
of said then “Most people take this long and you’ve had this happen and you are
still doing really well. You don’t need to rush.” That sort of reassurance that I am
doing normally or am I really sick or am I doing great? That would be good
feedback. (S07)
As the survivor above couldn’t reconcile prior knowledge and physical ability, she
experienced a negative impact and perception of herself, she recognised that had she
had the knowledge this would not have been the case. Whereas another survivor (from
the quote below) felt more positively because she had a ‘cause’ or knowledge of why
they were encountering this experience. She was able to accept and self-manage the
period of fatigue. It is therefore evident that knowledge helped survivors to find
personally acceptable causes for negative experiences:
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… just in part of my brain, from the conversation I’d had with people, there was
just a seed that was planted that said, you might feel a bit down and know that it’s
just the drugs … It’s just enough there to help me go, okay, to separate me and
the process … It’s really, really important, because otherwise it’s like selfidentifying as always down or always feeling fatigue. And just going, now hang
on, there’s a separation between who I am and what I’m capable of and the fact
that I’m just going through this really debilitating, depressing phase (S01)
Survivors indicated that hearing about the physical experiences of other survivors
helped them to understand, the information or ‘lived experience’ of other survivors
helped them to understand and fill in a prior knowledge gap:

One of the things that I understand now from talking to other cancer survivors that
I didn’t know is like body stiffness. Like getting pains in my hands in the middle
of the night. It shifts around my body like in my hips which talking to other
people post treatment they’ve all said “Oh yes. That’s normal”. (S04)
And that might sound funny but if she’s gone through it and you hear someone
else say that it makes you go, “oh, okay I’ve finished chemo but it’s going to take
a while for my body to get over this”. (S01)
Survivors who felt unable to self manage their experiences identified limitations in the
new information they were given which limited their ability to prepare and instead
encountered negative experiences and undue anxieties:

Right from the word go I had been very annoyed that they give you an overview
of what is going to happen … you read the documents on it and that gives you
some of the side effects, had they have been clearer I would have been much
more prepared … I know the effects are different for different people but if
you’ve got that little bit of information you know what to expect … instead of
thinking something has gone wrong. (S14)
This survivor felt that the limited explanations compromised his ability to self-care,
“They don’t explain the blood test very well … I had to ask for the blood test results …
nobody told me whether this should or should not be a worry. If I had the blood count
or the cell count then I would have responded properly” (S02).
Survivors were able to identify areas of knowledge deficit that would benefit
from information and enhance their ability to understand and self manage situations.
Survivors wanted to understand the impact that chemotherapy had on their body
particularly the long term impacts of the drugs in their system:
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I would find it really useful to have some guidance around after chemo has done
its job; I suppose I have this image of wanting to be able to clean my body out.
And whether it does make any difference like a detox or a cleanse or that kind of
thing. Maybe it’s psychological but it’s like I feel I have got residual chemicals in
me that maybe are creating problems now. (S04)
Survivors were aware of their limited knowledge in regards to both treatment planning
and how little they understood from their actual treatment. They sensed the
fragmentation of health information relating to their care. This enhanced their anxiety
about future care and the need to gain knowledge and take control, “I just sort of went
with the flow and half the time I didn’t even know what was going on” (S05); “They
don’t explain … They look at the results and they don’t tell the patient very much … I
need to know but the chemo guys don’t tell you anything” (S02).
It’s hard because you get confused about everything and then the medical system
and the doctors are using computers and whatever and the medical records and
you go in there and you go to see the doctor/specialist and it is totally
discontinuous and no one has got it … so it’s very hard I think for them to know
your allergies and how you are with chemo. (S08)
In the transition phase survivors expressed significant information gaps about
plans for their future care and not knowing if the treatment had been beneficial, this
prevented their ability to take control and self manage: “I got a CAT scan, I did it a
month ago … they haven’t told me what they are going to do yet” (S02).

Survivors continued to feel lost and had information gaps relating to support they could
access: “… the support stops and you are not sure where to go” (S03), “ in general
feeling I’m a bit lost in terms of where to go from here” (S04). Knowledge was clearly
an important commodity for survivors, with appropriate knowledge and their prior
learnt behaviour survivors could take control by being assertive. If the survivor
encounters an experience they have dealt with before they can draw on prior learning to
forge a way through the issue no matter how arduous, even whilst still experiencing
significant fatigue one survivor recounts how she managed to achieve antibiotic therapy
at home:
They sent me home with some antibiotics … and I had an allergic reaction to the
oral antibiotics and they wanted me to get back in the car and go back up to Perth
and I knew what the problem was so I chucked them (the antibiotics) in the bin
and I said I am not going back up to Perth … I said it’s ridiculous, we’ve got
trained staff here in Bunbury, I need a new script, I need a different antibiotic and
so I rang up my doctor and I rang up the haematology centre and I made them talk
to each other and I can get a blood test down here and I can get a doctor to
prescribe an appropriate drug down here. I don’t need to travel 200km back to
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Perth and neither of them were happy. My GP wasn’t too happy but the
haematologist was quite co-operative in the end. (S07)
And how she managed her planned follow up care:
In December I had to remind him (the doctor) about that (missed PET scan) and
then by the time we had booked another one that was six months. The doctors plan
was that I was to have Mabthera (a monoclonal antibody given IV after acute
treatment for a period of several months) and that hadn’t been initiated either I had
to tell the girls that I needed that at the next appointment as well. I felt like I was
managing myself completely without even a written plan from the doctor and then
I had to double check and ask “Can you double check that I have done the right
thing?” In my March appointment I booked myself to have Mabthera. (S07)
And how she clarified information about her treatment in order to manage future care
episodes, realising that this may be important knowledge to have:
I mean I didn’t know what drug I’d had, I don’t know if I’ve had the swine flu
injection or not because I got treated as a swine flu patient at one point. I don’t
know what went on; it was all a bit of a blur. I just had to cross my fingers and
hope they know what they are doing. I really should have some idea of what I
have had. And I had to ring up and find out what the drug was that was making
me sick four weeks ago because I thought ‘I need to know what that antibiotic is
that is making me sick. I’ve got no idea. (S07)
One survivor attempted to control the process so that she did not have to endure the
period of awaiting results, this sadly did not come to fruition, “I asked if it was possible
to get results by email rather than wait six weeks for an appointment, that was arranged
and teed up and I never got it. And I didn’t get onto it, I waited for the appointment,
you know the resignation thing” (S07).
Knowledge also enabled the survivors to set realistic expectations, a central
action to all the survivors’ behaviour in coping throughout their journey whether it was
immediately post treatment or in the transition phase as they started to recover from the
impacts of chemotherapy was that of planning. Whilst on chemotherapy planning
appeared wishful:
Initially I was quite excited to finish chemo and really sort of looking forward to
that wishful thinking, you know all the things that you are going to do. So I
suppose having had chemo I spent a lot of time thinking of the resolutions if you
like of the things I was going to do. (S04)
As survivors moved into the transition phase their planning became more hopeful and
they started to set new goals which were solely focused on their physical abilities such
as, actively thinking about employment:
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So now I am kind of looking at what am I going to do for a living now? … At one
level I would have loved to have gone ‘okay, I’ll pack myself off to uni’ or travel
but at the moment I just want to work or see if some of this art therapy takes off.
(S04)
For others the desire was to return to normality, “It’s best to certainly struggle on
and that’s it. People say ah well, it’s all free go and live, run around see the
world, for me it’s just go back and live the way you always did” (S08). For some
having things to look forward to in the short term was important, “I had a holiday
at my sisters for nine days” (S13).
For those who had returned to work planning centered on maintaining normality and
honoring work commitments:

I’ve been very protective of my job and I haven’t wanted to take any time off that
I don’t have to take off. CAT scans and doctors appointments I haven’t been able
to avoid but other than that I’ve been very reluctant to take time off … I did offer
to be the co-coordinator of an after hours support group which was never taken up
from my local leukaemia foundation support service co-coordinator … I cant take
three hours off in the middle of the day, there must be other people like me who
are back at work and integrating back into their life who might want to meet in the
evening. (S07)
Finding work life balance was also important to survivors in the planning stage:

So I’ve come to the conclusion that I’ll at least get some part time work doing
something to pay the bills and then the opportunities for me to do what I think is
really important in my community … and I’ve also got to look at my own stress
and energy levels and find a balance. (S04)
I can’t go back to fulltime work yet, I’m not up to that. But I’m wanting to go
back two days, then three days, then maybe up to four days, I’ll see how I go.
(S01)
Survivors had obviously gone through the treatment and transition journey hoping that
their cancer was cured; their initial plans would always centre on this premise even if
the fear of recurrence was in the back of their mind. For those survivors who hadn’t
achieved the desired outcome from this round of treatment, the planning needed to start
again and information was said to be vital in helping to reset realistic expectations:

When the cancer came back the second time I found it more difficult to deal with
than the first time. Because you think that with the first one because you beat it
you aren’t going to get it again. So when it comes back I think that it creates more
anxiety for people. (S03)
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I didn’t get remission out of my treatment. I found that out in March … So I’m
feeling a little bit tired and emotionally I feel I need to spend more time thinking
about things. And I just feel a bit rushed working full time and I want to
contemplate my navel a little bit. So I’m feeling a little bit crabby now … it would
be good if somebody had followed up that by saying if the result wasn’t good then
where to now instead of waiting three months for the next scan to see if it has
grown. (S07)
Or in the longer term:

It’s given me a new lease in life, I want to train to be an enrolled nurse, I want to
go travelling and I want to go to India and see the leprosy mission and see how
they work with lepers, I want to go into nursing or OT (Occupational Therapist),
It’s always something I wanted to do. (S13)
Self-informing.
Where knowledge wasn’t easily available survivors were incredibly adept at self
informing. A range of skills throughout the interviews were displayed, survivors were
acutely aware when they did not receive enough or timely information, analysis of the
interviews displayed a range of information gathering strategies including nongovernment organisations such as breast cancer foundation (S01) and Cancer Council
(S03) to other health care professionals not directly related to the chemotherapy
experience i.e. chiropractor (S01), liver surgeon (S02). One survivor actively avoided
written information believing that it planted ideas, she chose to gain her information by
observing friends and family who had also been treated with chemotherapy:
I’m not a great one for reading all that sort of stuff. I’m more inclined to … You
know how we just discussed how many people were sick, I think if you know that
more than half of the people that go in and have chemo are crook with the
medication. To me that would make you think that you are expecting it so you
would be down anyway so that may help that happen … my husband had bowel
cancer. He didn’t get sick with any of his chemo’s. I’ve got another friend and
he’s got a multiple myeloma and he hasn’t had any sickness with the actual
treatment but he has had added side effects of other cancers come up so they don’t
know which is his first and which is his second so he is a different thing all
together but he is bright and happy as well and looking forward to the rest of his
life. I’ve never personally met anybody that I know that has let it get them down.
So how it affects certain sections of the community I don’t know. (S06)
Whilst others actively sought information and validation of the information they
received:
I have always supplemented the information I got from the hospital from people
who’ve gone through chemo and friends who have, who’ve done it … I’ve just
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supplemented the information that I was given, and I’ve read through the booklets
and all that stuff so that helps me, to get a realistic idea that as soon as chemo
finished I’m not going to feel well. Like my friend was saying no, it was six or
twelve months afterwards she was starting to feel back to herself, you know … if
she’s gone through it and you hear someone else say that it makes you go, “oh,
okay I’ve finished chemo but it’s going to take a while for my body to get over
this. (S01)
Another survivor discussed the challenge in receiving, retaining and the timing of
information:

I realise people can try and give you all the information but there are questions
you cant ask because you don’t know and I would be much wiser knowing what I
am asking or what the journey was going to be next time … I don’t remember her
telling me that information but it was probably that when she told me it wasn’t
relevant and I just flipped it out of my mind. (S10)
The gathering of information and planning for follow up appointments with the doctors
helped survivors to take control and gain the information that they needed to plan for
their future:

Just information gathering that helped me, independent information gathering has
helped me to have that ability to go “hang on, hang on”. Making lots of lists
before I went in to the doctors and taking that with me … the night before
appointments I would review the literature again …I would ask myself the
question …what do I want out of tomorrow’s appointment? … it is a very good
question because it’s taking back charge as well and not being passive. (S01)

In summary, during the transition phase, analysis of the interviews has
demonstrated the personal resolve the survivors drew from to begin to take control. This
included resilience and empowerment through self-awareness, self-protection and selfmanagement, all based upon their own individual beliefs, values and attitudes which
one survivor summed up as “ I dare to hope” (S11). In order to self-manage survivors
needed new knowledge and life experience (acquired knowledge) to apply to the range
of challenges that they may encounter during this transition period. Knowledge enabled
the survivor to take control, set realistic expectations and find further information they
required. Obviously to self manage one needed the ability to be self-aware, which was
required for self-protection an important skill used by all the survivors in various forms.
Self informing provided the necessary information to support self management.

62

Summary of Chapter Four
In conclusion, completing chemotherapy treatment for the survivors’
encompassed experiences of loss of belonging and disconnect, loss of identity, loss of
the treatment community including ready access to support and finally a fear for their
future knowing that treatment offers no guarantees. The completion of chemotherapy
treatment was an emotionally tumultuous time; survivors expressed a myriad of mostly
negative emotions including fears, isolation, low moods and unpredictable emotional
behaviour. This was clearly a very difficult all encompassing experience to navigate
through. From the descriptions provided by survivors it is clear that in the weeks
immediately post chemotherapy treatment, the survivors are clearly physically unwell
and whilst they still have connections with the treatment community they are not well
enough to begin their transition onwards.
Analysis of the interviews relating to the transition phase has demonstrated that
personal resilience, knowledge and the ability to plan are all vital coping components
for survivors during this part of their journey. Personal resilience detailed the personal
resolve the survivors drew from to begin to take control. This included emotional
resilience, empowerment, maintenance of a positive outlook through self-protection and
a range of self-management strategies all based upon their own individual beliefs and
values.
The information gaps identified by survivors related to understanding the
physical changes, treatment side effects, and future plans. Survivors found themselves
completing treatment and intending to move forwards without all the necessary detail to
make informed decisions or begin to achieve an appropriate plan, whether that be back
to work, back to social engagements or onto the next step in their treatment plan.
Following the qualitative analysis the literature was reviewed and gaps were
identified in terms of information needs that survivors had identified. These will be
discussed in greater detail in the Chapter Five.
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Chapter Five
Phase Two: Instrument Development and Testing

Introduction and Background
This chapter describes the quantitative methodology used in Phase Two of this
study; it illustrates the processes employed to collect and analyse the data and also the
ethical considerations that occurred before and during the study. The process followed
to modify an existing tool in this research was deliberately similar to the process
followed when developing a new tool. Following Phase One of this study in which key
qualitative findings were established, a comprehensive literature review was undertaken
to identify whether a suitable tool existed for use with this population. It became evident
that no valid and reliable instrument was currently available to assess the transition
needs of cancer survivors on the completion of chemotherapy treatment. However, an
instrument titled Quality of Life- Cancer Survivor (QOL-CS) was identified that was
designed to explore longer-term survivorship (Ferrell, Dow et al., 1995) in cancer
patients. The findings from the qualitative phase were used to adapt this existing cancer
survivorship instrument with the permission of the original authors Ferrell, Dow et al.
(1995) (Appendix G). The instrument was modified to allow the exploration of
survivorship issues that occur during the first three months following the completion of
chemotherapy as identified in this study. The revised questionnaire was then tested for
clarity, content validity and apparent internal consistency with an expert panel of senior
oncology nurses from a large tertiary cancer service in Western Australia.
Ferrell, Dow et al., (1995) developed and tested a quality of life instrument for
long term cancer survivors that was based on the City of Hope quality of life model.
The purpose of this instrument was to measure the specific concerns of this group of
survivors. The instrument has been widely used in cancer care and adapted for several
different cancer populations across a range of ages, tumour types and languages, for
example: Hispanic patients with cancer (Juraz, et al., 1998), breast cancer survivors
(Ferrell, et al., 1996), and ovarian cancer survivors (Ferrell, et al., 2003).
The Quality of Life-Cancer Survivor (QOL-CS) tool contains numerous items
that were consistent with the key descriptors identified from the interviews conducted in
this study. Given the universal acceptance and use of this tool, as well as the relevance
of many of the items to the population of interest in this study, the researcher opted to
make a minor adaptation to this instrument by adding seven additional items designed to
capture the full scope of key descriptors (needs) identified from the qualitative phase of
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this study. This adapted version of The QOL-CS was titled the QOL-CCS (Quality of
Life- Chemotherapy Cancer Survivor). Following refinement of this new instrument,
preliminary validity testing was undertaken to determine clarity, content validity and
apparent internal consistency. This preliminary testing was conducted using six
experienced oncology nurses from a major cancer treatment centre in Western Australia.
The QOL-CS tool initially described by Ferrell, Dow et al., (1995), recognised
that most quality of life tools focused on measuring acute cancer and treatment side
effects rather than a longer term view of cancer survivorship which results in a diverse
and different range of side effects. Not surprisingly, the origin of quality of life
assessment in the cancer population was initially linked to clinical trials (Gill &
Feinstein, 1994). At this stage most tools used measures that had been determined by
the clinicians based on their clinical experiences, rather than the experiences and
perceptions of patient themselves. The QOL-CS tool was revised over a one year period
following a series of interviews and focus groups with cancer survivors and for the first
time, explored the construct of positive adjustment, following the City of Hope
researchers recognition that most of the tools focused on the downside of having cancer.
Given the identified gap in the cancer literature related to the immediate
transition needs of patients who complete chemotherapy, and the lack of a valid tool
that could be used to plan individualised follow-up care, the need for a more
contemporary survivorship instrument was identified by the researcher. It was
considered appropriate that in order to ensure suitability of the new tool for
chemotherapy transition survivorship, and in keeping with Ferrell’s (1995) approach to
item generation, new items generated for inclusion the revised QOL-CCS should be
shaped by patients’ own perceptions rather than those of health professionals.
Therefore, the themes identified in the findings of the qualitative interviews were the
source of the additional items for this revised tool.
The World Health Organisation (1997) defined quality of life as “an individual’s
perception of their position in life in the context of culture and value system in which
they live and in relation to their goals, standards and concerns” (p. 1). Within the field
of healthcare, quality of life is often regarded in terms of how it is negatively affected. It
is well recognised that the meaning of health and life itself can be altered following a
diagnosis of cancer, cancer survivors have reported struggles to achieve a balance in
their lives and a sense of wholeness and life purpose after a life altering experience
(Ferrell, 2004; Vachon, 2001).
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Quality of life measures are now commonly used and reported in the literature
and this widely used measure determines how individuals assess their own general well
being. However, there is a lack of consensus on a health related quality of life
definition. Ganz (2000) labelled the health effects of cancer and its treatments on
perceived quality of life as “the price of survival”. (p. 324). Quality of life is generally
accepted as a multidimensional construct for which many definitions exist. Ferrell’s
body of work was focused on describing quality of life in cancer patients with early
work leading to development of a model of quality of life (Ferrell, Grant, & Padilla,
1991; Ferrell, Wisdom, & Wenzl, 1989). This model was based on the following four
domains of quality of life for cancer patients: physical well being; psychological wellbeing; spiritual well-being; and social well being. The QOL-CS (Ferrell, Dow, et al.,
1995) was based on these core domains and specifically adapted for longer-term cancer
survivors.
The QOL-CS instrument is considered simple and practical for use with it’s
intended population of long term cancer survivors. It comprises 41 items representing
the four domains of quality of life incorporating physical, psychological, social, and
spiritual well being as the previously described. Psychometric testing was performed on
a population of 686 respondents, and included measures of reliability and validity.
Ferrell et al. (1995) reported two measures of reliability. The range of test-retest
reliability scores were: physical (r = 0.88), psychological (r = 0.88), social (r = 0.81),
and spiritual (r = 0.90), with an overall score of r=0.89. High internal consistency
estimates were reported; Cronbach’s alpha subscale alphas ranged from r=0.93 overall;
and r = 0.71 for spiritual well being, r = 0.77 for physical, r = 0.81 for social, and r =
0.89 for psychological subscales/domains (Ferrell, Hassey Dow, et al., 1995). Content
validity was established by a panel of quality of life researchers and nurses with
expertise in oncology, stepwise multiple regression was used to determine factors most
predictive of overall quality of life in cancer survivors. Seventeen variables were found
to be statistically significant accounting for 91% of the variance in overall quality of
life. Pearson's correlations were used to estimate relationships between the subscales of
QOL-CS and the subscales of the established FACT-G tool. The FACT-G tool is used
the functional status of patients with specific cancer diagnosis. There was moderate to
strong correlation between associated subscales including QOL-CS physical to FACT
physical (r = 0.74), QOL-CS Psych to FACT Emotional (r = 0.65), quality of life Social
to FACT Social (r = 0.44). Further measures of validity were used including
correlations of individual items of the QOL-CS tool, factor analysis, and construct
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validity discriminating known groups of cancer survivors. Findings showed the QOLCS and its subscales adequately measured quality of life in the population of cancer
survivors (Ferrell, Hassey Dow, et al., 1995)
Findings from the previous qualitative interviews undertaken with 14 cancer
survivors who were in the transition phase following completion of chemotherapy were
used to inform the generation of new items in the QOL-CCS (Quality of LifeChemotherapy Cancer Survivor) tool developed in this study. As previously stated, this
48-item tool is a modified version of the 41-item QOL-CS. Table 2 demonstrates how
the new questions generated linked specifically to themes identified in the analysis
discussed in Chapter Four. Appendix E provides an overview of the development from
initial codes to a major theme The other themes identified were considered to be
covered by the original QOL-CS tool questions either directly or indirectly.
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Table 2
Links between new questions and identified themes

New questions added

Related themes identified in qualitative
analysis

q. 45 Did you receive enough information
about physical changes at the end of
chemotherapy treatment?

Physical

q. 46 Do you understand everything that
happened during treatment?

Self management

q. 47 Do you understand your plan of
care from now on, including timeframes?

Loss of identity
Loss of community
Isolation
Self management

q. 48 Have you tried to find information
from other places?

Self management
Self informing
Self awareness

q. 49 Were you provided with any written
information about life after
chemotherapy?

Self informing

q. 50 If you were provided with
information, was it useful?

Self informing

q. 51 Have you been able to make any
plans for your future?

Self management

Instrument Testing: Clarity, Content Validity and Apparent Internal Consistency
Given the time constraints of this Master’s study, only preliminary psychometric
assessment of the QOL-CCS was possible. This was undertaken between August and
September 2011 at a large tertiary cancer centre in Western Australia. This centre cares
for approximately 2000 cancer patients. The testing process used the method described
by (Imle & Atwood, 1988) for assessing the validity and apparent internal consistency
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of inductively generated domains. Apparent internal consistency is used to describe the
non-quantitative assessment of homogeneity of content (Imle & Atwood, 1988). Three
questions were addressed:
1. To what extent are the items in the QOL-CCS clear?
2. To what extent do the domains in the QOL-CCS confirm internal consistency?
3. To what extent do the domains in the QOL-CCS confirm content validity?

Target Population, Sample Size and Recruitment
In keeping with Aamodt’s (1983) recommendations, raters should be drawn
from the context within which the original data were generated. Six senior nurses with
significant experience in chemotherapy delivery were recruited from the cancer division
to form an expert panel. Each panel member met the following eligibility criteria:
•

working as a senior cancer nurse in either a specialist or managerial role

•

five years of experience with cancer patients who are receiving chemotherapy

•

experience in caring for patients post chemotherapy in a variety of settings
These nurses all had many years experience of working with cancer patients, and

use of this expert panel was in keeping with item generation for the original Ferrell’s
QOL-CS instrument first tested in 1995. This sample size was based on Lynn’s (1986)
method for determining the number of panel members needed to determine content
validity. This estimate is obtained by calculating the proportion of the number of panel
members who might agree out of the total number planned for use, and then setting the
standard error of the proportion to identify the cut-off for chance versus real agreement.
Using this formula, a minimum of five panel members is required to provide a sufficient
level of control for chance agreement. The six expert nurses were asked to complete
three tools determining the following domains of clarity, internal consistency and
content validity (Appendix H). Prior to the testing process, panel members were
informed there were seven new items in the instrument which were based on the
information needs identified from the interviews. With six selected panel members, a
minimum of five of whom should agree to attain a percentage agreement of at least
83%. Agreement of 83% (i.e. five of six experts rating each item acceptable) was preset as the minimum. This criterion is based on calculating the proportion of experts who
might agree, out of the total number planned for use, and then setting the standard error
of the proportion to identify cut-off for chance versus real agreement. According to
Lynn (1986), this computation allows the researcher to establish a necessary level of
percentage agreement at a 0.05 level of significance. For this phase of the study, nine
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eligible nurses were invited to participate by letter (Appendix I). Six nurses returned the
completed forms within the required timeline. Consent was therefore implied by return
rather than in writing.

Data Analysis
Clarity rating.
Participants were asked to indicate whether the language used in the
questionnaire was appropriate and whether items in the instrument were: a) clearly
worded, b) belonged together, c) were relevant and d) were complete. Item clarity is
desired to convey a single message or portion of the inductively generated concept
(Imle & Atwood, 1988). Once it was established that survey instructions were clear,
participants were asked to score each of the 48 items as clear or unclear. Space was
provided for comments and opportunities to discuss the comments were provided.
Information ascertained in relation to clarity was incorporated in the new instrument
(Figure 4). To aid the reader, Ferrell’s original QOL-CS is included in Appendix J
There was 100% agreement amongst the participants that the instructions on
clarity rating were clear. The participants rated 46 of the 48 items at 83% or 100%
agreement. Item 20 “time since chemotherapy was completed” was rated as being clear
by only one participant. The five participants who rated this item as unclear all
commented they did not understand the meaning or intention of this item. After
consideration by the researcher, it was realised the QOL-CCS related solely to patients’
experiences since completion of chemotherapy, hence the item was considered
redundant and so the original statement was reinserted. Item 21 “how much anxiety do
you have?” achieved agreement of 67% (i.e. four out of six participants). Comments
regarding this question included the potential for patients to confuse anxiety with
depression, depression was also considered to be a clinical term, the term “distress” is
considered to be a less stigmatising term which reflects the mix of unpleasant emotions
that cancer patients experience. This has been extensively validated in work undertaken
in the development of the distress thermometer (Holland & Reznik, 2005). Item 21 was
changed to reflect the term distress. Advocates of screening of cancer patients for
emotional distress consider that a systematic approach will promote equitable access to
psychological services rather than depending on clinician or patient initiated referrals
(Vodermaier, Linden, & Siu, 2009). The QOL-CCS tool has been developed as a part of
a research approach to learn more about a specific population at a specific time rather
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than for ongoing screening, therefore a more significant integration of distress screening
tools has not been considered appropriate in the revision of the instrument.

Apparent internal consistency.
Measurement of apparent internal consistency questions the homogeneity of the
content. There was 100% agreement that all 41 items belonged together and belonged
within the questionnaire. Despite this unanimous agreement for all items, item 20 was
reinstated to the original format as discussed above.

Content validity.
Content validity assessment involved the evaluation of the extent to which items
in the QOL-CCS “fitted” the conceptual domain of interest, in this case, transition from
chemotherapy (Nunnally & Bernstein, 1994). Not only is it important to assess the
adequacy of items in order to understand the meaning of the conceptual domain, it is
also necessary to also determine whether any redundancy exists among scale items
(Imle & Atwood, 1988). Assessment for content validity required the participants to
confirm their agreement with the label and definition of the instrument. Agreement of
100% was achieved. Following this, each participant read each item and was asked to
score “yes”or “no” in response to whether the item `fitted’ the QOL-CCS label and
definition. There was 100% agreement for 44 of the 45 items. Item 20 (as previously
discussed) achieved a rating of 83%, as did item 30 “is your sexuality impacted by your
illness”. Items 21 and 22 related to anxiety and depression achieved 67% agreement,
two out of the six raters questioned the position of the item within the QOL-CCS rather
than the items themselves. As discussed in the clarity rating section, questions 21 and
22 have been changed following the expert panels comments to reflect language more
commonly acceptable to the Australian population.
All three rating tools provided opportunity for comments. These included the
suggestion for additional individual questions in the physical domain about diarrhoea
and vomiting, as some patients will experience one symptom without the other. It was
also recommended that menstrual changes and fertility should be separated and written
as individual items, these suggestions have all been adopted in the revised instrument
(Figure 4). There was a query as to whether people would understand the word
“fatigue”; this was replaced with “fatigue (tiredness)”. It is the opinion of the researcher
that changes in language and chemotherapy agents in the past 15 years since the
instruments were developed may account for the suggested changes. The new domain of
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items related to “information needs” generated from interview findings from this study
were rated consistently at 100% across all three psychometric assessments, in addition,
no comments were provided by raters to change these items. The QOL-CCS tool with
amendments based on the above analysis is displayed below in Figure 4 with the
changes highlighted in Blue for ease of recognition.
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Quality of Life Chemotherapy Cancer Survivor Version

Directions: we are interested in knowing how your experience of completing
chemotherapy affects your quality of life. Please answer all of the following questions
based on your life at this time.

Please circle the number from 0-10 that best describes your experiences:
Physical Well Being
To what extent are the following a problem for you:
1. Fatigue (Tiredness)
no problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

1

2

3

4

5

6

7

8

9

10

severe
problem

1

2

3

4

5

6

7

8

9

10

severe
problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

2. Appetite changes
no problem

0

3. Aches or pain
no problem

0

4. Sleep Changes
no problem

5. Constipation
no problem

6. Diarrohea
no problem

7. Nausea
no problem
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8. Vomiting
0

no problem

1

2

3

4

5

6

7

8

9

10

severe
problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

4

5

6

7

8

9

10

severe
problem

9. Menstrual Changes
no problem

10. Fertility
no problem

11. Rate your overall physical health
0

no problem

1

2

3

Psychological Well Being Items

12. How difficult is it for you to cope today as a result of your disease and treatment?
not at all
difficult

0

1

2

3

4

5

6

7

8

9

10

very difficult

4

5

6

7

8

9

10

excellent

4

5

6

7

8

9

10

a great deal

13. How good is your quality of life?
extremely
poor

0

1

2

3

14. How much happiness do you feel?
none at all

0

1

2

3

15. Do you feel like you are in control of things in your life?
not at all

0

1

2

3

4

5

6

7

8

9

10

completely

3

4

5

6

7

8

9

10

completely

9

10

excellent

16. How satisfying is your life?
not at all

0

1

2

17. How is your present ability to concentrate or to remember things?
extremely
poor

0

1

2

3

4

5
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6

7

8

18. How useful do you feel?
not at all

0

1

2

3

4

5

6

7

8

9

10

Extremely

9

10

extremely

19. Has your illness or treatment caused changes in your appearance?
not at all

0

1

2

3

4

5

6

7

8

20. Has your illness or treatment caused changes in your self concept (the way you see yourself) ?
not at all

0

1

2

3

4

5

6

7

8

9

10

extremely

How distressing were the following aspects of your illness and treatment?
21. Initial diagnosis
not at all
distressing

0

1

2

3

4

5

6

7

8

9

10

very
distressing

22. Cancer treatments (i.e. Chemotherapy, radiation or surgery)
not at all
distressing

0

1

2

3

4

5

6

7

8

9

10

very
distressing

4

5

6

7

8

9

10

very
distressing

4

5

6

7

8

9

10

a great deal

23. Time since my treatment was completed
not at all
distressing

0

1

2

3

24. How much anxiety do you have?
not at all

0

1

2

3

25. How much emotional distress do you have?
not at all

0

1

2

3

4

5

6

7

8

9

10

a great deal

To what extent are you fearful of:
26. Future diagnostic tests
no fear

0

1

2

3

4

5

6

7

8

9

10

extreme fear

1

2

3

4

5

6

7

8

9

10

extreme fear

27. A second cancer
no fear

0
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28. Recurrence of your cancer
no fear

0

1

2

3

4

5

6

7

8

9

10

extreme fear

5

6

7

8

9

10

extreme fear

7

8

9

10

a great deal

29. Spreading (metastasis) of your cancer
no fear

0

1

2

3

4

Social Concerns
30. How distressing has the illness been for your family?
not at all

0

1

2

3

4

5

6

31. Is the amount of support you receive from others sufficient to meet your needs?
not at all

0

1

2

3

4

5

6

7

8

9

10

a great deal

32. Is your continuing health interfering with your personal relationships?
not at all

0

1

2

3

4

5

6

7

8

9

10

a great deal

6

7

8

9

10

a great deal

33. Is your sexuality impacted by your illness?
not at all

0

1

2

3

4

5

34. To what degree has your illness and treatment interfered with your employment?
no problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

35. To what degree has your illness and treatment interfered with your activities at home?
no problem

0

1

2

3

4

5

6

7

8

9

10

severe
problem

10

a great deal

36. How much isolation do you feel is caused by your illness or treatment?
none

0

1

2

3

4

5

6

7

8

9

37. How much financial burden have you incurred as a result of your illness and treatment?
none

0

1

2

3

4

5
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6

7

8

9

10

a great deal

Spiritual Well Being
38. How important to you is your participation in religious activities such as praying, going to
church?
not at all
important

0

1

2

3

4

5

6

7

8

9

10

very
important

10

very
important

39. How important to you are other spiritual activities such as meditation?
not at all
important

0

1

2

3

4

5

6

7

8

9

40. How much has your spiritual life changed as a result of cancer diagnosis?
less
important

0

1

2

3

4

5

6

7

8

9

10

more
important

7

8

9

10

very uncertain

9

10

a great deal

41. How much uncertainty do you feel about your future?
not at all
uncertain

0

1

2

3

4

5

6

42. To what extent has your illness made positive changes in your life?
not at all

0

1

2

3

4

5

6

7

8

43. Do you sense a purpose/ mission for your life or a reason for being alive?
none at all

0

1

2

3

4

5

6

7

8

9

10

a great deal

3

4

5

6

7

8

9

10

a great deal

44. How hopeful do you feel?
not at all
hopeful

0

1

2

Information needs at the end of Chemotherapy treatment.
45. Did you receive enough information about physical changes at the end of chemotherapy
treatment?
not at all

0

1

2

3

4

5

6

7

8

9

10

a great deal

10

a great deal

46. Do you understand everything that happened to you during treatment?
not at all

0

1

2

3

4

5

6

7

8

9

47. Do you understand your plan of care from now on, including timeframes?
not at all

0

1

2

3

4

5
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6

7

8

9

10

a great deal

48. Have you tried to find information from other places? (i.e. cancer council, internet, friends)
0

not at all

1

2

3

4

5

6

7

8

9

10

a great deal

49. Were you provided with any written information about life after chemotherapy?
0

not at all

1

2

3

4

5

6

7

8

9

10

a great deal

7

8

9

10

extremely

8

9

10

a great deal

50. If you were provided with information, was it useful?
0

not at all

1

2

3

4

5

6

51. Have you been able to make any plans for your future?
0

not at all

1

2

3

4

5

6

7

Figure 4. Quality of Life – Chemotherapy Cancer Survivor Tool (changes to the
original tool have been highlighted in blue).

Summary
Only preliminary assessment of clarity, content validity and apparent internal
consistency was possible in this study due to the scope of the Master’s study. The
researcher plans to conduct a comprehensive psychometric assessment of the QOL-CCS
following completion of this Masters thesis. This will include three further measures of
validity: stepwise multiple regression to determine factors most predictive of overall
quality of life in chemotherapy treatment; Pearson's correlations to estimate
relationships between the subscales of QOL-CCS and the subscales of an established
tool such as the FACT-G. Further measures of validity will be undertaken including:
correlations of individual items of the QOL-CCS tool, factor analysis, and construct
validity discriminating known groups of cancer survivors. Once the QOL-CCS has been
validated it is anticipated the QOL-CCS will be used by clinicians to measure quality of
life in a large cohort of survivors who have completed chemotherapy within a threemonth period to determine the needs as they transition to life immediately following
chemotherapy. This information will be utilised to plan approaches to assist in the
transition period for chemotherapy survivors.
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Chapter Six
Discussion and Conclusions

Introduction
This chapter will present and discuss the major findings of this two-phase study
in association with current knowledge about methodological, theoretical and clinical
domains in cancer survivorship. Following this discussion, the strengths and limitations
of the study will be explored. This final chapter will then present both the conclusions
of the study and the recommendations for future research, education, and clinical
practice.
The purpose of Phase One was to identify, explore and describe the experience
of cancer survivorship transition from chemotherapy patient to life after cancer
treatment as a cancer survivor. During this process, factors which improved or
exacerbated this transition were identified for consideration. Following this, the main
themes identified in Phase One were utilised during Phase Two to modify an existing
Quality of Life – Cancer Survivors tool (Ferrell et al., 1995) in order to later explore
quantitatively the experiences of a larger number of patients. For the purposes of this
study an expert panel reviewed the modified tool to ensure that it was clear, confirmed
internal consistency and confirmed content validity. The experiences of people with
cancer as they transition from the completion of chemotherapy to life after cancer is an
under researched area, the findings of this study will therefore contribute to the
understanding of this part of the cancer continuum from both an Australian and a time
perspective. The study findings represent the experiences of 14 cancer survivors from a
tertiary cancer centre in Western Australia.
This study was initiated following the researcher’s search for information about
this subject whilst preparing patient information plans in the clinical environment; the
lack of available information and research findings were the impetus for this study.
Findings from this study will add to the current knowledge deficit and provide a
platform for a myriad of future research and clinical information developments.
This chapter is organised into two sections. Part one presents a discussion of the
key findings in relation to the following themes identified in Phase One: the experience
of loss; the experience of changing emotions; the experience of resilience and the
experiences relating to empowerment. Part two presents a discussion in relation to
Phase Two of this study which includes the adaptation and testing of the existing
Quality of Life– Cancer Survivors tool based on the findings from Phase One.
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Following this, strengths and limitations of the study will be considered, prior to the
conclusions and recommendations that have been drawn from this research study.

Part one: qualitative phase (interviews)
Experiences on completion of chemotherapy
The experience of loss
The findings of this study indicated that participants were experiencing a range
of losses including the: loss of the treatment experience; loss of identity; loss of
treatment community and loss of the perceived planned future. The experience of loss in
relation to cancer is not a new concept. There is detailed literature about loss when an
individual is diagnosed with cancer and throughout the subsequent continuum
including: loss of disease monitoring and loss of an action plan against cancer (Allen, et
al., 2009; Shaha, Cox, Belcher, & Cohen, 2011); loss of a safety net and loss of contact
and support with other cancer patients (Allen, et al., 2009; Doyle, 2008; Jefford, et al.,
2008; Jefford, et al., 2011; Shaha, et al., 2011). There is also detailed discussion in the
literature relating to the physical, psychosocial and spiritual losses that cancer
survivors’ experience. This literature acknowledges that facing a cancer diagnosis and
the stress associated with medical choices and treatment side effects is a traumatic event
for any individual to face (Alfano & Rowland, 2006; Allen, et al., 2009; Costanzo et al.,
2007; Doyle, 2008; Pinquart, Silbereisen, & Frohlich, 2009; Shaha, et al., 2011).
Participants in this study found the time immediately following completion of
chemotherapy, to be a time of change. During this time they moved from the structure
and culture of being a chemotherapy patient in a community that supported and shared
their experience, to an individual who was still dealing with the burden of treatment side
effects without the supports they valued. The loss of identity from the status as a patient
was a concept they clearly struggled with, alongside the awareness they had changed in
the process of the cancer care to date. One survivor described the feeling of not
belonging and not understanding her position in society now that she is no longer
receiving treatment. This sentiment is certainly reflected in the literature with
descriptors such as “warriors without a war” (Morgan, 2009). Despite the planned
nature of chemotherapy, all participants expressed their shock at the abruptness of
treatment ending, this was coupled with the vulnerability of not having ready access to
health care professionals and fellow patients for support and information. The final and
largest loss in terms of impact on the participants was the loss of their perceived
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planned future and the vulnerability this brought with the lack of ability to plan for the
future in case treatment had not been successful.
A small number of research studies that capture some of the domains of the
current study have been identified in the literature. A quantitative study from the USA
which addressed breast cancer survivors’ adjustment to life after treatment by Costanzo,
et al. (2007) identified that of the 89 participants in this study, 71.6% had received
chemotherapy as a part of their cancer treatment. The survivors were surveyed during
treatment, three weeks following the end of treatment and three months post treatment.
Costanzo’s (2007) study identified that fear of recurrence and side effects or physical
problems were the greatest sources of stress at three weeks and three months post
treatment. The sources of post treatment stress all reduced between the three-week and
three month survey milestones (Costanzo, et al., 2007). Research identified that women
who had received chemotherapy reported more worry about recurrence and cancer
related intrusion than women who had received radiation therapy. This was attributed to
the longer length of treatment and the severity of side effects experienced. Overall the
post treatment period was identified as a distressing time when women not only dealt
with physical side effects of treatment, including fatigue and lymphoedma, but also the
distress of the unanticipated longevity of these treatment effects (Costanzo, et al., 2007).
It was suggested the psychological struggle may be come to the fore, when survivors no
longer had the treatment routines to distract from reflecting on the impact of a cancer
diagnosis (Costanzo, et al., 2007; Karahalios, et al., 2007).
Another USA study of breast cancer patients as they transitioned from patient to
survivor was undertaken (Allen, et al., 2009). This qualitative study used focus groups
to capture the experiences of 47 women in this transition phase; the cohort’s average
time from completion of treatment was four months with the range between 1-14
months. It was not evident how many participants had received chemotherapy as a
treatment. Overall the descriptors used to describe the findings of this study were
congruent with the psychological experiences expressed by participants in the current
study. The element that was not discussed in Allen et al’s (2009) findings was that of
physical impact, or the management of post treatment symptoms. Further, there was no
discussion relating to fatigue or it’s impact on psychological adaption, which was a key
factor for participants in the current study.
An Australian study addressing survivorship issues following completion of
treatment also used the focus group approach with 22 participants. Of these six had
completed treatment within the previous year although the type of treatment received by
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participants was not stated (Jefford, et al., 2008). Findings from this study were
congruent with findings from the current study. Of the 12 key themes identified in that
study the only disparity noted was in the descriptors relating to positive experiences of
having a cancer diagnosis, which perhaps is attributable to the length of time in
survivorship. The findings in relation to information needs were consistent with the
findings in the current research, survivors wanted to know: What were signs that their
cancer was returning? What they should do now treatment was over? How to improve
their health and reduce their risk of a cancer recurrence? Who to contact for practical
advice and support including resources? Finally if how they felt was normal? The
Jefford team [Peter Mac Cancer Centre, Melbourne] has continued to build on these
initial findings, testing new interventions such as written information (Jefford, et al.,
2007) and nurse-led packages (Jefford, et al., 2011).
Lethborg, Kissane, Ivon Burns & Snyder (2000) interviewed eight women with
early stage breast cancer who had completed adjuvant chemotherapy two to four weeks
previously at a cancer centre in Victoria, Australia. The intention of the study was to
identify issues, which arise as medical support becomes less intensive. This study
identified three distinct time points for the women, firstly at the time of diagnosis when
crisis, shock and bewilderment were the key experiences described. During treatment
when trauma was identified as a key domain this encompassed confrontation with
diagnosis, and physical and psychological impacts of cancer. Attempts to regain control
and the importance of social support were also important during this treatment time.
The final time point highlighted three main themes, recovery, ambivalence and fear; and
processing the experience. The findings and discussion of this study are highly
congruent with the findings from the current research study.
Overall the participants of Lethborg et al., (2000) study had a need to tell their
story from diagnosis onwards. Once the trauma of treatment was completed the women
began to process the impact of this journey and the spiritual issues that it had created.
The survivors in the current study all had a story to tell and shared their experience
willingly. In hindsight the interview itself provided an opportunity for survivors to
reflect on their recent experience; like the Lethborg study, they were able to recall the
exact diagnosis conversation as if it was yesterday.
Finally, a quantitative study assessing the unmet needs of Western Australian
patients with haematological malignancies surveyed 66 participants who had completed
treatment an average of eight months earlier. Again, it was not evident how many
participants of this cohort had received chemotherapy. On the whole the top ten
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identified needs were consistent with the views expressed by participants in the current
study, although the language was different as it reflected the items in the quantitative
surveys. For example, 33% of respondents identified the “need for an ongoing case
manager to whom I can go and find out about services whenever they are needed”
(Lobb et al., 2009).
The vast majority of literature focuses on survivors who are much further into
their survivorship journey than those survivors in the current study. The main point of
difference in findings between this study and the wider literature is the perceived
positive impact of a diagnosis of cancer. A number of papers discuss cancer as a life
changing experience with positive outcomes, recognizing that as humans go through life
gains and losses are a normal part of life’s trajectory. Further, whilst a cancer diagnosis
may begin with negative associations, the longer the person lives past their diagnosis,
the more likely positive associations and actions will be when survivors are reassessing
their life to determine what is important in life and establish new priorities (Breaden,
1997; DeMarco, Picard, & Agretelis, 2004; Doyle, 2008; Leigh & Logan, 1991;
Meraviglia, 2006; Pelusi, 1997; Pinquart, et al., 2009; Shaha, et al., 2011; Thornton,
2002; Vachon, 2001; Wallwork & Richardson, 1994). It has been suggested that
survivors who report higher levels of stress early in the transition period tend to have a
diminished longer term adjustment (Allen, et al., 2009). Therefore in identifying and
reporting the true experiences in the early post treatment period, this study can
contribute to the understanding of survivors as they begin their transition journey to life
after cancer.
Apart from the current study, no other study has focused solely on the
immediate transition time following the completion of chemotherapy. It may well be
implied that survivors need time to recover and adjust from their diagnosis and
treatment side effects before recognition of positive outcomes begin; as displayed in the
longer-term survivorship research.
The literature supports the physical side effects identified by the participants in
this study, in particular fatigue and it’s impact on daily living (Alfano & Rowland,
2006; Broeckel, et al., 2000). Other previously reported outcomes such as goal setting
and mixed emotional reactions were all congruent with the experiences of the survivors
in this study (Cheung, Thompson, Ling, & Chan, 2005; Deimling, Sterns, Bowman, &
Kahana, 2005; Dow, 2003; Dow, Ferrell, Haberman, & Eaton, 1999; Doyle, 2008;
Ferrell, 1996; Lancee et al., 1994; Pinquart, et al., 2009; Vachon, 2001).
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The positive emotion of elation related to treatment completion is often marred
by negative emotions. The anxiety associated with the loss of contact with the treating
hospital, grief and uncertainty about the future is well described in the literature and is
consistent with the findings from this study (Auchincloss, 1995; Diamond, 1998; Dow,
et al., 1999; Doyle, 2008; MacBride & Whyte, 1998; Mellon, Northouse, & Weiss,
2006; Mullen, 1985; Pelusi, 1997; Wallwork & Richardson, 1994).

Loss of a perceived planned future
Cancer survivors differ from other survivors because they live with a fear of
cancer recurrence in addition to the physical, psychosocial and spiritual impacts related
to their diagnosis and treatment (Breaden, 1997; Welch-McCaffrey, Hoffman, Leigh,
Loescher, & Meyskens, 1989). Alfano & Rowland (2006) described the fear of
recurrence as one of the most universal and durable legacies of surviving cancer; its
prevalence is said to range between 5-89% of cancer survivors (Alfano & Rowland,
2006; Allen, et al., 2009; Costanzo, et al., 2007). The participants in the current study
all expressed their inability or unwillingness to plan too far into the future, in case the
treatment had not been effective or in case the cancer recurred. Uncertainty is a
common element of discussion in cancer survivorship literature and a given part of a
survivor’s existence (Morgan, 2009). Uncertainty ranks in the top 10 of the 50 most
distressing unmet needs (Lobb, et al., 2009; Moore, 2011; Schlairet, et al., 2010). Lobb
et al. (2009) confirmed that 73% (n=66) of survivors identified their need for help to
manage fears about cancer recurrence and 43% considered that this need remained
unmet.
Many authors discussed the Damocles syndrome in association with cancer
survivors, inferring there is an inability to enjoy living in the present due to the fear of
cancer recurrence having recognised their own invulnerability and mortality
(Auchincloss, 1995; Breaden, 1997; Doyle, 2008; Fritz, 2001; Koocher & O'Malley,
1981; Moore, 2011). The link between surviving cancer, fear of cancer recurrence and
fear of death are said to be omnipresent (Cheung, et al., 2005; DeMarco, et al., 2004;
Doyle, 2008; Koocher & O'Malley, 1981; Mellon, et al., 2006; Mullen, 1985; Pelusi,
1997; Vachon, 2001; Wallwork & Richardson, 1994), although this is disputed in one
study of long term survivors who described that participants found the experience
largely unremarkable (Killoran, Schiltz, & Lewis, 2002).
Conversely, Dizon (2009) identified that up to 40% (n=153) of women treated
with chemotherapy experienced a degree of distress which persisted for up to 20 years
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for some. Uncertainty has a huge impact on survivors spiritual well-being with frequent
descriptions of survivors searching for the meaning of illness and the meaning of life;
highlighting a sense of both mortality and vulnerability (Breaden, 1997; Doyle, 2008;
Hassey Dow, 2003; Morgan, 2009; Shaha, et al., 2011; Shanfield, 1980). The days
prior to a routine follow up appointment bring an experience of heightened anxiety with
an increased fear that they may be informed that their cancer has returned, many
survivors often have a scan or blood tests prior to the specialist appointment as a routine
part of monitoring. The time between this procedure and the actual follow up
appointment when they will get results is particularly traumatic (Jefford, et al., 2008).
Coping strategies related to dealing with uncertainty may be positive or negative
(Morgan, 2009). Rowland & Baker (2005) discussed the belief that people are
essentially goal orientated and for those people diagnosed with cancer there is a
disruption in working towards personal goals whilst going through cancer treatments.
The goals that people strive to achieve are what provide both meaning and quality of
life; therefore a disruption to this process can in turn affect one’s perceived quality of
life. This belief is supported elsewhere (Breaden, 1997; Pinquart, et al., 2009).
The cancer survivors in this study were very aware of their vulnerability and
uncertainty about the future, to the extent their ability to plan was virtually stifled in the
early days following completion of treatment. Shaha et al. (2011) acknowledged these
experiences related to anxiety, vulnerability, fear and loss of control all impair the
individuals inability to cope. The literature discusses steps that survivors take to
reassess values and embrace changes as they progress through the survivorship journey.
Again, the disparity between the participants in this study and the wider literature
appears to be time since treatment completion (Shaha, et al., 2011). As Doyle (2008)
confirmed a researched model to find a new normal life after cancer is yet to be
identified.

The Experience of Changed Emotions
There is overlap between the experience of loss and emotional change; it is not
possible to feel a loss without feeling an emotional response. Findings from both this
study and that of Costanzo et al. (2007), identified that cancer survivors in the early
days following the completion of chemotherapy experienced a myriad of emotional
changes, many of which were unexpected. Participants who were excited about the
prospect of completing chemotherapy were caught unawares with emotional mood
swings in the time period immediately following chemotherapy completion, recounting
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how low in mood they felt. There is evidence in the literature that going through the
experience of being diagnosed and treated for cancer changes a person’s outlook,
perceptions and expectations even though they hope to return to their usual normal pre
cancer state (Doyle, 2008; Schlairet, et al., 2010). Fear of isolation and changes in
existing relationships can impact on the survivor’s positive responses to these changes.
The participants in the current study not only identified the physical isolation
from their treatment community of health professionals and fellow patients, but also
their emotional isolation from their own social community of family and friends. Upon
removal from the treatment community the survivors expressed anxiety about needing
to take responsibility for themselves, including their own self monitoring. In the
literature this theme has been identified as “losing the safety net” (Allen, et al., 2009;
Squiers, Finney Rutten, Treiman, Bright, and Hesse, 2005). The emotional isolation
theme links with the previously identified experience of loss of identity, where
survivors have recognised they are not the same person as they were pre diagnosis. The
participants in this study identified some changes in the behaviour of friends and family
on completion of treatment, for example loved ones no longer phoned to see how they
were or else they avoided contact with the survivor all together. Others expected the
survivor to “be back to normal” and therefore they no longer treated them like a patient
experiencing limitations due to treatment side effects; these changes in behaviour
occurred before the survivor was ready. The immediate post treatment period has been
identified as a time when friends and family celebrate the survival from the cancer
treatment and remind the survivor that they are “lucky to be alive”. This makes it
difficult for the person to express any fears or needs they may have at this time,
particularly if they are feeling ambiguous about their cancer survival due to fears of
recurrence or physical and psychological compromises (Itano & Taoko, 2005; Morgan,
2009).
In addition, one study found that survivors perceived that maintaining a positive
outlook and getting on with life was the approach most respected by health
professionals, family and friends (Leydon et al., 2000). It is acknowledged that people
are comfortable talking about strokes or heart attacks, but that discussions about cancer
remain difficult due to a general lack of understanding about the effects of the disease,
treatment and the societal stigma attached to cancer (Carlisle, 2011). Additionally,
following treatment completion survivors now have limited contact with health care
professional further highlighting their isolation. Authors have suggested that more
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rehabilitation assistance may therefore be required in this period (Breaden, 1997;
MacBride & Whyte, 1998; Mah, Bezjak, Loblaw, Gotowiec, & Devins, 2010).
In a review of literature undertaken by Holland & Reznik (2005), it was
determined that up to 45% of patients in ambulatory cancer centres may have significant
levels of distress whilst only 10% are referred on to appropriate supportive care. This
may well be an indication of the reluctance that cancer patients may have about asking
for help with psychosocial concerns due to the stigma attached to issues related to
mental health concerns (Earle, 2006). If Holland & Reznik’s (2005) claims are correct,
then as many as 35% of patients may complete cancer treatment with some level of
unidentified emotional distress before they commence their transition journey. All the
participants in this study experienced a tumultuous array of emotions in the immediate
post treatment period, which was compounded by the social isolation due to the
inability of non-cancer survivors to truly understand the experience.
The participant’s experiences in the immediate post treatment period do not
wholly correlate to the findings in the wider literature currently available. The negative
experiences detailed are certainly congruent and mainly link to physical and
psychological issues associated with treatment side effects and the meaning of illness
(Doyle, 2008), however the positive life changing experiences illustrated in many long
term studies are not evident at this period in time. Researchers have suggested the
positive aspects of cancer survival are linked to experiences of personal growth, self
improvement and appreciating life more (Doyle, 2008). This sentiment is supported
suggesting that when people have confronted their own mortality and re evaluated their
life goals and priorities a more positive outlook is achieved (Andrykowski & Hunt,
1993; Cordova, Cunningham and Carlson, 2001; Davies, 2009; Pemberger, Jagsch and
Frey, 2005). Finding meaning in becoming a cancer survivor is clearly a process, which
is either helped or hindered by all of the points discussed above. Survivors each bring
pre existing experiences, ideas and assumptions that have evolved since early
childhood. These assumptions shape how survivors view the world and their role within
it (Lethborg, Aranda, Bloch and Kissane, 2006). A diagnosis of cancer and surviving
the experience forces a shift in beliefs which the survivor has essentially held since
childhood.
Perhaps time is of the essence in this transition period; fatigue described as a
persistent lack of energy, is certainly the dominant all encompassing symptom
described by all but one of the participants at this time. Several authors have identified
the difficulty in achieving any goals towards personal growth when fatigue is present,
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given the omnipresent and unrelenting nature of post treatment fatigue and the
associated distress it causes. Fatigue is described as almost ubiquitous amongst cancer
survivors disrupting routine activities and causing a negative impact on quality of life
that is more alarming than pain or nausea as it cannot be relieved (Ahlberg, Ekman and
Gaston-Johansson, 2005; Dizon, 2009; Donovan & Ward, 2005; Hjorleifsdottir,
Halberg, Gunnarsdottir, & Bolmsjo, 2008; Karahalios, et al., 2007; Morgan, 2009;
Pinquart, et al., 2009; Prue, Allen, Gracey, Rankin, and Cramp, 2010). Ahlberg (2005)
stated that cancer-related fatigue is the most frequently reported unmanaged symptom
that affects 70-100% of all cancer patients for months or years after treatment. Several
studies have demonstrated that fatigue is a major obstacle to patients normal functioning
and to their ability to achieve a good quality of life (Ahlberg, et al., 2005; Broeckel, et
al., 2000; Loge, Abrahamsen, Ekeberg and Kaasa, 2000). This is disconcerting given
the importance that quality of life holds for cancer survivors and their families (Ahlberg,
et al., 2005; Ferrell, Dow, et al., 1995; Morgan, 2009).
There was certainly a notable change in the experiences described by
participants in the current study. Fatigue was the most monitored of symptoms and as
fatigue levels began to improve, there was a constantly identified awareness of new
goals reached and improvement in mood levels. This became a recognizable next step in
the participants’ transition to life after cancer with some participants already able to
identify that for them the “new normal” may have some physical limitations that were
not present in the pre cancer days.

Experiences in transition
This part of the transition journey has been defined as the process or period in
which the person with a cancer diagnosis undergoes a change and passes from one stage
to another. For participants in this study this stage involved dealing with highlighted
personal challenges whilst finding a new balance, working towards future goals and
achieving a normal life. The discussion in this section has been divided into two
sections: experiences in resilience and experiences in empowerment.

Experiences in resilience
Resilience has been described as the ability to bounce back or cope successfully
after substantial adversity (Earvolino-Ramirez, 2007; Herrman, Stewart, DiazGranados, Berger, and Jackson, 2011). Resilience is depicted as having four
characteristics to achieve this positive adaption:
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1. Hardiness: - a dispositional characteristic that includes a sense of control over one’s
life.
2. Benefit finding: – the ability to make sense of adversity by focusing on positive
changes and personal growth.
3. Thriving: – which occurs when the person not only returns to a pre stress level of
functioning but attains a higher level of functioning with acquired skills knowledge,
confidence or improved social relationships.
4. Post traumatic stress growth:- described as a stage beyond thriving and resilience
which includes an increased appreciation of life, closer intimate relationships and a
greater sense of personal strength (Earvolino-Ramirez, 2007; Herrman, et al., 2011). All
of the above four characteristics rely on finding meaning in the experience of cancer and
reprioritizing for the individual their own unique life goals. Resilience is the personal
characteristic that enables the cancer survivor to cope and re frame meaning in the face
of adversity. This does not occur in isolation and is intricately connected with the
process of empowerment in order to achieve resilience.
As participants’ energy levels returned, so do did their resilience. This was
characterised by language which became much more focused on positive outlooks,
fighting spirit and normalizing of experiences. Some participants accepted their cancer
diagnosis as a personal challenge; this has been described in the literature as
inevitability (Mok, 2001). In this study participants often referred to their coping skills
or ability to cope, which is considered to represent the ability to deal successfully with a
difficult problem or situation. Participants discussed their surprise at the inner strength
they found to deal with their situation for some this was attributed to God and
strengthened their spiritual beliefs. There were a variety of emotional resilience
approaches displayed along a continuum, that ranged from choosing not to believe in
depression and therefore not experiencing it, to acknowledging depression as a potential
problem and seeking professional help early as a preventative measure. From the
experiences shared by the survivors in this study it is clear that resilience is a complex
web of personal values that is unique to each survivor.
The literature confirms the positive link between developing survivorship skills
and coping mechanisms. Failure to cope has been identified as increasing the risk of
more negative outcomes for the survivor (Hewitt, et al., 2006; Jefford, et al., 2011;
Rendle, 1997). Studies with longer term cancer survivors have shown that coping
mechanisms change over time for almost half of all survivors; the dominant coping
styles that have been successfully adopted include optimism, supportive, confrontational
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and self reliance (Rendle, 1997). Survivors in the current study were using optimism as
their dominant coping style in partnership with maintenance of hope and avoidance of
negative information. Hope has been closely associated with ability to cope and a
perception of a positive quality of life and adjustment to illness amongst patients with
cancer (Benzein, Norberg and Saveman, 2001; Herth, 1989; Hjorleifsdottir, et al., 2008;
Vellone, Rega, Galletti and Cohen, 2006). Hope is represented in the literature as being
present from the beginning of the cancer journey, even when initial descriptions about
the shock of diagnosis are listed they are closely followed with actions towards a
positive outcome such as maintaining normality, faith, hope and a belief that the
treatment will be effective (Benzein, et al., 2001; Herth, 1989; Hjorleifsdottir, et al.,
2008; Vellone, et al., 2006).
Hope has also been described as a universal human phenomenon essential for
the overcoming of adversity and the fostering of resilience. It correlates strongly with
health, wellness, strength of will and determination to endure rigorous medical
treatments and strive towards a successful outcome (Hjorleifsdottir, et al., 2008; Leung,
Silvius, Pimlott, Dalziel, and Drummond, 2009; Mattioli, Repinski and Chappy, 2008).
Health professionals need to maintain a delicate balance between encouraging
reasonable hope and creating unrealistic expectations. If health professionals fail to
display a minimal sense of hope there is a risk that patients may become anxious and
distressed, however, if patients’ expectations about the normative experiences of cancer
and it’s treatment side effects are not adequately addressed then patients experience
decreased satisfaction and increased distrust (Leung, et al., 2009; Saegrov and
Lorensen, 2006). Survivors in this study provided examples of positive and negative
experiences when the balance of information was correct, and this assisted them in
managing their physical symptom at that time, or, when it was absent or diminished in
importance to the point where it caused the participant an additional anxiety.
Hope and fear are interwoven and survivors are caught between their desire for
more information and the avoidance of new information which may challenge their
optimistic stance (Leydon, et al., 2000). In a qualitative study with 17 cancer survivors
the narratives displayed a sense of hope yet were closely linked with fear. The survivors
were described to be creating a façade of hopefulness which was indispensible to
survival and interacted with information seeking in a complex way (Leydon, et al.,
2000). In keeping with Leydon et al.’s (2000) findings, the participants in this research
maintained hope on occasions by using periods of self censorship, searching by proxy
(usually through other friends who had already successfully gone through cancer
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treatment) or actively not seeking information. These actions prevent opportunities to
experience negative information, which may have threatened their hopes. Hopes are
beliefs concerning future outcomes in this study hope maintained the illusion of a
positive outcome that the participants were seeking. These illusions of a positive nature
can be powerful coping strategies in a time of immense stress (Houldin and Lewis,
2006).
The experience of resilience for participants in this study appeared to be a “light
bulb” moment or an awakening from one stage to another that was embroiled in
structure, treatment burden, treatment routine and passive acceptance and a transition to
the next stage of life. To move into the new stage, participants were carefully and
intuitively selecting information and support that met their criteria to maintain a realistic
but positive future. The participants in this study were within the first three months of
completion of chemotherapy but were already displaying some characteristics of
hardiness and benefit finding.

The experience of empowerment
Traditionally when diagnosed with cancer and becoming a cancer patient an
individual takes on a passive role as a recipient of health care from experts. Kvale and
Bondevik (2008) found that whilst some patients had a strong desire for information and
involvement in decision making other patients wanted to be informed about their
disease and treatment but preferred the doctor to make the decisions. Salmon and Hall,
(2004) postulated that information giving was a strategy to build relationships and
maintain hope rather than as a basis for decision making about treatment. At the time of
diagnosis there is often an inequality in the relationship between patients and health
professionals, patients self determination at this stage can be enhanced or impeded by
the professionals who are involved in their care. Empowerment is defined as a process
that promotes individual mastery and control over one’s life and decisions that affect his
or her life, information is essential for patients to feel empowered and gain control
(Anderson and Funnell, 2010; Buffum, 2004; Bulsara, Ward and Joske, 2004; Kvale
and Bondevik, 2008; Mok, 2001). These sentiments appear to be a sensible and
reasonable approach to promoting patient empowerment, however in the discussion to
follow the complexity related to information sharing will be discussed further.
The participants in this study identified several stages that occurred in their
empowerment journey which included: self awareness; seeking support; self protection;
self informing; and self management. Self awareness appears to emerge as energy
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levels begin to return; the person begins to reflect on the more passive role they have
taken as a patient when going through treatment and their expectation that it is now their
responsibility to become more pro active. Self awareness therefore for these participants
appeared to represent their understanding and expectations of actions and
responsibilities as the person with cancer. Participants were able to identify and enjoy
positive outcomes such as improved self care in the form of assertiveness or health
awareness.
In the early stages some participants did seek support from others, however they
were very careful who they chose to gain support from. This action was very much
about self protection; the participants were conscious of the consequences of sharing
their feelings with others, health care professionals or someone not too closely
connected were the favoured resource at this time. This behaviour has been described in
other studies. Byrne, Ellershaw, Holcombe and Salmon (2002) found in their
qualitative study that nearly all patients (n=28) interviewed described the importance of
concealing distress and unhappiness from others. Patients in this study anticipated that
the displaying of emotion would be catastrophic, the main reason patients had for this
concealment was to protect other people, or to avoiding upsetting, displeasing or
embarrassing others.
Whilst the participants in the current study did not wish to upset their friends
and family, there was a strong self protective method in their approach as they were
indirectly protecting themselves from exposure to more negative emotions. The self
protecting strategies that participants intuitively adopted and described in their
interviews were very much aimed at maintaining their hope and therefore positive
outlook. Any potential for negative feedback was avoided whether that was support
groups, individuals or written information. This behaviour was consistent with findings
by Leydon et al. (2000), who described how patients often stopped information seeking
at different times in their cancer journey because they were fearful of contradictory
information. This self censorship functioned to preserve hope and avoid negative
information thus helping to manage their fears. The participants were adept at hiding
their feelings to maintain this façade of positive emotion, often using humour or
storytelling to cover distress for others behaviours of avoidance and distraction helped
to maintain the approach.
Patients recognised empowerment being displayed when they were respected,
listened to, valued and given honest information. These actions not only increased their
self worth, they also gave participants a sense of control (Kvale and Bondevik, 2008).
92

Encouraging self management and patient autonomy have been identified as important
aspects of patient care (Jefford, et al., 2011; Karahalios, et al., 2007). Self management
and self monitoring enabled the participants to assess their progress and set new goals,
this positive and forward looking process strives towards improvement and maintains
the positive approach. The constant evaluation and resetting of goals was discussed
particularly in relation to fatigue-related limitations; this appeared to be the most
frustrating symptom to monitor and assess because the participants had no prior
knowledge of the recovery trajectory, but had expectations based on prior experiences
of fatigue with flu related illnesses for example.
The study participants were very clear that this knowledge deficit affected their
ability to cope and also highlighted their need for honest information, so that they could
set realistic goals. At this stage participants were keen to learn from and listen to other
survivors who understood their journey and needs. As the participants travelled further
along the transition continuum their information needs changed and focused much more
on the future, such as understanding the future management plan or planning future
lifestyle goals and less on the individual treatment side effects. The participants in this
study displayed an array of self informing skills that were delicately interlinked with
their self protection and self management needs for the longer term. This enabled the
survivors to continue towards their new normal with appropriate knowledge which
didn’t threaten their coping skills and facilitated the maintenance of a positive outlook.
There is evidence to suggest that self management strategies are beneficial for patients
as they transition from primary treatment to life after cancer, understand the signs and
symptoms of disease recurrence, manage long term side effects of cancer and its
treatments and re establish normal routines.
The experiences and wishes of the survivors in this study appeared consistent
with other studies. Hindle (2010) stated that survivors wanted; support and information,
to be empowered to take as much control as they wished, to be able to cope with life
after cancer and to get their relationships back on track. Information needs have been
constantly highlighted in the literature; the demand for better information in the post
treatment phase includes subjects such as post treatment care, physical activity, help
with everyday problems, and what measure to take to help them function better
physically and emotionally (Karahalios, et al., 2007; Saegrov and Lorensen, 2006;
Sanson-Fisher et al., 2000).
In summary, the major themes identified and described by survivors at this time
of transition were: the experience of loss, the experience of changing emotions, the
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experience of resilience and the experiences relating to empowerment. These themes
have been discussed in relation to current available literature and identified congruence
between the current study and available knowledge as well as gaps that this study
begins to address. The factors which were identified as having improved or exacerbated
the transition experience were intricately interwoven throughout this phase. Hope was
the overarching positive determinant which improved the survivors’ transition through
this time, whilst an information limitation was identified as the overarching
exacerbating factor. However, as discussed in the discussion, achieving stability
between hope and information is a complex challenge that must be survivor-led,
accessible, negotiable and achievable.

Phase Two: quantitative phase (Instrument development and testing)
Introduction
As previously discussed the aim of this phase of the research was to develop an
instrument which could be used to explore the needs of a large population of cancer
survivors as they transitioned from chemotherapy treatment to life after cancer. Rather
than develop a new instrument, the decision was made to adapt the Quality of LifeCancer Survivor (QOL-CS) tool as it comprises many items that were consistent with
the key descriptors identified from the qualitative interviews conducted in this study.
Given the universal acceptance and current use of this tool, as well as the relevance of
many of the items to the population of interest in this study, the researcher opted to
make a minor adaptation to this instrument by adding seven additional items designed to
capture the full scope of key descriptors (needs) identified from the qualitative phase of
this study.
The main identifiable distinctions between the items in the QOL-CS and the
findings in Phase One of this study were in relation to information needs. Therefore the
original questions in the instrument remained relevant and were not modified in any
way. Seven additional items were added to reflect the key areas identified in relation to
information seeking and deficits. These items were added to a new section titled,
Information needs at the end of chemotherapy treatment.
The additional questions were:
•

Did you receive enough information about physical changes at the end of
chemotherapy treatment?

•

Do you understand everything that happened to you during treatment?

•

Do you understand your plan of care from now on, including timeframes?
94

•

Have you tried to find information from other places? (i.e. cancer council,
internet, friends)

•

Were you provided with any written information about life after chemotherapy?

•

If you were provided with information, was it useful?

•

Have you been able to make any plans for your future?

The title of the original instrument was changed from the Quality of LifeCancer Survivors (QOL-CS) to the Quality of Life- Chemotherapy Cancer Survivors
(QOL-CCS).
The QOL-CCS was then tested by an expert panel of six chemotherapy nurses
for clarity, apparent internal consistency and content validity. Expert panel members
were recruited from the same tertiary centre as the participants in Phase One. Each
panel member met the criteria that had previously been considered to ensure their
expertise and therefore suitability to undertake the psychometric testing of the adapted
instrument QOL-CCS. This process resulted in tiredness being added after the word
fatigue in question one, diarrhoea, vomiting, menstrual changes and fertility all being
developed into individual questions within the physical well being section. Question 25
changed from depression to emotional distress in an attempt to remove a medical
diagnostic term and a word which carries a stigma in wider society.
The changes and suggestions identified by the expert panel are in part due to
language changes or the awareness of language. It is now 17 years since the original
tool was devised and during this time there has been a rapid rise in awareness of
information provision in language that is acceptable to patients (Jefford, et al., 2007).
Furthermore, there have been rapid advances in chemotherapy treatments in the past 17
years; physical side effect profiles have changed considerably, anticipatory nausea and
vomiting once a constant research and publication topic is now minimal due to the
introduction of highly effective anti-emetics changing the emesis profile of
chemotherapy side effects (Sharma, Tobin, and Clarke, 2005). Likewise, diarrhoea is
now recognised much more commonly as a chemotherapy side effect with the
introduction of new chemotherapy agents (Richardson and Dobish, 2007). The changes
that were recommended are therefore much more a reflection of physical changes
related to treatment. The domains of psychological, social and spiritual apart from a
slight language change as discussed appear to remain as relevant today as they were 17
years ago. In addition the newly added items based on feedback from in Phase One
received no comments or scores less than 100%.
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Summary
Overall the preliminary assessment of clarity, content validity and internal
consistency was successfully achieved in keeping with the original purpose of this
Master’s study. The researcher plans a more comprehensive psychometric assessment of
the QOL-CCS in future phases, as detailed in the summary of Chapter Five. Once the
QOL-CCS has been validated it is anticipated it will be used for a much larger scale
study with survivors in the first three months as they transition from chemotherapy to
life after cancer. The findings of this larger population of survivors will then contribute
to the care planning and information sharing that is currently delivered with a limited
evidence base.

Limitations and Strengths
Limitations
The researcher acknowledges a number of limitations to this study. The first is
the extent to which the findings of Phase One can be generalised to the wider
survivorship community with any degree of certainty. Results from a population of 14
participants from one tertiary treatment centre cannot represent the many thousands of
cancer survivors currently living in Australia.
Second, one third of the participants had the same haematological diagnosis of
myeloma. The potential differences in needs between haematology and medical
oncology patients were considered and discussed with the Director of Haematology
prior to commencing the study. As the focus of the research was on patient needs in the
immediate post chemotherapy treatment period it was considered appropriate to include
both groups of patients to provide a baseline of information related to the immediate
impact of chemotherapy treatment.
Third, the expert panel currently work in the same cancer centre and whilst this provides
congruence to this study, it is not possible to be reflective of the many thousands of
cancer health professionals practicing in Australia. In addition the panel were all from
the same discipline of nursing. This may have been strengthened by the addition of a
medical oncologist and haematologist. Finally, the scope ofthis study was limited by
the time available for completion of a Master’s research project.
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Strengths
All the interviews and analysis were undertaken by the same researcher who was
able to reflect not only the words, but the passions and inferences which were applied to
the conversations. This ensured that a consistent approach of interpretation occurred
across all 14 interviews. There is a high level of academic and clinical interest in the
field of cancer survivorship, particularly within Australia. This study has provided a
strong basis for a future program of research with an instrument that is ready to be
utilised immediately. This will provide opportunities for study findings to be useful and
clinically relevant in the very near future.

Conclusion
This study intended to explore and describe the experiences in transition from
the completion of chemotherapy to life as a cancer survivor. The aims for Phase One
and Phase Two of this study were achieved. Specifically, the experiences following the
completion of chemotherapy have been themed following analysis using Grounded
Theory to a descriptive level. These identified themes have been the key to adaptating
and testing an instrument which is now considered ready for piloting in a large
population of cancer survivors. The identified themes have been explored in the wider
literature and whilst elements have demonstrated synergy, there has also been a
demonstrated lack of research related to this cohort of cancer survivors at this particular
time of transition. The development of the adapted instrument QOL-CCS will add to the
current body of research evidence and provide a basis for a larger population study and
the shaping of future cancer survivorship care delivery based upon its findings. The
findings from Phase One provide a strong base on which chemotherapy nurses can
begin to question the role that they play in preparing cancer patients for life after
chemotherapy, particularly regarding the provision of information and resources which
assist self-management.
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Recommendations
Research
•

The key recommendation from this study is build on this work by conducting a
follow-up study to explore the psychometric properties of the revised QOL-CCS
tool, followed by implementation of the tool in a large scale study of this
population across all tertiary chemotherapy services in Western Australia.

•

Once there is a more comprehensive understanding of this populations’ needs at
this particular time, then further research and developments would be warranted.

•

The development and testing of delivery methods to facilitate self management
of survivorship issues is also recommended.

Education
•

The development of appropriate information materials such as pamphlets, DVD’s
web resources and methods of dissemination to reach all survivors in a timely
manner.

•

The introduction of transition education sessions to patients during the last two
weeks of chemotherapy treatments and to chemotherapy nurses to further reinforce
the information.

Clinical
•

The development of peer led survivorship clinics,

•

The introduction of psychosocial ‘drop in’ clinics where survivors could seek
council from allied health, social work and legal teams regarding financial, social or
psychological issues,

•

The development of nurse-led clinics for patients post chemotherapy across a
continuum from tertiary centres to practice nurses in primary care,

•

The development of shared cared models immediately post chemotherapy between
specialists and primary care.
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Appendix A: Invitation letter to participant
Opt out form
Participant information sheet
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9th April 2010
Dear Participants name
We are writing to ask if you would be willing to be contacted about a project
“Issues and concerns after completing chemotherapy” for which we hope to recruit
suitable patients from this hospital. From our records you would appear to be a potential
participant for this study.
We would like to improve the amount and type of information that we provide to people
when they complete chemotherapy treatment. In order to understand how we can make
these improvements we are conducting a research study which involves an interview by
telephone. We would like to interview people who have completed chemotherapy
within the last 1-4 months.
If you do not wish to hear more about this study, or be contacted further, could you
please complete the attached slip and return in the envelope provided. If we do not hear
from you within 3 weeks we will assume that you are willing to be contacted and Violet
Platt will contact you shortly after this to give you more information regarding the
study.
We have included an information sheet which provides further information about this
study. If you are happy to be included or wish to discuss this further you do not need to
do anything. You will be contacted during the week beginning 3rd May 2010 to discuss
this further.
Whether or not you participate in this project, any future care you receive at this
hospital will not be affected in any way.
This study has been approved by Sir Charles Gairdner Hospital and Edith Cowan
University Ethics Committees and the confidentiality of all participants is assured.
Thanks for considering this request
Yours Sincerely
Violet Platt
Director of Nursing
WACPCN

Tina Crosbie
Haematology CNS
SCGH
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PLEASE TICK THE BOX, THEN SIGN, DATE AND RETURN THE SLIP IN
THE ENVELOPE PROVIDED.

 Please do not contact me regarding my participation in the Study “Issues and
concerns after completing chemotherapy treatment”

Name: Participants name

Signature:……………………………………….

Date :……………………………………………
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Sir Charles Gairdner Hospital
PA RT I C I PA N T

I N F O R M AT I ON S H E E T

Lay Title
What are the needs of people in the first 3 months following the completion of
chemotherapy?
Title of Study
Survivorship issues following completion of chemotherapy.
Investigator’s Names
Mrs Violet Platt
A/Professor Leanne Monterosso
Ms Christina Crosbie
Please take time to read the following information carefully and discuss it with your
friends, family and general practitioner if you wish. Ask us any question if some part of
the information is not clear to you or if you would like more information. Please do this
before you sign this consent form.
Who is funding this study?
This is a study for a Master in Research Nursing at Edith Cowan University. The study
is funded by the student Mrs Violet Platt undertaking the research, and the School of
Nursing, Midwifery and Postgraduate Medicine.
Contact persons:
Should you have questions about the study you may contact:
Mrs Violet Platt Phone No

0439 512 903

(after hours)

0439 512 903

All study participants will be provided with a copy of the Information Sheet and Consent
Form for their personal records.
You may decide to be in the study or not take part at all. If you do decide to take part in
this study, you may stop at any time. However, before you decide, it is important that
you understand why this research is being done and what it will involve.
Whatever your decision, this decision will not lead to any penalty or affect your regular
medical care or any benefit to which you are otherwise entitled.
The following information sheet will explain the study and will include details such
as:
o Why this study might be suitable for you;
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o The nature of your participation including how many visits you will make to the
hospital
o Your rights and responsibilities
What is the purpose of the study?
This study will identify if there are common issues experienced by people when they
complete chemotherapy treatment following a diagnosis of cancer, and whether the
hospital team have provided appropriate information to deal with any issues that may
arise. The study will take place at Sir Charles Gairdner Hospital in the medical
oncology department. We will be inviting up to 24 people who are completing a
minimum of four cycles of chemotherapy and have no further cancer treatment planned.
Why is this study suitable to me?
This study is suitable for patients with cancer who have completed chemotherapy and
have no further cancer treatments planned.
How long will I be in this study?
This study will run over three months following the completion of your chemotherapy.
What will happen if I decide to be in this study?
If you decide to participate in this study, you will be given a small diary in which you
can jot down issues as they occur to help your remember them. This is not compulsory.
You will also be asked to complete a brief interview with the researcher (Violet Platt)
12 weeks after your last chemotherapy treatment and no more than 16 weeks after this
date. This will last no longer than 30-60 minutes and will take place by telephone at a
time convenient to you. This interview will be audio taped and transcribed (typed into a
written document) which will not contain any personal identifying information. The
recording will then be destroyed.
The interviewer will ask questions about:
• Your overall quality of life in the weeks since completion of treatment, if any issues
or side effects caused you trouble and if any further information could have been
provided to support you during this time.
Personal details such as your age, gender, type of cancer, type of cancer treatment and
when you commenced treatment will have been recorded at the time you agreed to be a
part of the trial.
Your involvement in the study will cease following the telephone interview.
Are there any reasons I should not be in this study?
No
What are the costs to me?
No personal costs will be incurred.
What are the possible benefits of taking part?
We wish to discover if we are preparing people properly for moving back into life after
cancer treatment. We hope to discover the issues that affect the quality of life in people
who have received cancer chemotherapy in order to improve the way we care for, and
prepare individuals more appropriately in the future.
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How will my safety be ensured?
Taking part in this study will not affect your personal safety.
What alternatives do I have to going on this study?
You may choose not to be a part of this study. This will not affect the current care you
are receiving.
What are the possible side effects, risks and discomforts of taking part?
None.
What if new information comes along during the study?
Sometimes new information about treatments becomes available as a study progresses.
You will be told about any information that could be important to your decision to
continue in the study. If you then want to continue in the study, you may be asked to
sign a revised consent form.
Stopping study treatment early:
Sometimes a study needs to be stopped early due to unforeseen circumstances. If this
occurs the reasons will be explained to you.
What happens if I change my mind after I have done the interview and wish to
withdraw from the study?
If you decide to withdraw from the study after your interview, then simply inform the
researcher and your interview will be deleted and all related information will be
destroyed, none of your information will be used in the study.
What happens at the end of the study?
At the end of the study you will continue with your cancer care follow up plan as per
normal department follow up.
What if something goes wrong?
In the unlikely event you experience any emotional distress during the interview, it will
be stopped immediately. If you need to be referred to a health professional for
emotional support, the research assistant will ensure this occurs as soon as possible.
This treatment will be provided at no cost to you.
Your participation in this study does not prejudice any right to compensation which you
may have under statute or common law.
Will my taking part in this study be kept confidential?
The researchers will need to collect personal data about you, which may be sensitive
(e.g. date of birth and relevant health information). The researchers may also need to get
some of your health information form your medical records.
Any personal or health information will be kept private and confidential. It will be
stored securely and only authorised persons, who understand it must be kept
confidential, will have access to it. Your study details will be given a number so that
your identity will not be apparent. The study records will be kept in a locked filing
cabinet in the office of the Research supervisor at Edith Cowan University during the
study and in a locked archive for at least 5 years from the time the study is closed, and
will be destroyed at any time thereafter.
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Authorised representatives of the study funders, the investigators, the Hospital Human
Research Ethics and Research Governance Committees may require access to your
study records to verify study procedures and/or data. In all cases when dealing with
your information, these people are required to comply with privacy laws that protect
you.
Will I find out the results of the study?
You will be sent a summary of the findings from this study. The result of the research
will be made available to health professionals through medical journals or meetings, but
you will not be identifiable in these communications. By taking part in this study you
agree not to restrict the use of any data even if you withdraw. Your rights under any
applicable data protection laws are not affected.
Who has reviewed the study?
The Human Research Ethics Committee of Sir Charles Gairdner Hospital has reviewed
this study and given approval for the conduct of this research trial. If you have any
ethical concerns regarding the study you can contact the secretary of the Sir Charles
Gairdner Hospital Human Research Ethics Committee on telephone number (08)
93462999. The study is also approved by the Curtin University of Technology Human
Research Ethics Committee (Approval Number HR 73/2008). If needed, verification of
approval can be obtained from either by writing to the Curtin University Human Ethics
Committee, c/o Office of Research and Development, Curtin University of Technology,
GPO Box U1987, Perth, 6845 or by telephoning 9266 2784 or by emailing
hrec@curtin.edu.au. This study is also approved by Edith Cowan University Human
research Ethics Committee c/o Research Ethics Office, Edith Cowan University, 270
Joondalup Drive, Joondalup, WA 6027 or by telephoning 6304 2170 or by emailing
research.ethics@ecu.edu.au
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CONSENT FORM

Survivorship issues following completion of chemotherapy

Investigators:
Mrs Violet Platt,
Ms Christine Crosbie,
A/Professor Leanne Monterosso
Participant Name:_________________________________________
Date of Birth: _______________
1. I have been given clear information (verbal and written) about this study and have
been given time to consider whether I want to take part.
2. I have been told about the possible advantages and risks of taking part in the study
and I understand what I am being asked to do.
3. I have been able to have a member of my family or a friend with me while I was
told about the study. I have been able to ask questions and all questions have been
answered satisfactorily.
4. I know that I do not have to take part in the study and that I can withdraw at any
time during the study without affecting my future medical care. My participation in
the study does not affect any right to compensation, which I may have under statute
or common law.
5. I agree to take part in this research study and for the data obtained to be published
provided my name or other identifying information is not used.
If you are unclear about anything you have read in the Participant Information
Sheet or this Consent Form, please speak to your doctor before signing this
Consent Form.

Name of Participant
Date

Name of Investigator
Date

Signature of Participant

Signature of Investigator

The Sir Charles Gairdner Hospital Human Research Ethics Committee has given ethics
approval for the conduct of this project. If you have any ethical concerns regarding the
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study you can contact the secretary of the Sir Charles Gairdner Hospital Human
Research Ethics Committee on telephone number (08) 93462999
All study participants will be provided with a copy of the Information Sheet and
Consent Form for their personal records.
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Appendix B: Interview questions
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Welcome
• Ensure interviewee is comfortable, needs are met, drinks etc.
• Confirm interviewee is comfortable with the purpose and process around the
interview and happy for this to be recorded.
Opening Question
How have the last 3 months been for you since completing treatment?
• Opening, question to set the scene and relax the person
Main questioning
1. Can you tell me about any side effects that you may have experienced?
Prompts:
Nausea & Vomiting
Sore mouth – eating & drinking
Constipation or diarrhoea
Fatigue / tiredness
Altered sleep patterns
Pain
Any other symptoms
2. How has it been for you in settling back into your life as it was before your cancer
treatment?
Prompts:
Has anything been difficult?
Work
Family expectations
Friends
3. How have you been feeling in the last (12) weeks?
Prompts:
Tearful
Glad to be alive
Anxiety about treatment success
4. Can you tell me about the information & support that you received?
Prompts
What else would you have liked to know?
How and when would you like to know this?
5. Would you like to tell me about any support from GPs or hospital staff that you may
have received?
6. Is there anything else that you would like to tell me about this time?
Finish with another thank you
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Appendix C: Transcriber confidentiality form
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(ECU Letterhead)
Transcriber Confidentiality Agreement Form
Applicants name:

As an employee of the research title …
I certify that I have read the sections of this document regarding the legislation and
policies of the National Health & Medical Research council (NHMRC) and Edith
Cowan University (“the University”) that govern access to and use of participant and
employee personal information.
I acknowledge that I have been instructed regarding the confidentiality of the project’s
activity and records, and except as required by law in the course of my duties or where
instructed in writing by management, I am aware that all project raw data records, files
and memoranda are to be treated in strict confidence.
I agree to keep project information confidential by observing the following:
• I will comply with the legislation, the policies of the NHMRC and the
University that govern access to and use of information contained in employee
and participant records and raw data and other university documents or systems.
•

I will make a reasonable effort to access only the information/ data that is
relevant and necessary for me to perform my duties for the project.

•

I will be a responsible user of the information/data, whether it relates to my own
project or other projects, by adhering to the University’s rule of conduct
whenever I use E-mails, handle files, and answer, telephone or fax queries.

•

I will restrict access by others to any confidential information and/or data that I
obtain, by following the University and the NHMRC policies regarding the
storage of information and data under secure conditions.

•

Before sharing information/data with others, electronically or otherwise, I will
exercise reasonable care to ensure that the recipient is authorized to receive that
information/ and understands his/her responsibilities as a receiver of this
information/data.

•

When sharing information with appropriately authorized personnel, I will ensure
that I am in a private setting where others cannot hear, see or otherwise unduly
access the confidential information.

•

I will make every reasonable effort to interpret the information/data I obtain in
an accurate, accountable, ethical and professional manner.

•

I will use information/data that I obtain only for tasks specifically related to the
project I have been employed under.

•

I will log-off or secure any computer system that contains participant and/or
employee information/data when I am not actively using it. (Securing the
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information/data is considered to occur through the use of
screen saver)

password-protected

•

I will keep any password(s) issued to me, ore devised by myself, confidential
and will not disclose them to others unless my immediate supervisor authorizes
such disclosure in writing.

•

When working on my home computer, I will password protect any project
information/data to ensure that there is no inappropriate access.

•

I will not disseminate project information/data from my home computer without
appropriate authorization from my supervisor for the release.

•

I will dispose of confidential information/data when I have finished using them
in a manner that will preserve the documents confidentiality (e.g. in accordance
with ethics form requirements (where applicable) or NHMRC and/or University
policies, which ever is the most stringent.)

•

I understand that audits might be conducted on the project, such as financial
telephone or E-mail usage, records, etc. and I acknowledge that I am required to
ensure compliance with these audits.

•

I understand that this confidentially agreement will remain in force until my
employment on this project is terminated (either voluntary or involuntary)

•

I understand that my employer has the right to take disciplinary action up to and
including my termination of my employment for breaches of confidentiality.

Signature ---------------------------------------------------------------------------------Date -----------------------------------Witness -----------------------------------------------------------------------------------Date ------------------------------------
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Appendix D: Open and axial codes identified.
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2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46

Level 1 Codes
1.Different phases
Looking ahead to the future
Positive approach to finishing chemotherapy
Planning for the future
During chemotherapy / thinking time
Rewards at the end of treatment
Lots of support whilst on chemotherapy
Transition to non treatment
On a journey
Changes to work status
Need to change from being a patient
‘new life’
Transition behavior
Unexpected feelings
Depression
Emotional feeling deflated
Glad its over – relief
Enjoying all the little things
Wants to celebrate
Pressure to be different and happy
Afterwards need emotional support – feel
vulnerable
Detox after chemotherapy
Psychological – residual chemotherapy
Enjoys meeting/ talking to others
Get energy back and boost mood
Exciting to get energy back
Unforeseen upsetting moments
Disruption to life after treatment
Surprising – a challenge
Time after treatment
Later months physically stronger
Four months, physically well, look normal
On treatment no energy and lots of time
After treatment lots of time, not well enough
Physically weak in the first few weeks
During treatment – don’t feel like a victim
Lack of structure not in a cycle
Not having treatment, loss of identity
After chemotherapy, isolation, not being cared for
Loss of friendships
Not belonging
Out patient and the system has finished with you
Finances
Tired
Hair growth, eyebrows and alopecia
Constipation
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Level 2
Planning

chemotherapy

Transition

Emotion

Time

Patient role / time
Loss of patient structure
Loss of patient identity
Loss
Role change and loss
Finances

47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82

Nausea
Mouth care
Too tired to work
Body stiffness / moving pains
Don’t look different/ what others think
Treated normally by others
People are kind during treatment
Miss the amazing conversations
Key people ie psychologist
Can’t avoid the feelings
Everyone goes through a crisis
In a different place, not identifying with other
survivors
Sense of community- ‘looking for belonging’
Tolerance
Altered expectations
Cant return to normal/ feel different after treatment
Wants to meet other survivors without recurrence
Worry about recurrence
Wishful use of skills
Reality of finances/ part time to exist
Opportunities based on importance/ community
benefit
Wishful thoughts versus reality
Need to find balance between stress, energy and
priorities
Questioning future directions and work role
Making a commitment & ‘re-engaging’
Getting on with it / keeping active
Attitude/ approach important
Assist ‘ long term benefit
Feeling a bit lost, where to from here?
Information timing and booklets
Identify community support
Doesn’t know what’s normal follow up
Started smoking – rebelling
Feeling virtuous – making health choices
Coping mechanism – old behaviour
Feelings about self
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Physical

People and others
expectations

Normalizing

Different

Recurrence/ avoidance
Recurrence

Re evaluate

Values and attitude

Information

Taking control, making
choices

Appendix E: How the codes developed to themes
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Appendix F: Example of memo showing trail from codes to the themes
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Example of a memo showing open data exploration from which open codes were
identified.
Date: June 17th 2011

Properties and dimensions of the survivorship experience relating to feeling different.

“Initially I was quite excited to finish chemo and really looking forward to that, wishful
thinking. You know, all the things that you are going to do. So I suppose having had
chemo I spent a lot of time thinking of the resolutions if you like of things I was going
to do. But I was actually quite surprised I went to see a psychologist at the same time to
kind of pre-empt the transition back into non treatment and I was really surprised how
depressed I got and how emotional I became probably about a month after treatment
[stopped]. Talking to the psychologist, she said its actually quite common and was quite
relieved to see me upset, its quite common because people don’t have a structure
anymore. And I think I felt like I had landed back on earth but in a foreign country, if
that makes sense, just the sense that I cant just re join the flock again and carry on as
before.”

Quote from interview with survivor (S04)

Memo

This women is describing her experiences of how different or changed she feels
following her diagnosis and treatment for cancer. The description is from her
perspective, in the description she describes the properties of anticipation, planning,
expectation, excitement, distraction, rewarding, surprise, low mood, mixed emotions,
unexpected emotions, normalising, validation from others, not belonging.
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Appendix G : Permission to utitlise Quality of Life – Cancer Survivor Tool
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From: BFerrell
> To: violet platt
> Date: Fri, 23 Mar 2012 06:38:08 -0700
> Subject: Re: Quality of life patient/ cancer survivor version
>
> You are welcome to use and adapt any of our instruments. All are on our website
http://prc.coh.org.
>
> Good luck with your research.
> Betty Ferrell
>
> ----- Original Message ----> From: violet platt
> Sent: Friday, March 23, 2012 06:30 AM
> To: Ferrell, Betty
> Subject: Quality of life patient/ cancer survivor version
>
> Dear Dr Ferrell

> > I understand that you and Marcia Grant have been very generous in allowing duplication of
the Quality of Life cancer survivor version tool. I would like to request permission to add some
questions (7 in total to the tool) regarding information needs in this phase?
> > I have recently been under taking a Masters degree in nursing research, I am especially
interested in survivors as they transition from chemotherapy treatment to life after cancer. As
an oncology nurse I have found that myself and my team all have a different set of, end of
treatment 'pep' talks based on our different experiences. Therefore my research set out to
understand the patients experiences. I performed 14 interviews and identified a range of
themes all of which harmonise very well with your tool.
> > As my interest is in ensuring that as chemotherapy nurses we prepare people in the most
effective way, I would like to use your tool and add some information questions which will go
through all the required psychometric testing before utilising with a larger population. I will fully
acknowledge all of the great work that has been happening in City of Hope over the years
which has been highly inspirational to me and I am more than happy to share my thesis (once
marked) with your team, as a small contribution to your vast works.
> > Many Thanks for your consideration of this request
> Kindest Regards
> Violet Platt
> > Director of Nursing > WA Cancer and Palliative Care Network, Western Australia
>
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Appendix H Tools utilised by the expert panel to assess clarity, internal consistency,
content validity.
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CLARITY

Instructions

This survey is based on a previous work by Ferrell et al. (1995). The original survey
was designed to find out more about the long term quality of life issues of cancer
survivors. I am interested in the issues for cancer survivors in the short term period up
to 6 months after they complete chemotherapy. I have modified this survey to ensure
that questions are relevant to cancer survivors as they transition from completion of
chemotherapy. These modifications have been made based on the findings of qualitative
interviews with cancer survivors who had recently completed chemotherapy. You are
being asked to rate: (a) the instructions in the survey, and (b) each question in the
survey on it’s clarity since you are familiar with this content.

(a) Are the survey instructions clear? Circle either yes or no on the next line.
YES

NO

(b) Read each question in the survey separately and respond to the same number on the
response sheet. Beside each question number on the response sheet circle C (clear)
or U (unclear) to indicate whether the question is clear or unclear to you.

After you finish you may wish discuss your comments with the researcher.

Thankyou for your assistance.
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Code ____
RESPONSE SHEET: CLARITY
Please indicate whether each question is C (clear) or U (unclear) to you.

Circle One

Comments

Physical Well Being
1.

C

U

________________________________________________________
2.

C

U

________________________________________________________
3.

C

U

________________________________________________________
4.

C

U

________________________________________________________
5.

C

U

________________________________________________________
6.

C

U

________________________________________________________
7.

C

U

________________________________________________________
8.

C

U

________________________________________________________
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Psychological Well Being
9.

C

U

________________________________________________________
10.

C

U

________________________________________________________
11.

C

U

________________________________________________________
12

C

U

________________________________________________________
13.

C

U

________________________________________________________
14.

C

U

________________________________________________________
15.

C

U

________________________________________________________
16.

C

U

________________________________________________________
17.

C

U

________________________________________________________
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How distressing were the following aspects of your illness and treatment?
18

C

U

________________________________________________________
19.

C

U

________________________________________________________
20.

C

U

________________________________________________________
21.

C
U
______________________________________________________

22.

C

U

________________________________________________________
To what extend are you fearful of:
23.

C

U

________________________________________________________
24.

C

U

________________________________________________________
25.

C

U

________________________________________________________
26.

C

U

________________________________________________________
Social Concerns
27.

C

U

________________________________________________________
28.

C

U

________________________________________________________
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29.

C

U

________________________________________________________
30.

C

U

________________________________________________________
31.

C

U

________________________________________________________
32.

C

U

________________________________________________________
33

C

U

________________________________________________________
34.

C

U

________________________________________________________
Spiritual Well Being
35.

C

U

________________________________________________________
36.

C

U

________________________________________________________
37.

C

U

________________________________________________________
38.

C

U

________________________________________________________
39

C

U

________________________________________________________
40.

C

U

________________________________________________________
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41.

C

U

________________________________________________________
42.

C
U
______________________________________________________

Information needs at the end of chemotherapy treatment
43.

C

U

________________________________________________________
44.

C

U

________________________________________________________
45.

C

U

________________________________________________________
46.

C

U

________________________________________________________
47.

C

U

________________________________________________________
48.

C

U

________________________________________________________
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CONSISTENCY

Instructions

In this section, you are being asked to look at the questions in the survey and decide if
you think they seem to belong together.

Read the entire survey first. After you finish reading the survey, answer question (a) at
the top of the Response Sheet, then answer the following question (b) for each question
in the survey. Answer by circling the response you choose under question (b). Add any
comments you wish to explain your answers.

Thankyou for your assistance.
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Code ____
RESPONSE SHEET: CONSISTENCY
(a) Do these questions generally belong together?
YES

NO

(b) Does each question belong in the survey?
Please circle

Comments

1.

Y

N

_____________________________________________

2.

Y

N

_____________________________________________

3.

Y

N

_____________________________________________

4.

Y

N

_____________________________________________

5.

Y

N

_____________________________________________

6.

Y

N

_____________________________________________

7.

Y

N

_____________________________________________

8.

Y

N

_____________________________________________

9.

Y

N

_____________________________________________

10.

Y

N

_____________________________________________

11.

Y

N

_____________________________________________

12.

Y

N

_____________________________________________

13.

Y

N

_____________________________________________

14.

Y

N

_____________________________________________

15.

Y

N

_____________________________________________

16.

Y

N

_____________________________________________

17.

Y

N

_____________________________________________

18.

Y

N

_____________________________________________

19.

Y

N

_____________________________________________

20.

Y

N

_____________________________________________

21.

Y

N

_____________________________________________
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22.

Y

N

_____________________________________________

23.

Y

N

_____________________________________________

24.

Y

N

_____________________________________________

25.

Y

N

_____________________________________________

26.

Y

N

_____________________________________________

27.

Y

N

_____________________________________________

28.

Y

N

_____________________________________________

29.

Y

N

_____________________________________________

30.

Y

N

_____________________________________________

31.

Y

N

_____________________________________________

32.

Y

N

_____________________________________________

33.

Y

N

_____________________________________________

34.

Y

N

_____________________________________________

35.

Y

N

_____________________________________________

36.

Y

N

_____________________________________________

37.

Y

N

_____________________________________________

38.

Y

N

_____________________________________________

39.

Y

N

_____________________________________________

40.

Y

N

_____________________________________________

41.

Y

N

_____________________________________________

42.

Y

N

_____________________________________________

43.

Y

N

_____________________________________________

44.

Y

N

_____________________________________________

45.

Y

N

_____________________________________________

46.

Y

N

_____________________________________________

47.

Y

N

_____________________________________________

48.

Y

N

_____________________________________________
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CONTENT VALIDITY

Instructions

In this section, you are asked to look at the questions in the survey and decide if you
think they seem to belong together.

Read the entire survey first. After you finish reading the survey, answer question (a) at
the top of the response sheet – either YES or NO. Then answer question (b) for each
question in the survey. Answer by circling the response you choose under question (b) –
either Y (YES) or N (NO). Please add any relevant comments you wish to explain
your answers.

Thankyou for your assistance.
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Code ____
RESPONSE SHEET: CONTENT VALIDITY
Label: Quality of Life Chemotherapy Cancer Survivor Version
Definition: The survey is intended to measure the quality of life of cancer survivors as
they transition from completion of chemotherapy to life after cancer.
(a) In general, do the label and definition fit the whole set of questions in the survey?
Answer once for the whole survey by circling either YES or NO on next line.
YES

NO

(b) Does each question fit the label and definition? Please circle Y (YES) or N (NO).

Circle One
1.

Y

Comments

N

________________________________________________________
2.

Y

N

________________________________________________________
3.

Y

N

________________________________________________________
4.

Y

N

________________________________________________________
5.

Y

N

________________________________________________________
6.

Y

N

________________________________________________________
7.

Y

N

________________________________________________________
8.

Y

N

________________________________________________________
9.

Y

N

________________________________________________________
10.

Y

N

________________________________________________________
11.

Y

N

________________________________________________________
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12

Y

N

________________________________________________________
13.

Y

N

________________________________________________________
14.

Y

N

________________________________________________________
15.

Y

N

________________________________________________________
16.

Y

N

________________________________________________________
17.

Y

N

________________________________________________________
18

Y

N

________________________________________________________
19.

Y

N

________________________________________________________
20.

Y

N

________________________________________________________
21.

Y

N

________________________________________________________
22.

Y

N

________________________________________________________
23.

Y

N

________________________________________________________
24.

Y

N

________________________________________________________
25.

Y

N

________________________________________________________
26.

Y

N

________________________________________________________
27.

Y

N

________________________________________________________
28.

Y

N

________________________________________________________
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29.

Y

N

________________________________________________________
30.

Y

N

________________________________________________________
31.

Y

N

________________________________________________________
32.

Y

N

________________________________________________________
33

Y

N

________________________________________________________
34.

Y

N

________________________________________________________
35.

Y

N

________________________________________________________
36.

Y

N

________________________________________________________
37.

Y

N

________________________________________________________
38.

Y

N

________________________________________________________
39

Y

N

________________________________________________________
40.

Y

N

________________________________________________________
41.

Y

N

________________________________________________________
42.

Y

N

________________________________________________________
43.

Y

N

________________________________________________________
44.

Y

N

________________________________________________________
45.

Y

N

________________________________________________________
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46.

Y

N

________________________________________________________
47.

Y

N

________________________________________________________
48.

Y

N

________________________________________________________

Code ____
(c) Is the question unique, i.e. not repetitious? Please circle Y (YES) or N (NO).

Circle One
1.

Y

Comments

N

________________________________________________________
2.

Y

N

________________________________________________________
3.

Y

N

________________________________________________________
4.

Y

N

________________________________________________________
5.

Y

N

________________________________________________________
6.

Y

N

________________________________________________________
7.

Y

N

________________________________________________________
8.

Y

N

________________________________________________________
147

9.

Y

N

________________________________________________________
10.

Y

N

________________________________________________________
11.

Y

N

________________________________________________________
12

Y

N

________________________________________________________
13.

Y

N

________________________________________________________
14.

Y

N

________________________________________________________
15.

Y

N

________________________________________________________
16.

Y

N

________________________________________________________
17.

Y

N

________________________________________________________
18

Y

N

________________________________________________________
19.

Y

N

________________________________________________________
20.

Y

N

________________________________________________________
21.

Y

N

________________________________________________________
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22.

Y

N

________________________________________________________
23.

Y

N

________________________________________________________
24.

Y

N

________________________________________________________
25.

Y

N

________________________________________________________
26.

Y

N

________________________________________________________
27.

Y

N

________________________________________________________
28.

Y

N

________________________________________________________
29.

Y

N

________________________________________________________
30.

Y

N

________________________________________________________
31.

Y

N

________________________________________________________
32.

Y

N

________________________________________________________
33

Y

N

________________________________________________________
34.

Y

N

________________________________________________________
35.

Y

N

________________________________________________________
36.

Y

N

________________________________________________________
37.

Y

N

________________________________________________________
38.

Y

N

________________________________________________________
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39

Y

N

________________________________________________________
40.

Y

N

________________________________________________________
41.

Y

N

________________________________________________________
42.

Y

N

________________________________________________________
43.

Y

N

________________________________________________________
44.

Y

N

________________________________________________________
45.

Y

N

________________________________________________________
46.

Y

N

________________________________________________________
47.

Y

N

________________________________________________________
48.

Y

N

________________________________________________________

150

Code ____

(d) Are there any questions you think should be added to the survey?

______________________________________________________________________
______________________________________________________________________
_________
______________________________________________________________________
______________________________________________________________________
__________
______________________________________________________________________
______________________________________________________________________
__________
______________________________________________________________________
______________________________________________________________________
__________
______________________________________________________________________
______________________________________________________________________
__________
______________________________________________________________________
______________________________________________________________________
__________
______________________________________________________________________
______________________________________________________________________
__________
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Appendix I : Invitation letter to expert panel
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189 Royal Street
East Perth
WA 6004
23 -09-2011
Dear
I am writing to ask for your assistance with my Masters Research study. As an expert in
the field of cancer nursing and chemotherapy I would be grateful if you could review
the adapted survey Quality of Life Chemotherapy Cancer Survivor Version for
content validity, internal consistency and clarity the tools for this review are included.
The tool has been adapted from Ferrell et al (1995) Quality of Life cancer Survivor
Version which was developed for long term cancer survivors, the adaption’s that have
been made are as a result of findings from recent qualitative interviews that I have
undertaken with individuals who have completed chemotherapy within the previous 6
months.
The review should take approx 30 mins, I would be grateful if you could return your
reviews by Monday 3rd October 2011. If you would like a paper copy of this review
please let me know and I will arrange this
Thank you in anticipation
Kindest regards
Violet Platt

153

Appendix J: Original Quality of Life Cancer survivor tool
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